var title_f30_20_31040="Plantar ecchymosis";
var content_f30_20_31040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plantar ecchymosis sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 242px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ecchymosis along the plantar aspect of the midfoot is an important clinical finding in subtle Lisfranc tarsometatarsal injuries.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ross G, Cronin R, Hauzenblas J, Juliano P. Plantar ecchymosis sign: a clinical aid to diagnosis of occult Lisfranc tarsometatarsal injuries. J Orthop Trauma 1996; 10:119. Copyright &copy; 1996 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31040=[""].join("\n");
var outline_f30_20_31040=null;
var title_f30_20_31041="Pilocytic astrocytoma";
var content_f30_20_31041=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image of pilocytic astrocytoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal T1 post-contrast MRI of a pilocytic astrocytoma (large cystic mass with a mural nodule, arrow) in the posterior fossa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31041=[""].join("\n");
var outline_f30_20_31041=null;
var title_f30_20_31042="Gentamicin (topical): Pediatric drug information";
var content_f30_20_31042=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Gentamicin (topical): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=see_link\">",
"    see \"Gentamicin (topical): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/59/38835?source=see_link\">",
"    see \"Gentamicin (topical): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8107115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      PMS-Gentamicin;",
"     </li>",
"     <li>",
"      ratio-Gentamicin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10495066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Aminoglycoside",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Topical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10481296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=see_link\">",
"      see \"Gentamicin (topical): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Infants, Children, and Adults: Apply 3-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8107336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: 0.1% (15 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical: 0.1% (15 g, 30 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8107129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10481297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Apply a small amount gently to the cleansed affected area",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F13360197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10481292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Used to treat superficial infections of the skin including folliculitis, impetigo contagiosa, furunculosis, sycosis barbae, ecthyma, pyoderma gangrenosum, infectious eczematoid dermatitits, pustular acne, pustular psoriasis, infected seborrheic dermatitits or contact dermatitis, and infected excoriations (FDA approved for ages &gt;1 year and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8107104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Gentamicin may be confused with gentian violet, kanamycin, vancomycin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8107191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Dermatologic: Erythema, pruritus",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10481293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to gentamicin, any component, or other aminoglycosides",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13182136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prolonged use may result in fungal or bacterial superinfection; discontinue if superinfection is noted. Topical use has been associated with local sensitization (redness, irritation); discontinue if sensitization is noted. Not intended for long-term therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8107210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9749648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When administered I.M. or I.V., gentamicin crosses the placenta and produces detectable serum levels in the fetus. Refer to the Gentamicin (Systemic) monograph for details. Systemic absorption following topical application would be required in order for gentamicin to cross the placenta and reach the fetus. Gentamicin is measurable in the serum following topical application to burn patients.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10481295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits cellular initiation of bacterial protein synthesis by binding to 30S and 50S ribosomal subunits resulting in a defective bacterial cell membrane",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15995 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-2A6F391156-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31042=[""].join("\n");
var outline_f30_20_31042=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107115\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10495066\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481296\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107336\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107129\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481297\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13360197\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481292\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107104\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107191\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481293\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13182136\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299398\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107210\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9749648\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481295\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15995\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15995|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=related_link\">",
"      Gentamicin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/23/28020?source=related_link\">",
"      Gentamicin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/36/37443?source=related_link\">",
"      Gentamicin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/47/761?source=related_link\">",
"      Gentamicin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/8/18564?source=related_link\">",
"      Gentamicin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/63/8185?source=related_link\">",
"      Gentamicin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=related_link\">",
"      Gentamicin (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/59/38835?source=related_link\">",
"      Gentamicin (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_20_31043="Treatment protocols for gynecologic malignancies";
var content_f30_20_31043=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment protocols for gynecologic malignancies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Tim Brenner, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Shrina Duggal, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Jim Natale, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Scott M Wirth, PharmD, BCOP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     John W Mucenski, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31043/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/20/31043/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H15357686\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following material represents a subset of chemotherapy regimens that are used for the treatment of women with gynecologic cancers.",
"    <strong>",
"     This is",
"    </strong>",
"    <strong>",
"     not an exhaustive list",
"    </strong>",
"    ; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with gynecologic cancers. Additional regimens may be added over time, particularly as treatment for gynecologic cancers evolve.",
"   </p>",
"   <p>",
"    This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with gynecologic cancer. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15357842\">",
"    <span class=\"h2\">",
"     Ovarian cancer",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/11/21689?source=see_link\">",
"       \"First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tubal, and peritoneal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26231?source=see_link\">",
"       \"Adjuvant therapy of early stage (stage I and II) epithelial ovarian, fallopian tubal, or peritoneal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/21/37209?source=see_link\">",
"       \"Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29977?source=see_link\">",
"       \"Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-resistant disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15358532\">",
"    <span class=\"h2\">",
"     Endometrial cancer",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=see_link\">",
"       \"Approach to adjuvant treatment of endometrial cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/0/41991?source=see_link\">",
"       \"Adjuvant treatment of high-risk endometrial cancers\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22825?source=see_link\">",
"       \"Treatment of locally advanced, recurrent, or metastatic endometrial cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359201\">",
"    <span class=\"h2\">",
"     Cervical cancer",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7976?source=see_link\">",
"       \"Management of locally advanced cervical cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/37/33368?source=see_link\">",
"       \"Management of recurrent or metastatic cervical cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5498?source=see_link&amp;anchor=H1336437742#H1336437742\">",
"       \"Small cell neuroendocrine carcinoma of the cervix\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6938?source=see_link\">",
"       \"Invasive cervical adenocarcinoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359490\">",
"    <span class=\"h2\">",
"     Uterine sarcoma",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/34/44585?source=see_link\">",
"       \"Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/57/15257?source=see_link\">",
"       \"Treatment and prognosis of uterine leiomyosarcoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, protocols for the treatment of women with sex cord stromal and germ cell tumors are covered separately.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19858?source=see_link\">",
"       \"Treatment protocols for germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359315\">",
"    <span class=\"h1\">",
"     REGIMENS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359323\">",
"    <span class=\"h2\">",
"     Regimens for ovarian cancer",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359348\">",
"    <span class=\"h3\">",
"     Cisplatin plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef50698 \" href=\"mobipreview.htm?14/16/14606\">",
"     table 1",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359396\">",
"    <span class=\"h3\">",
"     Carboplatin plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65626 \" href=\"mobipreview.htm?6/57/7070\">",
"     table 2",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067422739\">",
"    <span class=\"h3\">",
"     Carboplatin plus pegylated liposomal doxorubicin",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef86168 \" href=\"mobipreview.htm?7/5/7262\">",
"     table 3",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359437\">",
"    <span class=\"h3\">",
"     GOG 172 regimen (intravenous (IV) paclitaxel followed by intraperitoneal (IP) cisplatin and IP paclitaxel)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef61475 \" href=\"mobipreview.htm?29/19/30014\">",
"     table 4",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1650215328\">",
"    <span class=\"h3\">",
"     Weekly paclitaxel with every three week carboplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef87790 \" href=\"mobipreview.htm?10/25/10654\">",
"     table 5",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1734336749\">",
"    <span class=\"h3\">",
"     Carboplatin and gemcitabine plus bevacizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef87827 \" href=\"mobipreview.htm?29/10/29870\">",
"     table 6",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359558\">",
"    <span class=\"h2\">",
"     Regimens for endometrial cancer",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359597\">",
"    <span class=\"h3\">",
"     Carboplatin plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65626 \" href=\"mobipreview.htm?6/57/7070\">",
"     table 2",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359621\">",
"    <span class=\"h2\">",
"     Regimens for cervical cancer",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H934171843\">",
"    <span class=\"h3\">",
"     EP (etoposide plus cisplatin)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef63222 \" href=\"mobipreview.htm?38/62/39917\">",
"     table 7",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359662\">",
"    <span class=\"h3\">",
"     Cisplatin plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef50698 \" href=\"mobipreview.htm?14/16/14606\">",
"     table 1",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359703\">",
"    <span class=\"h3\">",
"     Carboplatin plus paclitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65626 \" href=\"mobipreview.htm?6/57/7070\">",
"     table 2",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15359727\">",
"    <span class=\"h2\">",
"     Regimens for uterine sarcoma",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1535941416\">",
"    <span class=\"h3\">",
"     Gemcitabine plus docetaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef58713 \" href=\"mobipreview.htm?25/6/25710\">",
"     table 8",
"    </a>",
"    )",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85681 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-65E6C3AFCD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31043=[""].join("\n");
var outline_f30_20_31043=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15357686\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15357842\">",
"      Ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15358532\">",
"      Endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359201\">",
"      Cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359490\">",
"      Uterine sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15359315\">",
"      REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359323\">",
"      Regimens for ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359348\">",
"      - Cisplatin plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359396\">",
"      - Carboplatin plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1067422739\">",
"      - Carboplatin plus pegylated liposomal doxorubicin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359437\">",
"      - GOG 172 regimen (intravenous (IV) paclitaxel followed by intraperitoneal (IP) cisplatin and IP paclitaxel)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1650215328\">",
"      - Weekly paclitaxel with every three week carboplatin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1734336749\">",
"      - Carboplatin and gemcitabine plus bevacizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359558\">",
"      Regimens for endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359597\">",
"      - Carboplatin plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359621\">",
"      Regimens for cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H934171843\">",
"      - EP (etoposide plus cisplatin)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359662\">",
"      - Cisplatin plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15359703\">",
"      - Carboplatin plus paclitaxel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15359727\">",
"      Regimens for uterine sarcoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1535941416\">",
"      - Gemcitabine plus docetaxel",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/85681\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/85681|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/16/14606\" title=\"table 1\">",
"      Cisplatin and paclitaxel for SCC of cervix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/57/7070\" title=\"table 2\">",
"      Paclitaxel and carboplatin chemotherapy for EOC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/5/7262\" title=\"table 3\">",
"      Pegylated liposomal doxorubicin and carboplatin EOC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/19/30014\" title=\"table 4\">",
"      Paclitaxel-cisplatin-paclitaxel for epithelial ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/25/10654\" title=\"table 5\">",
"      Paclitaxel carboplatin ovarian",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/10/29870\" title=\"table 6\">",
"      OCEANS gyn protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/62/39917\" title=\"table 7\">",
"      Cisplatin and etoposide for relapsed germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/6/25710\" title=\"table 8\">",
"      Gem plus doc for advanced sarcoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26231?source=related_link\">",
"      Adjuvant therapy of early stage (stage I and II) epithelial ovarian, fallopian tubal, or peritoneal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/0/41991?source=related_link\">",
"      Adjuvant treatment of high-risk endometrial cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=related_link\">",
"      Approach to adjuvant treatment of endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/34/44585?source=related_link\">",
"      Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/11/21689?source=related_link\">",
"      First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tubal, and peritoneal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6938?source=related_link\">",
"      Invasive cervical adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7976?source=related_link\">",
"      Management of locally advanced cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/37/33368?source=related_link\">",
"      Management of recurrent or metastatic cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29977?source=related_link\">",
"      Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-resistant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/21/37209?source=related_link\">",
"      Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5498?source=related_link\">",
"      Small cell neuroendocrine carcinoma of the cervix",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/57/15257?source=related_link\">",
"      Treatment and prognosis of uterine leiomyosarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22825?source=related_link\">",
"      Treatment of locally advanced, recurrent, or metastatic endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19858?source=related_link\">",
"      Treatment protocols for germ cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_20_31044="M mode color Doppler LV";
var content_f30_20_31044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Color Doppler m-mode echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color Doppler M-mode from the four-chamber view, recorded at a speed of 100 mm/sec, demonstrates the rate at which flow propagates into the left ventricle, represented by the slope of the filling signal. In the normal ventricle, the flow propagation is rapid and the slope is steep (panel A). The rate at which flow propagates into the left ventricle of a patient with cardiomyopathy and diastolic dysfunction is considerably slower (panel B). This observation is particularly useful when trying to differentiate normal from \"pseudonormal\" filling patterns in diastolic dysfunction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31044=[""].join("\n");
var outline_f30_20_31044=null;
var title_f30_20_31045="Rifampin, isoniazid, and pyrazinamide: Patient drug information";
var content_f30_20_31045=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Rifampin, isoniazid, and pyrazinamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/6/18537?source=see_link\">",
"     see \"Rifampin, isoniazid, and pyrazinamide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F218310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rifater&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F218311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Rifater&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700702",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause hepatitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692117",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat TB (tuberculosis).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to rifampin, isoniazid, pyrazinamide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703252",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Arthritis, high fever, gout, or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701351",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you had liver problems while taking isoniazid in the past.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you abuse beer, wine, or mixed drinks, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have porphyria, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698503",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696832",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 1 hour of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks. Alcohol may make liver disease worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697942",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of body fluids to orange.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A long-lasting change in color of contact lenses. Do not wear contacts while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone, joint, or muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694864",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow a diet plan. Some foods and drinks taken with this drug may cause very risky effects such as sudden high blood pressure. To avoid these problems, get a list of foods to avoid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694534",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid eating foods like aged cheeses and meats, soy sauce, soy beans, Miso soup, Italian green beans (fava beans), snowpea or broad bean pods, sauerkraut, kimchee, yeast extracts (Marmite), red or white wine, and beer including alcohol-free beer. Very bad side effects may happen. Ask your doctor for a list of foods to avoid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695129",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If this drug is stopped, follow diet for at least 2 more weeks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12106 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-FE77A46CF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31045=[""].join("\n");
var outline_f30_20_31045=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218310\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218311\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028230\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028232\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028231\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028236\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028237\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028239\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028234\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028235\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028240\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028241\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?18/6/18537?source=related_link\">",
"      Rifampin, isoniazid, and pyrazinamide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_20_31046="Granuloma faciale";
var content_f30_20_31046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma faciale",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A red-brown plaque is present on the face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31046=[""].join("\n");
var outline_f30_20_31046=null;
var title_f30_20_31047="Cicada killer";
var content_f30_20_31047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F70363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F70363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cicada killer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 402px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGSAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDqNO8ySQyS8s5LH3+tdPYJHIH847Bxgc1g6UhaMHfjacYPWt+3uDDZS+cSTuwgOMv6j6V+f4VwpLnlsc0U2Xrq5jitIWzmRScYPJ/+tWQrXF/dBctLJI2FHp/9aooI5rqVmAJYDJ9FH9BXDfFb4g/8IwjaF4elxqc8X+l3yYJiB6InofU0SqVcdUUV/X9f12Nkko36GD8a/HZM0vhTQn8qztpMXt0j83Mo/gBH8A6Y7mvG2I4OSQOKV5Gdi3LMSST1yaIgD1UYPU+hr6OjRjRgoo4qlRzfl0L2nNGFIkO18/K3XivfPg7pZ0/RrjVrgBJLxgls7dTGOp/OvBtMtWubuG3CkmRwoI7Zr6X82KKxsrSJWWC2hWFBn0HWvKzTEKlGy3ZpRk5Lley1LL3GCzDvwQT+tcz8WfGkvgHwrbNYsP8AhI9XVltembaIcGXHqc4X/wCtW1f30eiaYl9JAl1f3b+RpWnu2DeT57/7C9SaxJdK0jwvdXPiz4n6lb6j4luh9w4MduvaOJPQdK58qwKl++r7dF3/AK/I6btO6WvT/P8ArqfMem6Rd3s3mSLJJcTP1bJJJPU+pr2v4a+BYdIubXUdTj36gHDRrn/V/wD16j8KS2Gq6tfa9aW5itJZClnARg4HVj+Ndqtx5DqSd0xxkD+D2r3cRiJy916I4alRylZs7HxFpzoZL2LmT5VkUdh2Oe9c9dzNFCqqNx6sB/FXSarfLZ67YmZmNrcWu10HTII5NcvrN9Yz+IbXTdJikkuZt2Fj+YKo/ib+6K8ejU92MO+x3Yikp3nDdbjYnYSb5FzGp3YB/SrBuHc7iAAORz2q8+kPFD5dxdWsS5y5Mmf0FNH9j2zBZZZ7twM/KNi5roUorrc4eSXXQo619rfSp7fT5Vju5UKq5/hJFVPAvha70Lw+toI5JriV2lkkC4Uk1p6v4qs9CsZLto7azj/hJG939hmuE0HxjrXjjxnbWtrNNBpyt80e7G703Efyre9TlfKi+VdWesC5Hh7RFNxdRafJGWmllk5GB2461d8Pa9ZeMtFi1iwgctghlC7WcjuAetebfH1zBBpugWzM8966Qr6n5hmungU6VcWttp7tbpZxrCgU+g5rzamIdFKpF2cm9uy0O9tRfJukkbyahpusSm0ttQjiuN21o5sK6n0rC8SfC7w1r08ba/dzJKhOGgfYxHpn0rn/AIn+F38UwxX3h9ILDXFYeYzHAl993YivLPEuh/E/TYA1/JqNxa2ybvOglEiKv1HNddPEyxHw1Vfz0f8AX3Et0vtR+4r/ABk+H2meD7i1m0XVHktrlmVbaY5kUDvkdRXnEO1erOSPeug1bxBrms2UVlrF8JbeJty+Yi7l/HGfwrGjFvF96UHPoK9jD+0jT5azvLyMasot+4i7peqXWnzLJZSNC3ZgxBr2HwJ4+S5eCz1KwhMx4+1ueB9c143HPaKc+S7n+HnH51Q1rVruUCJD5FvjG2Pjd9aiphliHa1vMmkk37x9PeMPiRongq0m/wBJhvtaK5gtrbBVGPQuewr5k1nXdR8VeJJdU1qbz7yY5ZsYAA6ADsBWD6k9atadxdKfaunD4OGGg7as66tROHLBWRqcbs471Kg/+tUef7w5zUsee/4VLPOZeI3LEw/u1YiA6Z6Con+W2iPfGMkdqntwNgIIIPfNcxmzV8LBW8R2O/awEmeemQK9ZsYHuL95GAG5sjHQ15H4WR5fE2nxopJaToPT1r6D0qyEEmWGfqK+ezd2qRXdfqaU05GzpFtsTDLnH6V1mnQo+B0A5NYVsAqjGRn1rZM0VlpzTzyCNTySeMCs8M40lc7Iq5leNPEsGjWnmkF3Pyoua8Vv9Tk1W4ea5diWJ+XPApvj7xBLreubEZUgjbYiqc7vepNL0xhtJXGR1NZVNF7Wo9XsYVqnM+VbDrTTkJVvLBzz0res7BYuVjVc+g61a0622JtIH1rZsLfc4BGSeBXl1cRKbsghTuLpumb2XYOSa7HTreGwiUMqtKeCfSq+mwQ2MX79h5zfdHpVqV125I+Y1vRUaUeZvU6lGxdknimUbgRjow4NLaX0luQk4yp4Dg8GsmWXAHNUfEPiXTfCejpc64XaO6kEaQp97HdgPaurC4qpVrJR37lNaHYO6Sxlkc7/AGNZF4ZY9xmhhmhYfddAazre/jMNtd2Uwns50DRyDuD6+9asd5HckAnGBj6mu2WIhXXLL3ZEOLRkPPZBXSfTbcIw6oNrD6GqjS6KoOx7uAnja2GUVa1cgOQFLN/KuduFyzFsZ9K8evUnSlbf1SHp2N824ugn2N0kgRcAKcfpVNo1Xejx4PTDVgSSPbHCPgnnjtVm18TPCdt/ALgdNzHkCsVU591Zj5o9S0Iwo4RQwPYVUuotr7xGpU+1WH1Ga5kMlnZwXNpjJZH2yRn0IPX8KiXWYZF2vZsrjqC1PmnDZ6Ey5erJLGdcNa3kY+yTH7w6xt2I/rUSXE2lXsljd8qp7ngjswNU9U1OOS2K21usUp6MWyKx9L8RJ4mgvNMmhFvrumDeq7s/aIe+Pp6V1UuarFvt1J5k9IvU7LTIVjRp5SPIK8n39KQul4fPuW8qFCF4GeM9B71oLcaaqCARicLkcnC59aoXshm5YDavAUcDHalVrJpcruhKHKrEeo3tjeQfYns3a03BtomZBJjs+OWHfHSs6/0Tw1qrq+p+H9OlZGJUopjPI/iIOW/GrCxoFBK+oAJ6VYSNSvA6HH4VyKvVi7qTX4fkU25KzWhzN78K/COsSqbSO90W4CkYtX8yJiehIfJ/AEV5l4n+Fnifw2scklmt7byE7ZLHM23H94AZFfQumKPNxjDLzk9xWr9vkiiIRmAPbPFe5gsfONK9SV/UynRjLS1j52+Geit/abXd/byJ5IwFdCpB9cGvWrSA+VLdPbPcogPlQj5fNfsP93PU10N3HBfSFryASMVCeYBhh6c+1cX8WNT1vwdokt3Z6bcXcTOEFzHgxxJ/CpAOQP6msHz42upW0/rvoVToqG7MrxddWmjwQ+IPGY086vAQbZoiS8WOiRrnAH4V89+Kte1Hx34hQxQt+8cJEhOTknA3E96frFh4i17UIL+/tLmT7Y4EcsikR8ntntXYwfD97DVNOmW4fZE6tKhPDY9MV9TSdHCpXa5unWxnUrRhruz1Twx4Oh0HSLS21TULS3mijAKJ8xB79O9bVvDoVuCwF1ekHv8AIv8AjXLRozSBuv1rTszumWHqzEAYNed70nzSkcicVsvvOo8Sam1jeaKxSIvcRSBBINxQAAjFc00qSapc30aj7bKgWSRPlJA7UfEe/sh4v8L2KXIa9VJlaHnIBXhj+RrJv5EtYriWZ0ijCnLM2NpFRhYXpqVt7/mdWKb57ehYW4LPhieckj6Vyvinx3b6UTFYBLm+6dcpH9fU1x3izx150SWejl1T7sk/dx7Vw6ybnyOfc16lLC31lsYxp9WdRcahe69extezy3EzttRT0yegA7V6/wCDNL/4RQW6riS6VvMmxyd2Pu1xPwf8Lyao8mryYjgiyImkOBkD5m/Ct7Uviboegy20XhaP+3NanJTLAiFGJwuP7x57VnXfO/Y0162/rT5lpSm/d6dTuZLfUdU8WQa/rcAt7PR0K2UbLlp5ZB94n+6o/WtOw3yOXc8nk7qXU4rm3ttO068uDLcwW6rcvn782MsfzNTafFIsILQnyicAle9fIV6nPO0dlov682djbb11ZvQwu6I0YABGCc4ANXo08sZ35PQ471W09d8LKRt2kHI71eAySMZUdh3rVU043GecfEf4YeHfEVjfX1rCml6xzKtxHkpM391kHr6gV8vanpt1pl9JaX0DQ3EZwyOuCD9K+4Z0YFS2Q2c/SuG+LfgCDxtpUupWaFfEVlBlduMXSLztP+0O1ejluZyo1PY1no9vIipTurx3Pk8LtGOc02VElXZIPxParVxbvE7JKrK6nBB4IPpVZwOOnSvqYu+qOXZmXc2zQNj7y+oqezXB38ZWragSAxyD5W457VVlAt2aME8VupuS5eptGd1ZmnhZBvTB74z0oXrgHNZ9jK3nBBlg3UVobCHKtw3oa55R5XYxnGzNHH+hx7j7fWpYTtAAIwT0FQxfNZgHs2Pxq3YwSzuiQhnkc7QoHeuV6XMWdb8KLI3njizQgYQFzX0TPbbGO0ce1cH8MvCDeH41v7+MLeS8DI+6K9C8zzWCnr+leHi3CpUd9zppK0blvS08xlQqD9e1eafF27vLjWzZWd1JDBEgBTsxr1Cy/wBGtpJ3znoK4rXvD1xruuq9sY0URM8kkhwoxzya45T5bQNanNy+6eQ6Vol9Lfxvcp+7U5LZ616Jp8GIwCORxSWEJAI28jpitixQRzDIGDwa83F4t1nZmNOA63gY7dg3c11djZrbwrczJgkZVfeotOgADSTIFiQZz0zTZ72SebcD8nYe1YxUaS5nqzsjGyFuWErkt941IspSMhiCAOKgdhkH9KbPJb21rLd388dvaRDczu2M1i26s/dWpa0Kmv8AiLTvDWmtqOrvuHSGBPvSN6AV81eMvFF34h1efUtQZtuT5UO7KxL2A/xqf4m+Lm8T680luGSwg/d26njK92/GvNtYvGd/JXhB196+3yfK/YwTmvef4GMpObstj2j4E/EiC21Z/DGuXMcGkXbFraeTpDP2BPZT/OvdbkyWszwuQrD07jsRXwevXjrX1b8JPGreNvDA07UNn9v6ZEqq275rmIdyPUd6yz7LFGPt6S9f6/rX1NE9LdT0T7dH8sU2emd4PSoLi3MEJnZg6HkGsRZfMkz1xWhBekZQ4ePoVPSvlfa30miE0zNnRnZn2gE/lWXfQnKqQBnmuplgiuAHtGDxoPmXvmuducyzMQOOg45qeVwd+hlURzt7HLCS9vJIkg6FTimjxNrsMaLMLe4hQHduQBm/4FW3cwCJRuXJI4zWfNp7zrtCjaa7KdaNveRn7y0RXj8S2WoXUNt9lls92FLsdy57k+grlfGiXnhvWrDxdoytKtlOFlkVco69wfqMiusj0hFIDruc9SK6TStLjubKXT7mMvZSgo8Z6HP9a2p4qlh6ilBabNd11CKbkmt0N0+Ylt7Z5447e9a8bnaQT3rLsowEBwM9fpWkuMopOD2rzGrFwLCkkLlecZFSLyyoMgd8U2V4LKD7ZqUhtrRc7TjLyHsEXv8AyrNi8WeGrUGW9ub+FCMlnhVQPplquFCU3obI3rNgheVjgD5Rn1qZQ0rKq5IPp2rC8N+MdA8RXbWmjSXkpjyWxahFX6yMTz+FS3GvRxDabV3SMMZGFyRn6YHFdLpOmlCen4CvFdTqFlAfMak7fbrWnFdRxpslwQRhkIyGB9c18+3nxx0e11B7Z9G1RY4yQZra+D5P+6wHf3rprL4p+EJBG8viae1DruAu7GXg+hKhhXs06eKo2/dt3+YON9jtPFPgfTNesPJjee3jXDBI2GB9M9K4628B6hpO6K01C4ng6iO7UZX6MK7Pwn4x0nVo45dN1jSbxDxtWYRv+KnBFdTq1nYa/p22Wf7NMMhJ0bmNuxI7it1ThWg1F8r6p/1oS462kjxe9gnsJf8ASQsIx/EeG+lZ+p30lhYzX2n7UnjGVeQblB9cVbS48VLr1/out+HNPkhtZNn2nziEkU8hkBBzkc1m+JtAj+3waXpurXGnx+U11epM4aCCM8Bueck9ADWtLCyUV739ficXKlU06HncnjT7J8QJda1ZvOuUstkZQD5mP8uM1zPibxbf+Iph5p8q3jJKxRjPPqfU1j+JLYWOr3EMN/DqEStgXEa4DfTNZsVzPA4eKRkbswr3aWGjGKt0Wh18vM+bua1rpl/eEGC1lIPIYqQPzrptH8Kqg8zUGBY4Ploen41xj6zqbqqtf3JUcAeYcD8KRdTviebqb/vqlVo1pqykkTKnJ9T0y4hkk0+TT4ZJYrUg5RGIXmt/4F/CrU28X2fiLV4TbaPYSiaETL8904Hy7R/dB53dOOM1qfs2eDZ9e+0+Jded5tKtmMVtbvys8o6sw7qv8/pX0BcQfaryNkdgYsDA4VQOgFeLXrVMKpUqbTvv+vzFSg110KyWNrHK0qQBpi27zHO5ic9vSsjUbrffMkcm+JOcr61Lrmux2ryxQsj3ROzCHKx++fX2rEspWEob1zk18tWceZJLRHS3y6Pc6rQpd5wzblYYIrd2qIh5ahV61zmjtGbuMdBnrniumMUnk/viNg44r2cDHmg7kNmdMuVJHU1DGTDcB1JVgMrirFww2B8Y9BUEowxLdSOK86vD3rroWmeJftFeHLf+1rDXbZFRdSDRzhRgCZR976kfyrwm5tmiZgR+NfXPxHsU1X4d6tbycSQPHcxt/cIOOPzr5VlnWSV4LoAOGIDCvoMrxLq09723MqsE/UxZEwQetVr+MuqOo56Gte4tyjYYde9RQBfMAkGU64NezGpb3kc6k4sk0KxES/aLgcjkZ9KfeyLNIJB0zim6rfbYsRnag9B+lZ2nXJmWQHjac9eoqFGU71WVJNq50+g2Lantt42AdnwNxr3zwB4AsNNaK6mxPdAA5PIB9q8R8EeHtW8RPJBodrJNKjAtIDhIge7N2FfQGkaYvhG1EEF5c6jeom2WaWT92G77F9PrXjY/EqhK7enbqTCmpamjq93cyeJrOxgjkMCRNJJJj5FA6ZNaIuYVRWeQMewXmsiWe7unBllbEh5UcfpVu1gUIY2Vg2e/9a8OVaVSblFWudKsaE2qTXUccSRBIQMn1NMnuPK0+d1cY24I9TQkA2lVO1lOM9jVfVoR/Z+QuB5gBGazrPli2y02YVtEA8Zzz3rWsrDz7jy8cZzn0FVLW3aRtsa5bdxW9cOlnCbeJszsBvb09q8mCUvelshxiT38ySKsNuR5acfU1SRSTtRS3sKptKsMckssixQxqWd2OAo9TXhnxC+Kl9f3Mlj4dne201coZk+V5vfPYV34PB1cwqNRXz6IpyS1Z6x4o+IGg+FJRFeh7+9B+a2gYfJ/vHtXhvxH+IF/4xvEBVLTTomLRW0bEge7Hua4iSUuWd2OWOWLHk/jVG8uyEKJz719lgMopYa1tZdzCU3PRFu7vFWLCkFulYkzF3JJzTCSTk8mk617sKagaRXKrD4lywrtvh5rNz4c8TWWqWpbMDfOoP30PDD8q5C0TJzzxW1p7+UQQB6GufFJTg4PZmNSbi7rofWksUbpBf2wJtLtBNFkc4PNUb6Uom1Bjd1NeWeA/iqfD1uuma3bte6O3A28yQe6n09q9YljhvdNg1PSJlvNOuE3xyoc7fYjsa/PcZgKmFleS900upx5olW1uzbOsiMc+h71r26wXamZF2uAS6Dv9K5knL7icbexqWPUBaurxvmTPBB4FcsVbzRnGfcndWuZ3cKfYegqZYHQqGXGRke4q1bzJeQPJCuLkjBRR973FSQ6de+WNtvKXbgBhipnF9ClEzYogr5cEgn8q2bFgrr6D0qidN1CIjfauecZXmkkLwfKytG2e4wTWc1JbjjoPk+z6fZfbNTlkhtfuxhEy8rei/41ial44+zRSTWFvBp8EY5upm3yY9eeAfoKw/iDq0UGr3U13I62lmPKhj7nAycD1NeE634lv/EN+guG8u1ViY7dOFX3Pqfevosvyt4r3tkuv9dRX5bqPQ7fxD8Rry+uJDZ73b7v2q5JdyP9lTwK5FDc6jdAFpLm5lYAbiSSTVCCN5JFjjRpJG6KBya9F8M29l4TnivdR8u71WSMmO3HIthj7zH+97V77p0cFG1OOv4s5aknJ+Z6XojWXw78Dxm8ljXULgfMq8sxPXA/SvMtW8W6nqZuHLiG2VGZYUGBwOMnuaw9Z1ebV9QlurmVmZjtUZ+6PQCqc0u21cZO9vkGPeuKjgUpe0q6yf4egJrSK2OPidy0m/Jcncc9c1KLhoJl8webC2CyE8Ef0ppu3DkOqsAelFxtlg3KMbTnHsa+ltrqjsavuetQ6N4NstJsvFVrJLbpt+S2eTcWlxwB3yDz6cUkfxb16fU/L1R4pYoiu7y0ADKOzEdM15HZPE1xbx3rzfYw4LiM5IHfAPGa3PEmuWd0qWmh2a2GmxDaBnMk3vI3f6VwzwMZ+7U97zfRGUYSh7q1ufQ/ir4y+HoNLimhs5Z79kGxedsfsSev4V4Dres6n4jvrzU766Dy3bAvGp2gKPurj0FYltcm4jFtMw29VJ7GmvG8J2Mehq6OFjSb7lNO1upHNC6n51Ix60xUxkMBitSG6YxBZgJV9W6gU9LS3uD+5cK39xj1ro9o18RHtLbmHIhRyp61oaFpN3rerWmm6bE815dSCKONepJp91YSqNrJtYfjmvf/ANkbwfbXWpaj4pvS3nae4trZMDAZl+Zj+BAFKpWShdbl891pufQmiaTY+GfDun6Pp8CwwWsQTCjG5sfMT7k5JNQZeGIyxgFZJMMB1wBjP61t6gq7N+CRzz71lQlRYqcgguwPtXzWLT5kmy4q2xz03grSCEFlc3EVzJuO523Iz9s55FcpA0lvcPbzq0cyEqyMOhrupnLK4AORgjmsvxdaxT2tvrEUZ+0eYY7kg8H+6x9PSvBquNRu261+X/A39LjnG+qIdJnBEZPzEMGyK7g7TGzH5lPOBXnOn7g6tCcg84716HpSveW0RIKZQBgB1xXqZTO75epnuiv5W8KzD92nr0zVK7yW459MVu3wt4YmV5EiG04V2AziufklSY7oWV1B5KHIp5jRUNL6suJh+IbOTU/DXiOxhdUllsnkjLeqfNj8cV8d37GeZpP7/IPvX2na3K2ur20zDKF9r5HVTwf0NfJHjjRpNC8Ya3pckJj+yXb+WhOcRsdyH/vkiryGatOPVP8ABk1ldJmZZw3DDy7gEx9mPao7qFopDk8evrVv+3Amm+Q8YZsY96qWF4tzI1tcH7x+RvQ+le2vaayaMLOSs9zN1GISrg8E8iuj+FPga/8AF2uy2lt+7t4lEl1cH7sMeeT7n0FUJtOnnuIbWGPzLmV1jjUDlmY4A/OvqfwH4Wt/BHh1dLjUNqlyqtqUysSHkHRR7LmoxWOVCjZbvYqneS5TS0vStM0DS20bw/bm2sPM3sS255jjqx/pVeSLF1IHHzdwelakqiOSPHVhkmmvbCdtyt84HXHWvmKtOVV33kbXIbO0SdHUgccggdDWlb23kqVuOTjCsOfxpLCJ4iA6YY8H0NWZipX5lYEcY6ZreNNQhdqzBFR49jYWTd7EVT1gMtjajtLKT+VXCQckA+wp+oIqW9nNKNwiViqZ6knivMr/ALxNI1iihbJ/Ztq0zgefJwg9Pes15CWZ2PzdSfWqOteJ9F0+4La3rFraSHnYzZYD6DmuW8S/FHwtpNm76beDVbplPlpEpAz2yT0rnjgq1aypQbXoDdkYnxz8QT2WlW2kRSFfth8yYA8lB0H0Jrw533ZY9Kl8Qa7ea/qk2oalKXuJB+Cjso9hWez5UYJr77LcD9ToRpvfr6mEryY25nY5Vchf51VALHAFXVtzKoOcCpRGifdUE+tekpqKsg5lFGabeUniNqlt7KV2G5SFrqvD+gavrjkaVYy3ABALKPlB+tdj41+HTeFPC+n6hfakkmo3MuxrRV4UY9a5amPhCaptrmfTqJ1JWdkecR2ZVAAP/r06ONg3IxzzWlHGScYPvVyO2jCAscH1HWolWtuZbmJcRnytoU81P4U8SeIvDF08miX81tHkM0TfNHJ9VPFXZtuG64Heup+FHgWfxzqxubxXi8O2j7bmVWCs5xkIv6Z9qidWmqUvapOPmXRcov3T0DwX4mh+Idn5Zsn0/W1z5jxoTbSn1z/CfY10i6Zp+mIyTub67xgBQQiHv9a3Y7SDQ9KTTtCtVsLFCdscZyWJ6knqTWTLbEuobO/klq+JxNSDqP2UeWJrO1721NCPVH2J5MUcO0AKEUDpTLjUpWk3tI5ZuSQeKo3CNHBGVI4yM1WMvO3Hy44rkavuHO0X5dWuIjiKVh3znpVQa9NGXWcJOD138kD+lZxYmPljv5zVC7yAX6Z7VUaab1MnVl0Zw/xq0i6srC61i/mELXtyYbW0wWITqSW9a8y8EaDd+INYa1sgoKxl3dvuoOOTXd/tD6497rmn6Wr/ALq0iMrIDwGf/wCsB+dYvwr1q38PWuu6hMN83lRxQx5++ST+nAr7nDSqUsu56a1ey+dl/mOd1TbW7/U3fFWn6b4O0qCxsn87WpxulnPVE9vTPSuUiDx2mWOXnOck87agluLjWdWae8kLzytl29B7ewFLNMJbh2XKrnCj2FVSpShG03eW7f8AXQ50uXQfActjA9Mk1QvGmurpTbHfBAcFR1z3NXja3M6BIEIBPzP6j0FYrXEtjq8gAO0thlNdNKPM21uaU49SjeLtuZBjb8xODVjSbWa7lMccZMZ4Zz91fqa6G+h0y5WOWRGe5BH3DgOPRv8AOaX7Q5jEKL5UA6QocKK0eJbhZLXzLnWsrFC18PRRu39o3OMdI7bDk+5PQfrW1afYrPTjZwWUE6l95muEDPn69h7VVROMZx3qVAdvHXv71zTqTl8TOeVWUtyxC0CEtFp9kCTknygf59Kmki0q7wLu1eEjkSW74b6YPFV4lwuSCD1+tOAJ6Lx3FYPe6b+8lTaJ7LwNNqqS/wBjatp1zcL/AKuzkcxzTZPCrkbSfbNZniLwrrvhm5WDW9IvbWYruAKbgQP9pcj9auxxuGBQYweD/dr2L4X+P7+yddO1bUJI7Zh+7mZQ2D2DE9vem8XVp/3l+P8AkaxqJ7nz5BqyxqEaNpEB5Vuxr7l+DPhlfC/gbTrOW3SO9uV+13OzkkvyAT6gYH4Vzmq/C3wn4pu/t2qaUGvLjBa6tZzGWJ/i2jg/lXpVvOIpXh3nEQEanvheBmnUrRlytq1zaMVe6NScIYXyV2twAa5qVBBaXIRsoCHGO1aV6xKjOSWPTOKyUG2V48cOp4FcOPlz2Vv6ZrHcxHmLSDaxHrk9aTWHz4b19ScFLCS4H+9GNyn36UTovmPjJU+3SqOqOE8MeJS0vl40q4ww/wB2vkaSksTFPqzZbHgTeOdbaBVS82qw5KKAa2LPxjrE2hon9pXRkhlwGDkHaR04rzbIAUqcccV7R8M/DXhjWNHMU2ptNfvsaSPdsKnPQZr6+VGlSSaikecpTvaJT8MaZq3ivUFhjkldUYGSWRiQi17XpuiW+gaf9ktd5jHzMzHJY9zW9oWh2Ghad5Gm2wiiXqOpJ9z3pmodNx6nrVYnCqMHJmtOLWr3OSvVLKxA4z1ryb496ELiSw8SwB5GuIvstzheAyD5W/EcV7ZPbHKqMDqenWsnWNGa+0i7hEaSKgM21zxgdcV8/g41KGJUl10ZtN3i0fFkw+dhzx3qup8tlYcYINdh8QNGXTNfkW2jCQsocKOn1rkgFEq55GRwO9fcU5c0bnNGWlz3r4OaLDeam3iW6Qta6UEeEY4llYED8uv5V6rFdmWdnJ3Fvmye5rAsrb+wvCug6P8AMs8duJrlOmHk+bn8MVo2DlIu5wRzjtXxOJxDqVnbZaHQ3bQ6F4vMSNogSSMEVLaKqscE/ewPal0yQFwXGccD/GtprBXHnxFQx/WvRoUOde0iTcRlYQHzHUHGAwGc1nMiq2Tl/c1fuzGkQAY4AzismZ9zdTtWssbNLUtdg+aWdYk5LsAOK8c+L/xXttL1C70zRcz3sQMQcN8sJHBPua9F8a+IF8K+B9d10ErNDD5FqQf+W0nyqfw618TPM8ztJI5eViWdjyST1JrXKMuji71avwp7d3/kXJ2WhNczSXdxJcXUjTTyNuZ2OSTUBbPoMUZyPamn8K+vStoZ2DPGMc1askExw3aqhrS0eCW5uI7e2jaaeRtqRoMsx9BU1HaNxS2LixZUKvQdM16b8NPhTPr6LqWtl7XTldSke3DTDvj0Fdz8KPhgdEA1jxLFG9+6fuLRlz5RPdvevXbe2MuzOAF4CgYA/Cvl8bmc23Sw/wB/+QRpdZGbpmjWumWaW2m2yW1onSNRjJ9/WvGf2gZ861pllyPLiMp9iTxX0Fdgxx7SM45rwv8AaCt0TWdJucDzJLYhuOwPFeZgbLFpPfX8jSovcPIoYwMkj3+tNmbORu/+tUpK5AXO4nGAOtekeDfhLqGpNHeeIWOn2PyusfWSQdcY7DFfQVK0KS5ps5eVvYx/hX4Ck8Yaks11HjRbdwbp920v32D619IQWdtbWcdlYW8FrZwjEcMShRS2MUFhZi30+2htbRBgKAEUD6nvXP6t4x8NaTOItR8Q6dFMTgRpL5rZ9CFzivEr15YmV0r+R1Qhyqxe1GNWtQyDhDkgelZqwmRSpXBxlcd615buGN1SNZH3DPAAVgfQ1XuJTEGdraaJOuUZXOPpxXm1OSTvcfIc9cRt5bIVIz0PvWRMSACRyp6V0EWs2OomVdN1W2aUZ/dykRvn0waqXk00e/7TbxtleNw/qKSppbmUo9TBu5NkrheBjOKo3Lb7fzO4P4VsO1pcxs0iNEVH3kOf0qrLpxlsibaVJh1C5w35VpGBi4tnzX4r1WXV9aubmfDSs2HkxyxHFV9MH7p/dqozHdNI3qxP61q6TEz26gD7z4FfobjGnSUVsjWppA1rHFrYSz7RvlPlpn07mrdhp0qFZr1BFARuAbq3+ArV0bS5L/xDaWFrG80kKjbGi5Lt9PrXqR+DkklnLd+NNbh0y0Iy0MZDSbfdjwP1rx62KjD4na5jCDk9Fc8UW8vxq1lMkLCweURq4GVIzg/SrXiDQorjVZZIMi5AB2Z4ftn2r0W58XeCfBemS6f4F0hL+duJL27/AHmfcE/0Ap/xl8K2Vl4U8P8AijQSw88KJ5F4U713AgduciohiZOpFxi4p6JvS/qtzdxtdLc8ZAZJSJFw4PIPGKuoFKnHXPTNdH4atLfxZqENhLHGmoScK5fZuOO3b8K0/Evw81Pw3eWdvPLDN9rYiNY23Px2wK6J4mKfLPRnLKDaujkkQ+mAKnVDsHQgH8a9O8M/DVJU8/XHkRSv7uNMBs+9dPp3gDRAZFYzOOgwQpH4ivPqZjSTstSIwbPGrPT7mYoscDvI3CqBkmujtPAniCWM40ydfdl24/OvadH0TTNHhI0+3VHzkufmdv8AgRrXku2lXLliSOSTwK55ZlE0jRfU8Z0/4Y62dzPbxIDgZeYLitCT4d6vbktHDbykD+CcGvVYo57qNjGQsSfekkcIi+5J6VyHiT4leFNAFxELi71q6hHzLpu3ySe4Eh649hTo4urV0hG5oqHU2/htc69ok9tpusWcn9lyuEWXcHMJ/wAK6a1vpF1O5LE5ZmB/OvBND+PeoX3izSLSw0aztLOS9iiyxaWYoWAIzwM8+leupdGPVruJ2wI5WJJ69elZZlUrUXS9quV6v8uxtGPInG53MM3mgrtP4jP41BcL5UittYnIwRWZZ3rSRgxjbgY3E9atyXVzIOkfWr+sRqU9QMbU2eO7mVDsXcTjHGKxfEUjL4O8TkL5xGlzYBHqMZ/Cuh16PfPHKFGHUfTI61kS2qXkV3Ylwi3ttLbHPT5kIA/PFfPK1PFLm2TNj5NErps3fMoA71ueHLhxNceU7gtCckHFc9MkkUhjm4kjYoR0wRxir2gyldRt9x2qTtP4193UheDPN66n1F8F/Gv9s6I2lX8jNeWYAidn+aVfT3Ir0doJJkMrDCn34r5K8DX76b4u0mSIqCl5GpGcAgsB/WvqWzvpBc3ESuRF5rI8R7NntXPOqrqE9mb03dE0qK0yNxhc5NMNp50FzHGwV2ibB6gcVYlVY0IAznvUNtIxaVEILeS4GTgdDXBUioztJbmy1Pkz4xbTr1qUwCIcMF4HWsT4b+Gk8WePtH06QBbUy+ddEnH7pPmb9Bj8al8f3q3viW5dSxSPCdenrXq/wd0mTRvhveaosSre61PshlwCwt04OPTLZr2MTXWHw7qPf/MwgjYvb59T1y8u8HyiSEB7KvC/pit/SIfOh2kks46+lY9lZqkchIwpXJP48V0ejQEIicgnIJr46jDnmk+pUb3uzT0geafKIAbocmuiSJ4o+rFVHAHFZkWnmGVbiIH5j8wHetCaUxQsuDvxyAK+gpwdKm4y3/Qpb3M66LSsWkf5R2qhKwzx90dqtTseC3BzwKz7i4t7S1vL3UGZLGxge7uWUciNBkge5rxsVJzlyrVs1ieL/tV6yINI8N+HYJ/nk8y/uoR2z8sefw3V86qMV03xM8Xy+N/Gt/rTo0UEpEdtC3WKFeEXjvjk+5Nc0OetfbYDD/VsPGm9+oSHtwvHH0pvJGcVIxAQChckc103IuR4JPAz7V9XfBP4fR+EdBTWNbtIX1y6Cy2wbkwRkcfQnNeLfA/wdF4u8e2dreJIdPgzPcMnTA6Antk19g3sa3MxbkBQFUD0FeFnOKah7GG7GtdSrZRvO4kYlmJySa6WC2hMW8rhh/Os6wg2EEDg9K3LgBLUtwOOa8nA0FCEpS1Kbuc5qTfMQp4rwj9omZ11zRoyBtW0JBx1ya90u2BZsDj2rwX9pFmHiXSgHBX7EMD05rjyz3sY5eo6rtAyfhb4h8GaDI134mtLp9SRyYplXzIwvYBex681seNfjxLMXj8J2ItogD/pN4A7t9F6LXkdjaveXEcAONzYzWr478Jp4f0SO488OznBWvofq1F1vfu2zmVRqyRzWu+LfEXieUHW9XvLtP4Y2k2oPoo4rPS1IXpUNgVDZbFak9xHFCeQD3r1WlT9ymrLyFUnJux678HviLdNfWmgeIrqBdPjiKW88ow4b+FS3+Ne3+KfEPh/QNPNzqmp20flxbzEjgu/sB718NS3JllyBxUdxK8ozI7sf9pia8+rk1OrNy2T30OiMnZc257rZfFLwzqfiq5mvtLFrbOQsEoUMwH+1XqNrJpd3bkabq9o0E+P3bSDDenB6GvjrSoDNeIuOAc810UjiWcRAEkHtxXLjMkpOS9lJr8RPlgtj6E1W1bT0ZTJFJG4OPKcNj646Vl203KoDjHQg15f4eutQ0iYT2kjbDjfG4yjj0IrvrPV4NXF3cQWyWc0I8x4MnYRn+A/0rzKuDdLrdd/+AYtJ6xPOfHHhaAvLq+mYhilnxLaKvEef4lPpnt2qtoFmjPCwUCGAFs+pFdt4ykjsvDNyz43z/uo1P4Et+Fei+Dvh9pFt8FbLUNVi8mSa3e4muG+VljJ3fyr0oYyp9U5pXdnb5fqJKVRqJ414S8VzeC/EEWvRwx3Mp3J5Mjbcq3Ug9j6GtD4heONV8fvHcSwTWmkD7kRYkSn1J7gU/wb4Jm8aeIWvhayJoELbYQ4wZVB4XPYdyfwr3WPTdIsrVYLuGC62gAQKoESAdAPXFRiMTRp1IvlvNeei8u1/wAgU5pOMfmz5agsJZwRFESB7YVfxr6q8PaBaa58INJ0fXyBatZx73U42YOQQex96xLvwvpfiC/zFZRiVRlYowViGP7wHGK7HULpbDwkYjGtyYoREy2y5VcAn8BxXPiMb7aNtmtUbYajJyvY4/TPhbZaN576dZQX9ix3xXCvvljI/hP+NTWvg69l1g6mbG7kvAuyN5jkRr3256Zrx+XxlrGh63cX6aq9gbtRMlnG29WU8DK9AcDkmuv8M/HeCO4ks/G9tdiByPs+o2bFmiHdXTIyvfjn2qZ4KvXXNq9Oj37rb8rh7k32O1vre7s51jvI3jc9BVrT42DH5XDH1FXdF1zTfEdrLe+F9Sh1aADbJ5fE0Yz/ABRP8w6dasx6oTDIi7JO+Dwfy9a8n2Hs58s7p9mTKmk9whtJSjM6hI1GWZuAB6n2rlvFXjvRPD6rFYxXOu6xKAtva2cLGJnPC7nxjGccDJrq7jUg1kY5mUqOquMgg9jRDfzSHf5jKg4A6Dj2rohCmpJNX+ZWiPnHx0nxQ8YX8FnrWjamI4wXWytbcrAnqeMgnHqazPh/ol3a+M7YeI9F1OLRIpxFdlrVwkZPTcccA8V9G+fNFNOplkXdyVQ8NmpP7QnS3VRPIIg2cE55r0YZrKMPZqCS8romT5tzyjxV8GtT0vxxba54Ht0u9KguYro2+/a0RDgkc9RXpVxEsesXfJlHmn7h4JPatu01W4jZpFYu5X7x6+9UZLrTWPmSxyLM7ZYo3C+nHevOzDESxKhz7xuXLllsa1qyxhVZQGxjBPT6VbE7+VhIgQOAWaspA5iEzSoyHkAfeA9xV6zmgdgXfB9CMYqKU7+6nYNiS/3SaXyuGjfPBzwawGOwGRQS6kMMH0rqZkaSKZEAYNHxjtiuUlJDEOeR6V5+PhyVEyr6Hg/xi0MaV4ymuIAi2epr9uh2nO0sfnQ+4bNcbpr+XeQMR8u4fzr3n4j+HW8R+FzBZRNJq1kzXNtjkyLj95GB64G4fSvn62lAmTzAchhn25r7DLMT9ZwyfVaM5KsbO6O00BceJ7CN1Yqb6LKryeXHSvpm3vN3iO/QMhAnJBHfBr5y8DWzX3xL0S2D4Z7+JwTxwCG4P4V6zBqrf8JHcyliAblm2gY6tzmufF1PZypsIOyfqetsxkAdRkMcqP8ACqEhdJbkQoWlMMiKo4JJU1Y06VRaY4IHKkdxUcskZ3S5xJGhZh6j1rbHUrxVSL8zeDPjTStPn8ReM7XTW3ie+vhCw6Yy3zfkM19U6xaW8Eg0+whjgsLMeTDFGMBFH+PWvIfgjpUGqfFC/wBTW3WWHTfOnYu3CuzFUYep617TMoMjMckk8nHes8yk6sIw6CirGXaWhkDBvlRlxxWlpkREgjJO8n8abbgRMNxJAPX2rZFp5jLPH/rFwR9K5MLh7tNdAL8D7YlBXoAeaz72bczAMT3OOlaT4MBZxtGMkVlzOCCFUKPQCu/ENtN9Og/Iz5iRywx3we9eY/tB63Lo3wskt7dwsutXa2rHOG8pBvbHsSFB+tel3OMEgZ9K474l/DVPiO6WcervbXGkwgQxbcxiSQBm3d89K8vAqLxcZT2Rd7I+NY+tWAMsOvWvV9a/Z98baRG08Vvb38a9RbyZbHrg159f6LqOkzIuqWNxas2doljK5/OvtPb05/CyJTRmSISwAH4CnrGwPIIFdT4bOn+couce2e9dZfWmhXVifKeNXUcEHH51w1sf7KXI4swdV9j1H9mPTxpHgbUNSnCg6lPiMjqVXj+ea9VEwZm2/hXC+BbcaT8MfD1uT80iPMMcghmJFdFZ3BdsFuOBXyWNxkpYiUX3OuKVkdfpTKyop5PTFX9XYLaYXvxWRpOVuAoPHQ1e1t9sap6jNeoqnLhG36C6nOTtwdorwr9pORf+Em0lUXDrZAMfXJr3G4b+FT1614d+0v8AZlniuDcE3UKJAsXtjOa8rJP959R1tYnjZ1FLBg+8+YDkbTWdr3iG91lkW6md44/uhjWRK7OxZzkmox1r7yGGhF8zV2ZxppaslSQq3FLJIzkZJIHStHw14e1XxNqa2Gh2Ut3ctyQg4UepPYV9E+F/2e9GsI7aXxZqct3dgbpbW1O2MccLu6nmoxOLo4b+I9S7dkfNdvC8pxGjOeuFBNTHTrt42lS2nMa9WEZIH419y+HvDWj6JbJBomj2tvHt2ljGGd/ck1uxWSeUtuLeBYm6oIxivLWcSm/3cNBNPufE3hbQpDAZ3hfp0KnNRXF/Db3bKkTlgf7uK+yvE81h4e0+S9nt7dQRgIiAMx9MV8965eS6rqDzSRxICx8tFQDaKweLm6j9rH8SJvSyOT0e/mvb22s4YmLzOEjyO5NfW/hvwPpWjeFp4Zo45GmhIkZgDg47fjXk/wAJ/Ag8RX7XN4zxWlucgpwS3se1eyeKry08PeH5I1byrS0iLsznOcDue9cdaopyvGOn6nRQXLB+f5HnHh/4Z+H/ABdo+l6nr0tw0USO7xRttViTwCfpXqusaRZ6nosOk3ESpo8UQEsbHjYBhUP4da82SXTtFd4p/EAtNItQC1tF98sv3snp1HWvLPiL8d5dcil0vwxDPY6ahx5+795L7/jTwrqV4clON0ul9Pn/AJbvtY1lShRS1vpr/l/Wh3HxC8d6P4W2abYhY4I12x2lmBnaOm49AK0PDFpqeoaMmu69BHo+jsPMihxvuZl9STgKDXkXgmL4d3ttDeap4gY6ucNLbalEyJv74YZBH1Nez6iupX+nQyfa7S/0lVAVbadZVPHAOD0x2rnxOFWHTvFuXVvbXsjg5k23JWXRf1sc/pfxNstd8X2mg6Tbm30/zGd2UjEmwZwW/u8Ek+2BXUeGPEdv4i13xNp8LRNBFaBgyKQpGSpx64rz+TwfYjUWvdOVrG4kUxMI+QwbsFrpL3SbbwjosF3LAzasQI4o7VivJPVvXrzWMqtCStTu/Xu9P+GX5G1Co56y0seJeNvhD4h8NKt/Bt1TT3bcstqCzAHplev4jNc9rWn6jpdvazahp9zDbTDGbiBlBx6ZFe5aF4o1uPUb7QdTkaG7sHO2MHB8snIH4ZrW8Szz6h4F8SxTFrmM2DhUcbsMSMEeh4rt/tivGtGlWgn536P5GfuzlZM+adNc2d/DqGh6jNYX8Tbo5I2Ksp9mFey+GvirdXbQ2vj22jKEhf7askAeL3ljXhx6kYP1rwmCJlxt4JGKu6tdvp8CQRSZeZMuM8p/+uvdxOFjibU56/n94QbeiPq+f7TbWsNwJIrzTpRmG5iPmRSjqCG/pS212kpAVjH04Y5U/j2r5W8F/EDxJ4MEkehaiyWkrbpbSZBLBIfdGyM+4wfevVvCvxc0TW54rTxDYjQruQlRe2ZL2xY9N8ZJZBnupPXpXhYnJcRQfNT95fj/AF6Fyh1TPTb0yrqEjtkxscgqcjHpmiOTzlKcdTj61lObzSWUM6tBKA8ciMJIplPQq3Qg1bt5beRw7uttIx4AOUJP8q8hXuYtag180reXEWCAYJB60kjgAxqMnGTj+tUYoZra68uYYBJOQchvcGo4p/Nnc5zuJAzWck+pDZpGUQugilZSuCWUcVvWetW95PHC6xwuRtDDjt1Nc7eYgQbiGc4AUfzqk5bbuYjB5OBzWTTi7opTcdD0SxlEEyyK26MHqDkEd6o6pAYb916oTlTjqD0rmdF1wabDIt0rzIxG1d2No9veux1OeGaytriDDg/u2YHdgjtSrR5qTv0NoyUloYdxI1vJHLHlZIyGBHrXgXxV0FtE8USXVrEo0vUibm2ZCCq55ZOOhBzx6Yr32b5g2fmI9awdY8P22u2Vxpd1IIYrj5kkK7vKk/hYD9D7GtMqxv1Srd7PR/5/Iia5tDzr4WlZfij4VLKGEkq4BOOdjc/h/SuqaeRNUuQrtgTMCR3+auA0R5/DnjHQnv0US6beoJlc/KQsgz+GOa7zxlGLHxrqkCvhRcMyHPGGOc172OipODXZ/oYv4fmez+F5vOtLdxiRWiHJ65HFaUzLBdo3ylVPzAjgj0Irhvh7qGzS3wN7o23lsDn+ldTcTKV/ecOe+c4rrhVUsMu5cX1PP/CltaeCPHniuxuQbePV5I3sguCnlHLAZ7ckj8K7yQ5iJTgg9+9eVfHiWRRoF2mAPKeA7cghlOQfyNW/hp45h1SBNL1SbbfDEcTydJvQZ9a5JKVSPPuv6RTnaVmenlTLHmJQGTkn19a2LFwYlkPygLkj2rN0ly+UxjJwQw71trbEIEQqOdxz6dhXVSi1Hmju9ClrqyC7lVI+QC7cnniuO8d3Vxp2hjU4HeOS3mQ7VOA4PBDD0xXYPbrGWB+dh3POK4X4qgXVlo2lBCTe3qKTnoMgfjwTWypc1WKlsunktwT6nQIyNPHNLhYFUStnpgDdzXmngTx68njPUGvWEMeoXJkB7Lk4C/TAFdN8ZdZh0fwldWcLKL/UF8mJVOGjj43N+XH4189yStDMpXgqARg4xXlYej8TRUnypM+0o7wvHtTlgeoNZ+s6dZ6tavBqtnb3cLqVIlQEgH09K8j+E/jqS7xY6hIWulGFY/8ALQdvxr16+1S2sLfdezxxvtyI+r+3A6V2uvGUWqrtYFrqj5t+KHwLfS7GbVPCc0tzFGWeW1f7yL/s+uK8dtfD/iC5szdWekapNa5C+bHbOykngDIGK+07rxE8hKWURSI8F3AJI+napY59SmSMmeQL0RFO1R+Ap0czl8EFzepDijlPDmlamfBHha0FhPHNBZqkyS/Kyt34PIrZispbByLlJpZVAYJBGWzn36V0C2skcRkklZyTg8nNTj91GzI5UnnHauGplftZurN2bNFOxiWesTRyKi2M6t/HvHIrRk1X+0FQNDIvOM47USOZEIAZO5Yniq6SZJGWOOpzgVhODprkc7opO4xoXmuRb2yyNMT0K9Pqe1eFfGzwR4j1nXL7UNJsWvbSRE/1UgLKQOflzk/hXu9xfy+Q0Nu5TcMM44J9hWaYdsbOmVYZyPWsKFVYSp7SktfwCS5lY+EpY3jkaORSsiEqysMEEV1/ww8CXnjrxAtlDILayjG+4uWHCL6D1Jr6W8S+B/DnihYzrGmIJQSRcW2In5/vEdfxqvoXhVvDerQpozxDSQAhh6SY9Se9e7V4gjKi1TVp+ewtep0nhHw7o/gywmsfDNqYPOx51w53SS4GOvYe1dLZWzMQdu71Jp9narKR5IBXOM5ziujtbPyFGRXmYfD1MRPnqO5UnYr2dnyMrgnvUHiTVLDw/YefdOvmfwJnljWxcyLbwu68uFOAe5ry6+0K71rU3vNduPkz8kKHoK9DEV6eEjyrczs3scF4h1HUPFmrkxwu7sQI4kBIFcZPFcT+KIdAskP2wyeXKcchu4/CvYvGur2PgDw59ptLZRqF1mK0Udc45Y+wrI/Z18JTTXdz4n1YM8khIhZ+rEnJb8TXHSnKcXUkt9vPzCNK8rX9T2TwlokXh3w/b2UAG9Vy59W718wftM/EC4uLqTw5bjywDmdlbqOwr6G+KvjO28GeFLrUJ2BmKlYYycFm7V8Aa1qVzrGq3OoXrl7i4cuxNenl2FVWam/hj+f9anTOSS5ToPFuuCe4uLWxkcwu5Mj5Pzc9P8a5yAO4ZYlLt/dUZr6e8X/BXwdpGi3erC5nv7l28wIsyxxLnk4A7e2a8ku7zTLdWt7HT4Rbrxujblx7kV00sXThH2VGN2rX2Mqyabk3/wAE4e30kH57x9n/AEyTlvxPQV2fw9Kx+KtOhs08iNnO4Kx+fAP3j3rOeXTi/wDx5On+7L1/OtXwjHpcfiPTZPtr2rCdTmbBX8xRiqsqtKSkns/60OKpKTR9H+BrVLzxLa+djbGGl2n1A4/WodeDP4pjN43mItymB2C7ganj0W9gf7RZzRyH7yyQv1FZmpQav+7uItPu7qZZUwBGT0PrXxFNyXLBR1Tv+RutKbi+pjfFeCHRvi7p19jb/acTRMT3PGD+da+kXa6fOwmHmWs48udcZyvt9KwPil4X8a+LPEtjf2WkmJbJBt86dIxuznA3Hnp2rrl0C6EMTXs1nbSugLRPL8yn3wCK7swg6bhOD1V76+bt+DHUg41Xy6/59TxT4l/D+bRJ59c0C3l1DQpMuBbqXMDHswHKr7mvFZzJ5z+fuEpOW3DBzX2LeeGr5AJdL16DT9S28eXKy5B7MQMEGsm70Pxdf28f/CSaV4X15RlUjv2jM7Ie6SDBHtk5r1sFnXs4fvEnbfWz/HT8S0/I+Tu1XNMGyQyAAkDvXtXiL4UaXqbldKtb7wtqgOXtdQJmsyvqsyglef72frXLWXw61fQ9bht/FGnmPT33GO7jfdbTtj5VEq8ZJ7Eg9q9ynmFGvG0Xr26/8H5Ck7rQg8G+NNS8NiSGCcXOlzEG406ZsxSDP8P9xvRh+tesx3djq2nNrOhXKPpyYMkE0qrNaHONrgnnnow4Neeajay2EqPpgjtHQkjbGCB27jn8a4ye1e3cyKwLL65Ga4MRg6OKfMnaQ/Y6WZ9A6fqbYMchW4tuoQHOPcHtUq2yqoayYTAHLJn50+o/rXjVta2s1ppz6NrE0mqSw77m0aNozFJuI2K38fGDx61oaV4j1fSLkl5GZlODuGf/AK9eZXyxxbjGV2hSwztueo39wFEGwKZGJJ9hTFJcnc3A9TWHB4q07VrdBcqLa9QcOnKP65HUH861LK4jPzRyRynHVWBxXl1cNOCu0YVKM6bu1oKyeY+yIkgdWPSup0KUwWK2gYFNxcn1OMVyVrLsjJ4ySe3NPN00D5DFWA6d655xlL3URGXK7naA5lKuDjsDStAJH3rxjtmsjQtabUknSdIxJb7R+7GPlxjn3rUhkHfINefVg6cmmbKSZ5X8ctMS01W0vY2P+nJlgRjDAYPTr2qx4kvTq3h7w14hWPBubb7HcH/ptD8p+uRg1Y/aBdvJ0JdvHlM4fI5+bGK5Pw5cPd/DjX7NmydNuYdQhXHKhyUk57Doa+swkXUwVOct0/wbt/kRU0k0elfDa9xcSGRTtVAQo5yQfSvQ7kygCeUhW64PX8a8Z+G9+RqsCkghuNufavU57mSZsNJvY8gA8D2pX5IygRB2RyPxyuPM+H1kd67k1MEZHzcxnp7V4Xa3DLKHUsGByGBwR7ivZ/jMzP8ADroCiajFgkcqSrfjXh0O5mABHHSuzLHz0LvuxVt0/I+nfg/40h1y1FlqkgW/tYx+8Jx5qDp+NerxSN5OXAVmO489PQV8caVezaVBC8LlZpHWTOcfKpyPzNfWnh3UP7a0Kx1NVCJcxCQpnOD3rpoxam306fqXCd426mj8si9DjqT3NeceLdT062+JmmS6pc+TY6NZPeyh+FLEEIB2ZiW/DFeh3V1FbW1xc3UgitYELu54AA618qfGbxA2uaw97G6NZ3TqbcAYPlKvGffPNbJczkk9bfnoabK5X8ZeJ7nxR4nl1K7CxxOvlwRqeEjHQfX1p/hvw9f+LL6S10wIPs4UzyyHCRqe+e564FY/w88P3/i7X4NJsk3ZG+WZwdtug6sf5Ad6+p/D/ha08O6DFptiI9w+aWYjBnf+8f8ADtXBUpyj7tPdDjNSjqcj4c0LS/C77dEt3m1DbtfUJxmQZ67B0Ufr71fTS5J52aQySSvyXc811C2DIcYQdsqCTVyx04xMHZnJbqetcUMtnVknVuxNrZGRb6YqrHFtC5I4PU/WumW2SO3GSwbAJb0qaOKNCSCW44LVm3moLDIdhEj49eBXrKnRwiuxWbRYu5EWIb3Eaeh71lXN5CiEQ5Zicbm6fhVGe4ad9zgszHGOtWbW1WGQNcbGkxlYTzgerf4V5eIx06z5YI0UepHCjyqHnLCInA5+Y/8A1qkvoSkcTIAFDYKj+dWJiySK0mGJPXHSi5jEkByQg9W4FYSpKMHzO7He+xmsAHU4OP60rgl8LyakZreM/M5l46LwKz9S1u00+REnnW2U9lG5gPWuCclcpIl+zyqSSmBnA3ccVG1qzeu4dNoJritW+JMCTuum2qsQcLLL87HHf0rkr3xfrGoOWmvZVQnJSN8fhxWlPCzl9n7xOcV1PYIjcWk5e1lZZBwdvP51oW3iHWIgBlpVz/Emf1q14B1WK98PWtyEjB2bXwo6j1qzf3/nMdgCoDxx1rWbjhoKUZtN9F/w5aVymdavbgjz4sHPOFIrN8aeJrDwp4eGqX4kkkclIIBgea/YfT1NWdV1iy0cQHUn/fTgmC3U/PKfp2HvXmXivQNQ8X6vFea5efuoxtgt4+EiX0+vvRQpOrLnr7CqT5VocXpCa38U/G0LXjsw3AED7kEefurX1tY2droWiw2sQEVvbxgccAACuN+Hvg+Hw9Zw3FsojduvHLCuV/aO8fHw94fGm20mL29ypweVXua9F/vZqEF5JGkFyQ5nueD/ALQ3juTxb4qe2tXP9m2RKR46O3c15XDA0pAH511ug+FNX8XGWbTLT/R4v9bcyNtjX/gR6mqV1p0mlXslpMF86NtrFTkH6HvXv0J06UfYwfvLc53J9TJutX1K8iMVzf3UsQPCPKxA/CmWF6bOVAWPlZ+ZaqEY6mkMcjKzKjFF6kDgV1+zhbltZFPXc64bJkV0OQeQeor334ceL/CGoLb2U2kadpGsOnls8kSmG4OOSHI+QkjofwrwvR7BotBgLH964LAE44PSkTJ+R+p4IrxMTRjWvBvY5pN03dn2dHKLaLyV2wxgAqoA2/UEdqlXUpfLCKxCpkcGuG8NarPp2n2NsWE9lHEqeS3PGOx7VvQPDeAvp8oEjHBt5WAY/wC72NfPxx3LpA2i1NF/Un8wQ5clu3esS+j3T+XzlfvseefQUs99NHcENn93xtYdD6UjXMRcbiUkYjPGRzXPUxFOs7sbRU1O1kjsknMcoty2wOBgZxmsSVmcqxZlVRwM5wK9A13TzeadDaRqM2v3cdyRz+tefSxlJpI5EKBeDkYOa5sTR5JbaEzTSGQanqMEDRwXc8cbHJUtkH61YTxNJHbCznsrW4tW+aWFkG2Q5zkjuc1lX8pQrHFgM3zFz/Ss9w4zht+TyO9KEeuxj7SUepp6/oNh4sk83w2oi1ER75bCQ7c8/MUPcd8dq8i1jQL/AO3NHLbOVjOMJ93P1ruLtpIpla2nkiuInDJJGcFGHOQa07bUpNXuHaO6jtNedcnzSBDfN368JIfToT0x0r6PCYico73l59f6/E6aeIvpI8ih0qZZxtjEJVsq6MxK/j2retLOfUjNLDD9oljj3yhUIJHTPPX8K6BdfnBlg1GzVbtJB9+EckHkNmtSXVbK7iLajDEEUbiFJVo6dbFTuuaP3HbGpG1mcNK+BFE0YAiyVBGDz1FXbW4gYqWgaHHR4Dg57ZqDU9UsNQ1ieDTPMeJWCx74tqycdgehz+dNjizcmCRHhlPyjnjd7g1o4tpc2jK5mtjag1GeF40kl3IvJ81NrH8a04L+1uLkqXMbhRjzCAG+h71y8LTpmFyWUHG1jtKmtbTLhLQtHqtp51pJyxJCyL23I3c+1csqFOTtLczlh6dR6q3obWlSm21X7RHIyISVYEZBBH61a0nx7ptxcfZbpXtpwxQs/KZB9ar3ukRWtj/aHh68a+0w8syr80Dek0R5X03LxXEeK9Ovbu+OoRxQASoCwRxhiOOnY4rJ5dTqS5a3bR/1ozjnhakNYanT/G6ZJ10go6Mps5CCOx3jNcl8NSk3/CRWUhLfatIm2KDjc6EMP5Gsm/knNtaJcrIpWGSMFiTgA54rS+ErOfGlnEjInnwzw7nOBhomr0KWH+r4KVO9+VP8G2YSbclc1/AU3k31o7Nj94q+5zXtEuyNdkORIOqqK8N8NoLa8iDcvHIMH6Gvary5SO5kijTdNnLMD69q48S0pt9zOGxx/wAXwzfD6ZmXcftkQLZ6HnrXjGlwm5u0j4CZyzY6Dua9W+MTSL4StkAfE14uWI4O1Sa80sFNtp0kpz5kx2Jxnjua68svHDPzb/QJ62L3mG5uTIB8g+VR6KOlfRnwRm3eBmNxP5cEE7FndsCNcAmvnPT4mldUzx0PtVzV/EmoroT6Dp8zrpzy+ZMqH/WMPp2rqne6hEdPR3Z0fxn+J0/ie6k0TR3EOhwybN6Eg3LDuf8AZ9q5k6Le+KvENjo3hy0eWcQb2VhtCDjc7noAMf5NcqxZJEZocyIwKoc4c56Gvqvwtpsfh/R4bKwWP7beIs1/NGvLOVH7sHrtXpiqq1o4Slpq2/v8/wAjWPvp3NXwF4V0zwZpf9maOzTTylWu7p+szgdB6KOcCu1WNTgYwvfPX8KzNKtzFENxK59utam/yVC4J/WqoQfJzT3eo9NkKBjKlfu8j3pDIqxGV3EaDkt2/CoL68isg7SZ8xhlY8/z9K52+vJLrmRvlHYcAD2rDE4+NFcq3KUS5f6o0q7IFaOLPry1VbW3lvZtkK7jjJJ6KPc0adYvcjzCxjgztMh/pXR2zQ2lsY4VCQn7zN1J9fevKhz4p89V2j3KtYh06zgtlRlbM+MmQ9j6D0qCe3/fSTTbUA/iPX/69Zmt+KdN0lG8y4jEnYE5J+grznX/AB5c3bMmnBogTzK/LY9h2rWVSLiqdGPzE2luel3WrWlrueSRPXfIQAPwrmdV8YWRP3nu2HGI+APxrzPdNdOz3EkkrE5yxJzXeeF/DES2sd/qsYO75obfHUerf4VzVKcpL33clTb0Qy31LU9UGbSJLK0PWdhk4/2R3+teV+Mb+KfV7hLSaWSGM7fMkbLOe5r1X4i6hLpOhvMo8uSX92gUdK8Elkc7mJ3NRgaDcnJqy6GdWf2SzHNyA27A5zVmzcyMyqN3OfoPWsxXcjj7wOMVeWTykMcfLN95s/pXpTVtiYnsHwp1Rja3dihPlphs+prX8f8AjK28GaGbyULLfz5S0tyfvH++fYVwXw1vINM/tO+u5BHZW0BlmYn8h9Sa8m8WeILzxb4judVv2+Qttii7RRjoorzsNgPrGKlKfwx/qx1Oo4wS6k2p+JdT1HVH1O9vJJb+RshyfuD0HoK9i+A8eteKNUMt9MX0216kj7zeme9eJeHtLn17W7WytF3SzOERcdPc/SvuHwJ4ctfCXhm2sIAA6rl27se5NetjOSKVNLX8kFCLk+ZljxRrVroGjT3lwypFAhxnuewr4y15dT+JvxESJPMfz5BkqMiCLPLH2A5r0n4/eMl1PWDotlLm1tfmmI6M3p+FW/gfpUGneErrWwQ19qkjQAj/AJZxKeg+p5rldb6pSdfrsvmXL35W6I0NbsIdP02Hw/pIEen2cYjGwbRMw6ufUnrXDw+ErC8162udS3iKN8yIvHmAdBXpd3agkyDkZ71RmswG3oBk9sda8GjjKlNtp6v9TGablc+YPDPhy41u+EZdYYARvcnnHfA9a2/Ev2S2vodBs1UKZFEsmOdoP86NIYWl7HfaWWWWI7jG3Jx6e4r1+ODRfEuhyXwsYJbnym2loxuRwOmRzX1mMx0qVSM5K8fus/M55VLyXMeZ62IEcJaNmKNQFHpioLPTJtQiNzEjGID5tvY5wKw3v5oyyMoOCQRV3SvEFzYALbOFz1DdDW8qU+W8dzoqShNWZ79bzLa2lvFdSxxMsS7wWHYU467pqgKb62XY2QQ3zCvHbjxZHexK9zChnx827OWqtY61p19J5eZLaYcYkGVP4ivnHk0tXO/yMUmtj3mf4gaFK0Vtq0zTszEG9hUs8fGBu/vAfnWvploz61pocpd2U7h0uIW3RyIOScjpjHNfPsiSoN20FD0dDuB/GvXPgN9qisNavvtEjWokjtRbHld7AlmGehAx0655qnl8NJX1W/W5cajl7rPYYITJulmJLM+fl9a5bxppsHmDUncoGIjkJGQGxwSPwrtLNSlvGwPB5z/drJ1OGO7SeznYCG8jMG49nP3T+BxXo47DRlRtbU0i09zx3V4Zkv8ALHdGUARwcg/SoIQXYnbkjjrViOe40+Z7O4h3eW5SZJBwhBwfoc1Nb2azMzWj7ou6H7y/4185KLSsYON2c5duGklGMnPGKy7qHzY2VlDDOSCK1Hj2mR8fxenekntzHZzyMMPsPJPNdcJctrGb1MDUdVuDbJaziO6SPJBZf3i8dN45x7Gs/VNKvEsonsbuG80m+Qnz4XOUYfeSReqMDxg8HtkVZkjUKI0GN333PWp/hYtrF8RLGW7QtETKsUe0v5kxRhGNvc7iAM8Zr3cHyyfK/I2p1GtGzipdDeNOVdm3feVs5/KtGO6jS0+z3O8z7srMTyPY+tdL4otvEr6lFZeIoPsGFZi1skas+D8xbaeWHQjtUd34BslsTcl5ZQV3q8tyiKR+Ga6a9SC92roetTpua90zvEd2ZdWujFDBa/MoaK3VjGCFAJGc9TyR6k0tpqW238q4kPlHgBlIA/MVlLqsUHlWEscYSPcFnQ72PpuPf0q/Z6hMEUDIzz0ya5asG1qiOdpmno15Hb6rBjU5rKFnAmuLf94yJ3+T+L6VRuL28QzSeY7lnLorwgLjPXjpWlYhL0Ml9pTzjHEwjJZfc4HSoriHTo2MSwvEccNHKf1HSsOdL3XE1jO2qZkHVLd4gl7Zbt3eN88d+O1S6J/ZFhrNhqWn3ssDwTLIbeRTkgHkBsdxkVDPHskxFJKoyeW2kGn21o8gV3ltQ5OAJfkP1yMiunmio2WzKcY1FZpM1Lue1bWbqWwbZA8m6NWYFlGe9euuWWQHhQY0bp1yo5rxnVIp0mWW/vLYsMBWV1l6D1Q5/MVt6T4jTRraFEkiuQ+TLM0hlwDjaqx8kHPf864p4d1Lcr6f1qYPLOZXpu3rt952HxC0w654TeGHLTQuJVyDxg4J/I147ftH9tMUDAxwKI1GeeOteneOPiTp+n2AsfDlv505hVJ7uWQhfMPLKq4+YDoSa8rPiWRHWSawsZVLY2iMDP4jpXTgqFaELWujCeXOO81f5hqd6bS1W3t2P2mbAO3qAew9zWXNpup2Fv8AaJ7O7ghHBdkIA+vpXp3gjWPC0djqOqx6Wq66qMIo7gCVEyMblB79vasSTxROILbUrWBJ4rdtl3p7PgSgkYyD0/Cuym56xhHXrc0p5fCMP30mn0tqvmbPh3wQ6+FfDt7emZtW1zU4ks4eMRWy5Z3b/eVT9BivoXTrARysxVsMcAjB49q83X4gaNrPie1vbXTLxJNOtpY/stziKQXG3a0KjoD0GfTIxXavpPi+8s47jVvFcGgqwyLXSLJXKZ7GWTJY+pCgVyxSlJyrPWLf4mNXCzoqN9mjtYFAG0I/yjPTpVDUNSW3JFv803949F+led3nhrVHUqfiF4qKkksd0S7vwAqofDPiIyt9h8eawzsMKs9rHKF/AYqcRjIS91TS+TMUrHXyzNJIWkO4nkk9Sas6VZi6mDz5S3UZbnrXHf8ACP8Aj+ziiY+LNDuGTBdbuw2Fl9yuQDXGa98Q/GDpc6bdpo1xBu2GXT9yZX2JIP5V50MH7ad/aRa+f6pF3Udz1LxV8QtP0Qi2sUjv7pRwFbEcf5V5hrXjbWtWkYy3TwIf+WcPygfTvXGQ3qjm6sLqAsxBZDvA9z14q7ZPDeQLcWshmhb7rYIP5V6NTCuEeaWqXzRlJyZZaQyNuldnzySeTViJ1BXpxTYrO4kyFiYntkYxWN4zvLjw/p0ZEafabglUYnIj9/rXPFqc1Ti9WZ27h4q1820TWtjJtkBxJIp+6f7ua9/8FXsuqeH9Mu5M7nhXIPrivj9ZGa1QsxLOxYk8kmvq34bXSW3gXSnY7ljt8mrxlGNJR9WOm9WcP8cdbafXIdNQ7YbVMsOuWPevKGcZ4J56AVp+LNUOp6/fXZckSStjPpms23wsZmkGVU4C+prenG0b9zFvmZchxbwEsAZn+6PSpbUNKwCoSWPYd6oRMHYzStgD/PFW4r+VnWKE+XHu/E0pxfQu6O7f4a+KNU0N7WOS2sbe6ZHk81+WUdOBUkPwGlEW1/ENuvHy4iPzH869h0ZC2m2XJJMKglvpWva2ytEzNjINeVQxuIfuwdlvsdbhFHFfCP4X2fg7VpL67vY76crtiZU27B3rufH9/qcehznQ7OS6uGBVVQ81ejSNI0wASR2qz9qjjHULiuzl59astS1JpWR8T+KtI8QQ39x/aOmX0V07bnHksevuK9o8BSo3wt8OtBIzGIyQzKwwUkDHK17Nqmu2emWRvtWmt7S0HJmuWCg/TPWvEPHXjWzvtQtbvwldB9LdWJAi2o75+Yge570Y5LEUVCHR/oQm4p36nVxHzEG/g0yW3Yc9u3tXHaX41jaJUurZlYHlkP8ASuo0/X9OvBtjuAMdVcbT+tfOVMPUp7xGmmfNUmlarpmqPaTWlxFewvtZAuSD2r6B8AaXFN4T+W1EGpkFrmAHBbtuH4VlfE2xOj/ES8WPCxFVIA6kY/wpdJ1SaCWOSCRlwQQRxn617eYYmdaCjKNu/r/w5yz/AHc7PY8l8b+FrrQb2UtEzWbNlJNvHPY+9cmy4NfXGum21rRVluraOe1uR5dxHt5Rx3HpmvFfEPw2uI/Mn0aVJ4yT+5fhlH1713YLNYWVOs9e/cmfunmAkKnHDL6GrGxUQTwjCnqBztNMu7eS3maK4iaORTyrDBFOsW2OY3HyPw30r2W7q6KjPl1I9N1PVE1OGPS5ZDPNIsSQ/eWRicAbTx1r7J0GwttBsrbQ7eOFZoDvvXjB2STkAseeSByoz6V4j8BvBy2+p3vi7VYoZLKzMltpglGTJd4BEgXGMICef7xGORXs2lyMSbiRmeZid5bksW615OY4mHto04dN/wBF+pq7b/1/X/BPQ7Mj7JGAHPIHOOazNXRi0iE/IPmB6EEVLp90r/uhJkYGB3NV9SkZ3ZR0HykNW+IkqlLQEcL8QNHkvUttcs7cmWQtDeBOcsuMPj3Xrj0rzk6m8d2q2shGw5YjrmvdtJuWiuWgQqYZlZQXAO18cH+leE6tqMmpeI77S9S0qDS9RtJZPKmUbfMYcskmOCMchq8KNJVLyXz/AM/PuVOnzLmW5ryS2+pRgyNHBeZBXHCyH396rXNjeywSRw2k8szYQYjJDEnHXpXM2PifTrDUh9qhN584X5sqic9fU132q6zcagBcpc4iZdyrEcKo9gO1YVqc6LTaMbJ/Fuc+vhPVojM1xbRQiBd8nnzoo9MHnr7Vi3Pg25t2mnfWNHUwqLjelyQVbIwFOOWye3pV/VpXmRy77iy856sa5m/Uuioeh4Irqw0qr1ul8v8AgivHsdFqjahrdxb6hqsEEmtfK/2zzF8u5jUADKj5Q3GSepzUfjTxFNfaOtrpGnxM7AhpvJXauOw965TQr+TTNUHnHZbOQrhhkAZ6+1cz4rsri31fUrq0iuP7PM27zo1byxuGcE9K9anCVataq/NPv5HRSxMoLlRNFot+7Rvcq2yQFkJcIGAODtJ681qpfXWjzeVJHJKVODC/8PturmdCvbCwImn01ry6DZSRpsKg7ALg5Pvmur8K3el65ry2mvRT21vdblV7ZhlJDyoweME8c+tdmIpv7SvFFqpH5ksV/JMnnQ3IjkzzGGIYfjVy1nF1G1vOIhOPmSQgfN7Maw30i507Vfs1xFIsyPggDP4j1Fei+DPCDazqDm2tJL5bfndGuQ5B49MD3NebWUIxvHXtY1oRlVlypnn99bzNcROYvLTJBby+Ce1TaLYS37OYoP3aHDyt90fVjwK9L8caTqHhdJL3xbpuof2fM6AumJIkXoFLKcKfStDw6nhjxzf/AGOw8w2h8sRWvmrtU4+ZiAAT+uKXtqkYe/Br+vl+J6FbCezipUp8yt31/r+rHOaHoGn3CxXb3CPFbvl3+9Hkf7PcZ/Os3S9Vg1LxZdtqPlGeV/lzGqKx6ZCgAdq6b4lT2dtr8uiaaI7bT7crDGudq8Dkk/XNcq+h6bJqFxdwR3t/pawYlv7WPb9juQPvqv8AHHxgjvkmtsNhZ4iEm3ZPY6KeIWElHq+v+RP408JwIj3sUJj8kFpIwucjHJx7da8lnMakyrIrxk4G085r1nU/ictto0drqMCXeohNo8o5EqkEBs9wR+NeZ6RFZ3Ovi38TWGr2saqxEOk2ymdsnIyHIzgHr6YrtwEalFShU1S2Y8zlRrOFSn8T3sUrfUJdOvILm0baw5wRlXHce9dHH4kj0DWzq+mwRz2epWzW19aXKZDI4G7HI+YdQexArT8UaL4X0vSo007R9WjvMhvO1G5RzsZcj5E4U55IyetYsvg7Vbvw/Z6v5aLo08wQyIdzRDcQWYdQvHWtFiKTmqnw9NepzVaM6VFKo1rseraDrWl+CtUK+GJbi70wrDdP/aCAvMSAW7dRnII4+vWvZJ72bUpo5IiZhIAy46YPSvn+58MXdz4js/C/h+RdSl+yQA3kTF4oV5DF26DA7V9N2aWej2FvY2R3tDGsfmY5OABkflXiYxSnO8XvqZ5jKlJU1HdKz/S5StdHC4kv3x38tf60uqanY6RZPPKYLe3Tndjk/wCNYni3xTZaFbNJdXBe6IzHAPvH3PoK8O8R+Jb/AF65Ml7LmNf9XH0C59q5qVHXT7zyZTtojf8AG3ja816R4LYtBYDoo4aT6/4VyUas3QbeOlV45C2wYJY0zUNUXT4XVcSXWOI89Pr/AIV1whb3YrUy3L1/qFrpMPmXMvzEfLGPvNXF3Xim/lu1eHZbRBgwjiGM4Pc96s6V4X8U+KpjeWWkXt6juEM2zbHn0BPGK7fT/gfrc6+ZrOqaXpSjjaXM0n4qo/rXZzYbDL99NX/roCi3sdQupJqGlWepowInjAOOgbvXm/xZufNGnREDjc1eq6Z4Ct/DXhKeC88RNdzJmZVhtjsX1GSc9Krf8K/8KeKbTTb+/wBU1tVVG8yOGJAGJPAUnOPxrx8LOhQxPtOb3VfUHTk5Hz85YQ26j0r3nWNafQPAml6dDgXE1uFO3qBtyTU9z8IfB1xIptNV12CJF2qkqRuS3qcY49q6rUfAvhXUZVe6utannWA28ZTYiJx97biunGYuhiHBKWivf9BqlI+boQ1zOw3fL1Yn0qaWUzSBFwIIxgE17RF8HNHFtNFb+IL5pnBCk2oA/HnpWbcfAnXEiAttZ0eUDkqxdST9cV1RxNKbunsR7GSPI5HMpAGQi8gCtLSojNe20a/eeRVwO/Na+q+A/EGjzTLe6bM8UZ5nt0MsZHqGFa3w50w3GvwOqEJAd7Me1TXxEI03JPQUYPmsz6DtQILWGMgKI0AP5VMt0ojCx9M5JPrWbA0s8g2K0hPpVPXdb03w1HHJrNwAZT8kSnk/U9q+ZhUqVJctJHfZbs6SF5pjiMMcdT0AHrXlfxL+M2ieFrd7TQJ4dZ1o5U7TmC3Pqx/iOewryz4ufFXVPEl/LpPhi4ubfSEBSRbcked9SOcV5ha+H76dd7qkCesrYz+FfTYLKYwSqYuXyIc1Yl8VeKta8V37Xmu3811ISSqM2Ejz2VegFdt8No7rUfDE0MNvJKLW4wGU5+8M4x+H61yieGIlVTLfLnuFX+Ve5/s+RW1rpviPTYJTJGVjugjp8+4HbkN6e1dmZ4inHDNUlt5aCjKMvdTF0PwTeXDK92Rbx4zg8tXfaJ4M0uEqJIWmbOd7npWvZRErkjdj9K27eFYoucgsK+OderWd27IuMIoo/GD4Ux+NbiHU9OvPsOrRJsLHOyVR0Bx0I9a+ddfs/FHgu4a11AZYZ2703BwO6t3r7bnyYztGTXnPxc0pNV8J3UQtfNuY13x+zD0Pavt8bhqbvJ+upXsY1t9z5w8KfFG6spLi2vooZILhdp2jG1uxro7P4kaHNMsF/A1vKPvHbwD68V5JqllH5Uk9srLLGx3x47g88diKoTP9otVuFOWXCMT19q87+z8PU95Kx584te6+h694t1nwTdkSXipezAEL5SnI44Ga8YkTzLxktI32yPsiQnLcnCj3NLkn7vArpvhdYHUfiR4ZtzE0qnUIpXReflQ72P0AUk114XDRwydm7efQz1PfGsYvD2g6P4YMvmSaRFsmcDh5nO9yPxOPwq1YSM8/J2ooz+HrWJqN8t34g1C4ZtyNOzBlOQ2T2qzHMxGQSpYgbc9q+VdVzqOpLrqbzdm0uh6DojqilSP3j8rx0GKu35fbuBHQEYGcisXQnj3R5PJbaMnvitK8uyxSONMgLg17saidKzLjsZN4RlscDHIHavK/2gFns7my1m0tiialGsM9wMcSouCvsSuDz1xXq1wWbIZAexHpXMeOtIOueC9X0yONpblUF3bBVLMZE5wAPUZFeVTqqlXV9m9TVXaa7nzQhDYycseBkV2vgXVREx0u5b90/wDqmz0PcfSuMQcA4IPTn1qzEXUqwO3HT8K9zEUlWg4M5NT0+/gZGCBgSTwR6VnTWS4GAN56n2q14bvl1bT1WUASQ4Rjnqcdfxq/LbEgkfeU9BXg+9SlyPdDOPuNLEpJK8A85GfrVrRmvNPQwW0sT20jhnilXcvpz610clt5sYcEbupHrVaO3DplOcHlcck+1dHtuePLLYLdjjfEvgppLiW+0l7eONhua3+783fb2A9qi8L/AA/17V83L2txYaZCd0moyW8jxpjn5QgJY+wH5V0HjnUtV8M2jLJ4e1Lcygfabm3dIF3dOcYJ/GrPwo+OvijQbuG11iMatoo4a2jhVJLZPVGGB+DdfUV7eAhiKkP3m3Tub06V/iOT+IfiTWft39n3Gm+SY1DQ3dxbPBJcRfwyBXwQrAZxXJ6Z4j8QadfpeWOsXlnOrbg1vKU/MDqPbpX0B8XvBXir4nayni7w1Yw3+iy2ka2QFyiu0YBJO04w24tx+FfNesWd3pt5NbajE9tdROVeCRdrowPII7V6WHwtKjHljFI3SUHeGh9Bv438W/Gzw/H4K0+HTY9Sgj+031xLN5a3iKRt2Ljg5OWH8ulea634b8bfDDVIdRnsbnS5El2Q3cbB43Yc4yOCPrXMeEfF1x4W1PTdS023jXUbK7+0C6DsHkjIAaFhnbtPPbPJ5r7l8ZaLp/xj+FVutlfvaW18sd5BOq7tjD+Fh7HIPTpVzgldbo2jJuz2PhnV/EWp6zqkt1cPuu3kaWQfwsepOD/KvU/APivxX/wjk+nW+lLK8y7/ALUrIhWM84PPQj3rhfHHwv8AEHg7WIINYWP7LcTFIryJsq4GMtjqOD0ru5Fit9BtrDSolsNMiUm4ufMPm3Lf337DjjA6VyVsTToQUafU66OGqV5OU+hy6eG7GTVpDd6jIoWMmd7GIYhbOQN7cZB9Kh1LV1l1xbm3l1C/vMCK3lvLjeyqBgZwB78Umtass0CWGnxfZ7JMkL/E/PLue/t6U+ytE0/RLrVJhiV0KwcZ4/vVy88rJ1OuiR3KEYp8i9WUPEN+b/V4YfNEcUrrG/TAQAA5/wAa9z+HWveGRZwaYt9NqKQqVTTrK3ZYz6tI7YBGT0HFVPhr8GNAvvD9nc+KtWEmpazbiaC3t5AHhVwCDn1wRxiun0H4T6V4Ae7vp9buJYokO1WjVCi+rNnj9Ca4cZUp1IOMdXH7r92cs6tGrUvXb5V2O3h1i2ktfIsHhggjA/dQbSFHvjp0Nef+NPiDBpxe10aQXF4OGlPKRn+prh/H/i02dnPqkE0sNleFIIlhxmVFX1/X8a8pi8Sahqd5FZ6Bpry3kpCooUyux9lFZ4XDVcRHmey+R5mLoOnNKKsmk/S62Ozuri5vruSa5eSSSQ5Z25zmm21rLcXcVrbRyTXEhwsUa73J9gK67wD8E/EOqrDqXjzVrrT7Y/PHYWzDz2PbcOij8z9K980LQdO0WKOHQtMgsigwZgoMj567m6muz6tLaL+45HCKPF/D3wi1/Ulgl1K5i0a0kYhlI8y52/ToufevRvD/AMI/B+hwvmyOo3Dtkz3rb2B9h0Fd0sZztBLnqT71Z2COMmUZz19a6aVBR3FZMyLqx2wCG1CxRIOET5Rj2ArAurAeYCoLY5IrrrhHlwu0AHgbar/2a7jlFG3t61yYnBRrbItaHD6nYCfTrxAhUGFwefasLwFaeZ4TtDKcYZl469e1ek6laKthcHyiCsTbuOMYrA+GekqfCNlKW3sXc5Pb5jxXA8uafIvX+vvF9oSCwwn+pOD/ALXNWE08OwUAnB59q6v7AI1BK5GOhHX8aihszcyuTtRV7YrdZYo2RVzLgsCrAgqEz90ck1pCykdVAT3Y9hWrHaIrAIykDA59almQAbFPzMO1dsMHGC2C5UtITAvlhmVQPwqkdG0yCGTyrC0jDZLOkQDE+p962VtxvU9Ao59TTWZPJKuCsrdhWzw0JRtJId2jk9R0mWWP/iUXht5MEYuD+6x7YGa+bPi34e8TWepzTa3Zy3toq5+1WyNJbhT0+bHH0NfWUkJkXnCgcE4rOuWe1jdUZWiIKtEx+VlPBBFcXsI4Z88UOUnNcrZ8IrLIMBQEXr8gxkVbjdiDgnJHfmvoHxj8J/D+sMtxoDp4fu1yGhYNJBKfzyleL6l4a1bTNUXTr3T547pmKxr5Z2y84yp7itoYqlV+FnJOEovUy4oy8ihQS3TAGTXvvwZ8M3GjafqN7fK0dxcw7fKPdc8U34efDS00qyTVvEW37WuHVGOEiHv716HoWt6bqeo3WnaYTcSpFuaVR8qjPTNedi6kq1oR0j+ZrRjyu73LGnWm1RISVHU5FWnAnl2Lye7egqzNthhEcZG49j2964DUPibYadfy21tbNdwxkKZlOA57/hXBLDpS9kvmdPMlqz3kEEZHIrP1O3SeF1ccNxXzFcftSXMP2mOw8PRMuf3LTTngf7WBXI3P7SfjaWN1VNNjZn3BhFnaPTrX29RupFe6PmjF7na/EL4eQ2Op6ne2DbJJB5wjI4cjqB74rwe/t/suqNEvywXK7kA6D2/OtPWfi94u1XzRf3scpdt3EYXb7DHasTWdQa807SrncBId+5R2II5rz6WGq0p67PT9TKvyy1RACyybCeQcGvTvgPEYvFWp6szBYtL0ueUjbksXHlgD0PzHn2rzZZP32cKQwB55r1b4MRt/Y/jXEbl3tIIxIF+UfvCSpPQE46e1TjZ8lCb8jkh8aNzTpVJUZITd1IzW9asVLkAFuikfw56msHTIgFH3vlP61rwyDdCEXLc7ufevk5aPQSZ2vh0r9ttEVg4RcsffFbS7VgjIdTI3LDPbtXMeF3Eep26u4Dybs7e3BwK6zT7ZWtY5WYZAy2F59hmvVwb9pdW/rQ3j8OhUkJKN8uPq1Z7yvHIskGUlU8ODxitS8lBkISPeVJ4I/nUIjWRflhxjnGcg1z4imptotNnzd8SdIXS/GmoxRvE1vOwuojGCAA/JHPocisO3tJpCGjQ7emW4Fe1/G/T5RpOkakzpIY5WttnlkugYZGD6ZB/OuA0rwlreq7WWzuTGW6lcfiCcD9a9CjWfs0pbrQUqbcvdV7i+CEt7PU0W9vAkE37to0XOG/hOelekfZtNTKCKaZs5BZ9v8qTQfhxdw2cIh8N209ypLPc3+odT22ohwAPetnVtC1zS7OXUNT0nRI7G1jaSQxXjR4VR1yc1xYilVqS54wf3Fqk0YNx/Z1mpmeyjSBVLs7yN8uOSTXkHjH4mRXcv2Xwjp6WbrIG/tEFi5Kngop+7z36/SofHfjW78XWx07QbGaLTMK0ruQXlYeh7L7dfX0q14A8Drq2mvLbyQNNC+y4IYHym6gDnuO/TORnivayzKZW9piFr0X+YlZanqnhjxvr3xU8Bz+CtctbddX1BdkGpSuIkmRCHLGMAncNvVRg+2K8a8beENU+HfiGCDxLbT22nXThZJLWQMZod3zeXzjcBzg4wcZ61el8Saf4Mvnmm05bvxRassthdLcPGLIg8q6DhuO3TkjvXsfxUt3+OnwY0XXfCVuLjWLK4DTWUbDfGzDbLHzjodrDOMqM17skoWaZqm53i1YP2aviJoa+Ib/wNpLXq6Tlp9IkvpleR8DMiHAAGeXCjp8/NcJrXwM17xn4r8dXdnrMLX1jqrQxxXxYtMjKJFJk5IIVlA4wcdRivEymteCPFkZmhm07W9MnWQJIMNG6kEfUHj2IPoa/QLQfF2ma74U0/xBZ+TGmo26TSFcZDgYZGPcqcr+FZVZcvvJlrsz89/Evh/VfDOqy6br1jNZXsf3o5B1HqD0I9xxX0H+zV8SG8PeEdT0PVo3aNH8+wJIA+b76nuBkAj6mtv47a3pGsWQiuLGK/uoFIspWlZTDIWG5sD73yjGDx37V4THp1rbESlnknbkkt9z2rlq4jnp6PU2pwSlrsd74x1+fxNrUt1qNyZzEpaOIHCr2CqOw9TXES3E058mJd+T9wE7f/ANVLqM0giVIp45UZRuIyMH05549uKn0SzuYbhxK4yv31Aweelefy+zi5t3PVoyU5KLCy0OVdMnupmYRtIFJA4OOSM/jU3jJnaztoIwxRgFVR0P0/Ctm8uDYQfYTxtXMgPOCa5y81mZdW04oAklkAeQCHBGM4PtWVJ1Ks1UetrtfodNf2FOLhe1v6Zj6VPNa3EU0E0kckZ3RurEFSOhHpXRrqeo3MDpcXtxcwzEeYk0hdXHuDWdqlj5GpMqqPLkwyjPAB7Vf0y3JOQCeOdw4rerKE0pny9SnOnUcJbo0bu1sdW0VIL+IA2zBYUjYrsT2/lXVeBPEsvhCF4/Dum6VbMy4Nw1vvl+pcnJ+nSsLS4/Ju4JjapdRRuN0Tg7XHdeK9Kn0nSNFs5dSu9FV9XhQS/wBk+duEYc4jZ1z+O3tkV506zj+7jd9Ur9TqkniEnf3kretuv3fkdX4bHiXXbTzZ9eupWdgzC1VEVfQbsV2+iaL9kT/TLy7ucksfMlZhmvBp/i74iEGyyFnaR8ArFCBx+NUz8VPFhcE6gCOvEagfStaUUverXk+3T89fmcLkloj6eR0BYxkADsO1N+0RkFpCME5XnpXgNh8bdWRgLnTdPmG7krHtOPbmvS/BfjV/Eumm88uOzIcx+WRkHHvit55jGnrNWCKT2Z2jXokwxwe2PT3p6zrkYYHjgmufutV1GHlkRVPIbAYH8arya7fMARIg46bQM1nLNoR6Fcpta7dw2+h6lOXyEgc4Y9OKpeAhDb+EdJik2hmhD49zzmuU8TeI7u9hh0q3dRc3Djf8mdqA8mt+PXpYkWNEgOwBQdnUCp/tSmpXe1v6/IlK+x01xKkiFd4IB55p9tcwIhQEbwPvY61yz67cyZBitt3r5dEWuuMpLb24OeQE601m9O97D5DrjdRqvyEHd09zUXnRqMmbI7nPeudOukr8sFuwHYrVa51ZTFn7DFjviRhTlm9IfIdi04QcyAn/AGepqqJ987OzABW2nPNcvHrUalQ9tgY6CU8U9NUtWZsx3Cn0Dg5NH9q0pPcXKzqvPV3Y4BVSeprAlT7XdTYBwhA56E1U/tWFoyrGXHvjNEd3EOI5nJJ5ylFTGUqqS6ByjdVsfJtjKX9zxnArGs7hhcQvdZlgU8fKGKj1UnpWvql2JrDymlUEnB96xyv7oxgruU5AzXm4pU+dOHT8wV0YPxItNX1SxVtLklntBw9pCp83HqR3H0qn8CmNvc62qRFQVRGZvvKQT8uK6+SV9iyRK4fcAdnUDFRw6gNNluJLaCBLmdCTJ5f8XZmx1xSdRxs7iikpXMb4qeJn0yA6bbti/u1/fkdYY+w+p/lXjJCHIDMpzj61S8ceIL/Q/EdzB4msZpLiV/MF3GxZJ1PIZSevXp2qnZ+JdHumVIrvy2I4Ey7ef5V1ww1RR50rp633/ImV3qzzBm+b/PNESbyc9PWpFhJ3BlZWBxgjofegIYuAOM9a+quuhV+gkMi286yuiyBTnY3Q/Wr+rPvFooRUAi37V6Dcc/4VlMjbvm+6TzWrqgVr99oBRcKv+7jiomlzIiWjRcgG+1gfGSPlPvXs3w1ZV+FHiDZ/rG1WHeAeQoi4/UmvHdPJNg64HDg8969e+Esn2jwT4wtLdFF3FJb3ZOPmaIblYfQHB/GvIzC/sJpf1qjKPxL5/ky9YvI7FVIUEcnua1YXXeABzjGRwKwbS4BbcjBmOOFFascp3BUA2j065r5ecXcyudj4XKrrVnvO7DAZ/CumN0pjEUABK8NIDj8AP61xPhaRo9ZsWBbd5oHHvXUJJBas8R3yS5I8tG5HPc9q7cLUcVZvv+h0U/hL67CN3IBwOvX6VaRNrgqXIxnqKoWzsPm3fd9AcrVoSEKW3qQepxg1s5rc0QutRCWxtnKxPGk+fmwSDjriqzSbtpDGmamZRp8bI6eUs6hwc5OQQMdutZkN6ryMqdQcVNOredzuoO0TudJkLwLtr5z+OXju68dyS+E/BcLXlpaO0lzOnJuSnUIeyjB+v8+u+N3ixvDnwxuIbW4aDUNSf7LDtOG2dZCPTjjPvXkvwA8TaZ4Gur7W9am8u1uIDHGqqXLSKQcYA+99e1fR4Gkqvvy2RFaTi9D0P4c/C6WPwe3iTWW/s5fswkiW8G0QjC4fHXPXGe2OtebeOPi1fT6faaLo621vp0Ee1/s8YiaV85EjEDOeh4OOTnrWT8UfiZqfinxVf3tjqF//AGVMvlpbSyMIwuMHameAcZwc4JrzgoVYhwVI6gjmvXlU6LRHOofzbkuoXcl/dy3MwUSSHJ2jAr0H4G/Em6+HfiZpGE0+j3q+VeW0ZyT/AHZFH95f1BIrH8JeDl1rS7/ULm68iG0ZVKBclyRnGe1dH4M8UaD4ZSe1uNHtpJHBRriRBJIR6ZPT8MVwVcVH3oQXM0aRszd+Nt3H8SfEml3Xh6Np50gMDsUKHaGyu4tgDGT781laLc6j4U8Oz2FxqV3ARIxFqHDKGxyygjjNbvinxjFLaRi2gEN2BujXbjYD647+1ed397PeztNdStNIRgsT0rzITq1o8ktI/iRVqqLaTuzqbuQjTrJmkeeaWLzMtlmyepY1mSwfZSd7RyzOBynzKgPv6/yqlomuappDTDTb2eKKZPLnhDfJLHnJUg8Vf1llnLSWLxPDIu5ZOec9Rj1HStOTlNqNXmRlKPtMjqoxEhwXI6n2r0K006HQ7CFrlU80Dz5HbscfKn0GR+NcdpEsNtGRNDuxgrubBPuRW74n1CW8eNmZcSorOqn5eecVyYtSqSjTWi6ns4GcKalUlq1sYc08t7fO0/3WO447+1aOg6Lp3iHxQ9rfX6afFHZSOjnHzyAgKvPrk1mL+9vEhgJLscZxWxonhea+S5vbQrLOsvkIr8dBkt78mrqVI0lzN20OTESvTl5mg9rbWWroviK3eO3hXy0SFgzPgfyrct73RShNoqA/wQkcr9fWsSfw/eQbbPUbm2R3bzACxdx27Ctnw5pNlFe3GpME+waejS7mbAbbwM57s2BXj15U5Q5uZv02f/DmFbmqSVT+b9NzcWWTw68V1bwQ3GqBTIsTsD5BI+Vivdh1Arz7Ubma4vZLm7Z3vJG3ySSEl3J9TUuq3lxd3Et5csTJM5dnU9SfQ1VF7I2BKwmTHSTr+B6iuvC0HTjd6vqcFSfM9NiE84ycDkn61G5I6c/4VZeGGUAxsYm6bWOQfxqGaCWNgWXAPQjpXWkmYuI2IkAvivonwRpp03wlpkLDErJ5r/Vua8H0GxbUNZsrIcGeVVz1xzzX05HHHFH8v3ANoHsOleZj48yUTSnoyaF5IwRwEODtIyPpiobqCOWOVrOLZc8sI93ysfQelWCpaMBlKkj8apXed3y5ByOnUGvMqJxVzdGDHHBaySS3kii+fiRicY/2cegq3bXK3E3l2z+e54wik4qxqcl7PpU8mm29hcazApdY7pD+/VeSoII+bHTNeH6p478R62qwXN+bezLc2tqoiTnsQOT+JqsPh3ibyT0Jk1DQ9V1XxVpGk3Bhvr+JZVOHRGDEflTbbxh4YvE3f29DB6edE4/MgGvnu4QLO2EABJ59KRJRHuwMg16Sy2FtzL22ux9P2Uq39t9p02aC+tzkCS2cNn8Oo/EUhmVTsJKsOCGr5fSSSFhc2kksLZxviYqR+IrqdG+I/iLToVh+0w30Q6Lex+YR/wAC+9+tZVcsla9N/eNVo9T3QqM/KR609dzOREjt67RmvLY/jDfx7W/4R/Ri4HzEmQqf+A54rK1/4j+JdX2LFqZ0pACBFYJ5K4PqRyfzrnjllT7TS/Ev2kT2iaO4Uhmtph6koeaapmBBaOQAdAVNfOM+ueI7dy51vVGbqri6c/1pR4z8ULIsn/CQaoXUbVzcE4HpzXSssnvGaI9tHqj6NmW4lVQsUpwc/dNMaGdTlo2Qj7zHgD6183XHi3xHdp5F1r2pvGOQpnYfyqj9ru5VZJbu6cOcsHmZtx98nmn/AGZU+1Mn20Xsj6Sub42JFy1zFH5B3MwlGR+Fc9deM/D0Msf2zxFp3mSgtgS7h+OOn0rzj4b2S3niq2inTzbfBMyEnlccisv41fDGLwxKuuaNKJdHvJinlt96BzyF9x71VDD0pVvqtWo03qv67jWq57HpWq+Kfh54i0+PS/EWsWk1lMcbxndAf76nGVIr5r8T6fYad4k1Gy0i/XUtPgmZLe7VcCZOxqm9sxblQB709IFTDM30Ar6TA4KOCTUZNp9GVzLc+k/GXhPR/GxE8KQaTrwbc88S/LejuHX+/wCjd+hrx/x9PbRXaaPZ2T2n9mp5cvmxmOR37llPNezT+YoDBtjLyCDz9awfEkdn4mhW38UpvdRsg1VQTcQD/a/56KP7p/Aivm8szCVK0KvvRW3df5mXtFJ+/v8A1ueBSNtBycnHArY1BN92JeT5iKwJ4J4FXdb8D6la3Ep0djrtioZhPZRszhR3eP7ycdeoHrVLQoptTtGgtYpJ57UFyFGT5ZPp7H+dfUOrCcVUg7r/AD/IdRWV0WNPBEEynpgHPoa9U+COlamniS31CPMWmSK1tdMw4mifhlx69Dntiua8DeC9Q1trwSQmCCFBI7OMbgGAIA/GvZPGGp2vw/8ACVi87K+9B9nihPzN/n3rysXiHdwpx5r/AK6GEU5O6PP72SLR9d1LT3D7oJ3RVxzgH5f0xWvZSrJtZiE469smuf8AHbvL4ssdQYJE+raZbXbIDuILJ39+K09LlzAigc9Oe2K8ivStCMnv19eoVLczsdpoBMV9bOCcCRMNng811ccAGqXQGxGEzZZjz17VwmnuzTwyBgrKRz0wBXoV0Ibe/u3k25lKvleTyAaxw1ubU0p6xZZaQkKI3w57A9ajaSZHDM4dTxg+neq4kV8/MmD9ePpSyzIqhCpIA61Vap1uaoy/HWprp3g4yFwM3sDKM8kBskD8KzdLuoheSjPfP1B5rO+MepRw+Ara1Y4ee+DqMZ+4pyf1rlfh9qZu4I1lk+eI+Xn1Hb/Ct8NTc6ftF3Oqg7zUPIwv2mJZrvW/DdnAkkjC2dkRFJLMz44A6n5RWJ4V+CXirWQZtWiGi2YAdpLs/OR6hBz374r6W06z0+3ltdXv4ovOI8mGVl3S7MknZn7oz1NV728n1S681mKRA7FjU5G30/lXp/2jOjTVGmtRYmUYyZ51oPwo03T7mF9FvZY7yJ932+eNZH46FFI2p9cE1uj4X+H47sXd1aS3+ou2ZJLmUyGVj1Y+5r0a109rRTPKqhGUBRnkVBaE3GsREj5Qchc9K5cVVqxilOT5mc0by3OZ+K3hzTvDnw0nSwt4LVsCVxEoUFuP6cV8t2trFBKmp3J3zuS9vBtyP99vx6CvqL9obVraLw6ILwkpK4AjB5cjnH0r5cuLh7iXe4VRwoVRwoHQCvRw9tYw0W39fqXiJclkhGkaSQu7lmYksSetD4bgAAUbeM8fnU8aEuOB7A10NpHGQRmQFlQkL6Ada6HQbJ5dOu32LJDGyjqcxk98eh/pWVDGSw55J5re8PajfaS862CiQXaeTLAy7xIM5Xj1B6EVEpLqa05cruUNRRFjBKjfnjitXU9GC3FlF5hO6JHPOAcj7xP9K7a38Ay3lrbXN9az23nL5hWZMMAfbtS6kj6K8sdrA97fSKsVuAm5zxgKAK8+ribSUY7nuUJJ05P0OFmSGwtwlpskvZyYkKjlRnnH19a67Sri6a0tdE8MwxtMik3F4QcK55Yg/p+FTWfgo6RF9o1ryptdvB5cFsCGW3yOpPcgcnHSuv0zTYdKsIrG0wDgeZIo5du5JrycdjqfLyx953+V/wBUvxZzVJuo+VbGTBp0enW0sdqxe5biW7blmbHJrk/Fn2y28Gz6ObYo9zOtw07NgTxqSSB/wIg/hXoOyOW7dFytnbIZJ5h0UAZJJrxn4jeLT4g1gyWZaHT4UEVpAeqIP4j/ALTZJNRlcKmIrX3tZtvv0/4Yv20KVJxqap7d79/8zmrW9Glyko/nM4xIpbK49B7+9bkcsbqk1tloJORnqh9DXIbeR04rT0m6Nozq4Jhl++vp6EV9XVpJrmW55HMdFE25sNyevtV6CZ4wdrDaB8ynkH8KoQQtIolt/wB9HngoMn8RXWeDPD39paptvw6QxruZRwWPYfSvOrVY04uUuhcTd+FMdt/wkMNzPazIzKwilRcxqe5Ydq9tgiUfvWPnKvZOn41y9gkcMQSBEiRRtCouAPatSGdo/mVypzge9eHLGKc79DaK0NmVyymXGF/hXvUBgZI/MkBDHp/hUltemTJkCs2eCBjFW0VLkH5x8p+73zXVyQr6thtsYWxo5Q8bFXU5Q+hrzv4leEBfO/iTQrZy4YvqlsnRD/z2QdcHnIHTrXrU9mzEsijK8/UVmMkltci4iOMEqwBwGUjlTXNGlUwVTnSunv8A15DupKzPle+AWZwfXpVGVhk/yr1L4qeCE0/Ot+G7Of8AsZh/pEX3vscmenqUPUHtXk9y23JA5Ne9RlGpFSi7o5Zqz1Fur0WtlApyXuHOAPbFFvIXG4gDtg1T1R8TW8a7iEjB/E8mmNrAtIh56LJ6KBg11Km3Fcq1Zq6XuppmyG5G08GpQSSGJ57CsC18RWTOqyRTQg9WJBArbDlSvKkMNysOQR7VjUpThpJWMXFrcuRyttKKAy9welQ3VnHJloDh+pUn+VEbZPPfipUDbhnkjp71jqndFbrUxijpJhwQcYPFW4ux71pLGkoxIuSOhHWuj8D+CZ9e1FHUZskOZSe49B60VcRGEbyEqbb0O1+E2hGy0mTULhAJbnHl5HIWun8R6PD4l8O6hodwqiS4jL2zMcbJh905rZjtRbQrBGuxVUKq+mKpTq+N+cEHg9818fUr1Pbe32le51pJLlPjjU7O4sr6e0vUaK5gkMciHsw4NUiMcDoa+g/jN4GOu6fL4o0SCJby0TOpRK3zSjOBIo7n1r58kkRD8zD+tfomBxUMXSVSBz2adj6v1Lw7q0ahfsxuIWyEe3HmKcc9ufzrj723kMjxMkisOCHj2Y9sV6jK88ZdbSeUbvvFQRj6UyS684hdUgjv2AOzzot2DjuetfHez9m/dJcYni0dtc2F1JLp8s0E7qVeWN9nHpkdqyl8PahbXp1/w/eiLXBKE+wQwlmu1b7xUAYyem3HPXg17Fq3hEXJSbQYSzlcvakg7fdSeo9jXHR2k0cwlhDwzRtt8wfKynofoa6qeMlTevo79V29CbOGvQ6DwDr+napdTfZC9s/lmG6sphiW3foQQeSMiuG/advlm8TaLbRhB5ViCQvADHj+lQeOvA9ymmS+KLC7Md5Bjz4FBEroOsoYenp6DNeR3c895cGe5mlnlPBeRizEfU16uV4em37SlLRdOqdtr9tS4qy8mep61JDd6H4JvrQlmNh9kmfcWKyROVKn04xgemK1tPkVi0a8beSwPBPpXP6ak958LLUQEhNM1iVphjgGSNNpP1wRWro5HlrgMSxBIP8ASuXFRSUl2b/F3/JmNTf+vQ7Gzl2xrtGe5I6V3dwGu5dPf5gZLVC23pkZBJrzuyZgAqcZOPrXoUcvl6Hpc0aDzCjwgZ4G05zXkxspalUtU0Xy/wBnXCHeMcqMZqnJOxQK6gjqOeRUcAfadzAOx6/xGnSyKAFXhgc8jg1NZto2TOE+M3mHwfpbHc0P29gG7KdhyPr0rO+CWlQrHqWuaoinTLSVY0Vs/v58EhR644JroPH2l3Ot6fpGlWe37Re6kkaA9FJVvmPsByfpVu5it9OtbLQNKMZstP4Z0BHnTYG+U57sRXZh66pYRRW7bsJycZc67f5mnJqUt/OrzyZfARBjhMnoBXT+HrFFICqX2tvL44B9K5jw9btNdiNOW4ONucV6PbKLHTcn7mDk9CT9PWu7LqOntJdDON5O5U1uYJEIyfmxkVT0Jo4BdX124jtoU+d26ADk/oKpX85kldjkgHjPU15x8bfEd5pFla6FZuY1eEy3bAHDO/RM9OFAzj+9WNWTxOIutkdEGo6voeUfEvxbceLfE93esziz37beInhUHAIHv1rlFA3YH+TVyGxuLuYrbwyTMOQqKSR+VLd6beWFwI762nt2Ybgkq7Wx2OK9uHLBcqOWcnJ8zKi4DcnNb2gaPe63era6ZZzXVw/RIlyQPU+g9zWQYs4x+Zr6d/Zshij8D3syR7Lh71kkkA5ZQowM+g9KdufQSV2ec+FPhJrGo3J/tJo9OtUbEjMdzjn+EDr0r2vwl4M8P+Gph/Y9qJrry9rXlwQ7deWGRhfwrdMDfaZmUoinljj7tUr2+jWPyLXBj7tnk/WvKxGI9krS3OmEFuP1m9Romt4CCp++xH3jWLJY29rcrcQpGs7RqGZecDGeM9M96JpFwCOxqleWzoGeTzDa3EYMiI4EmBkDYCcAtyMnj8q+fnXniZyjHdnfh483NBdV/wAE5aF21HX7u+iHnqCba1VQTwD8xA9z39qp654k0fQ3eHVtR8qcZDW1qPNnz6Hsn1JrhfEfxQ1jUdltoSLoOmQDZFb22BKwHH7yTqT9MCuGdIbpnKlYZz1BPDn6+tenSyXmlzVnp2W/zOR1uXSO51fin4gXOs2T6Xp0I03RWwTbg7pJSO8j9/p0+tce8qyZLpG31UZqrKJIpNsg2nPQ+lKjbuR0xXvUcNToQ5aasjmnOU3eRKksA+SS1RlPccH86lFnDMcWcuZD0jk4P4GqZOR3BB7iljmaCaOVMZRgw/OtXF/ZZCfRmpoV5f6ZqUdxpcxhuIzy2Ayn2YHgivX/AAL4z0Od5YfETDTL1xu+3JGTBIf7rKOV+vSvJ7SSO4WR7QHH3mTuP8acOucHBrzsTh6eIf7yOv4myk4adD6e06BL+0jutIuLfUbWQfLJbShifqvUH6ilyY22shBzkhuDXg3gCyluvE1s9s8kLRHzGliYqQB7ivbtc8VT6XZNPd3MUxI2RrcqrZJ6df5185isPCjVVOLbb8jWM01c1Ipsfdyc9B6VpWVwqtwRuB6mubk8S6CbGKa6hdSEHmTafIJBuxydh/oaqab448G3SDy/E0NvN5nl+Te27xN1wCDjGPxropYbEUndK68i2u56ZaXKSsqLgMR8xpbjR43Y7nXawB2jnBrDttrOht7ywuEkbCNBcowZvQc1vWi3iceWwlUZweeK9ehVjWXJViZtNGUNOa0nbYC0UgKyI2CHQ8EEHqK+b/i/4APhG5W+05/O0C6k2QuzAyQvjPluPzwa+sc+aQJkYM3XcMciqup6TY6jY3NpfWkU9pcrslhcZBHrnse4Paumlho0nelsyZLmVmfCOtziGztXYBR5e3djrg1yl3Osrkrn8a9t+OHgmTwpLZxx2J/sRi6W9yTv5JyFc9m/nXi9zZruIiypHZu9ejgpRcdVZ6/mNStoyjke9dP4Z1VfKTT7nG0E+VKT932NcyUZGw/B96kWcIPlHPrXXWpKrHlZb1PTI4HTgjkHjvW9pHh3VNTP+iWr7D1d/lA/OvP/AAd4+1Dw1qS3Bt7bUbcKUNvdLkEex6g16nb/AB00qd0D6PPZcc7XDoD+hr53G4fG0/4UObzv+hCp2NjSvBkFrqttBq8xk8z+CLj869e0qGHT4Y47RFihQYVVGK8a0TxvaXepPqRX7ZhfkEUgzGPcV1UHxG03IWW1uE5714VWGJc17RNji0lqen7Y7jIkHz/3hVK/01lQkAEeoriT8TNNiUCKCdv97irX/C3LFYlCac7sOu5q2hhVWVqisDqIv75LG4E8CqJF455BHcEV8/fHL4eS2mqSeJfDtko0O9cb4YTuNtKR8wI7AnJH1xXq2vfE21uAfKsPKPZyeDXM/wDCwbV4rq11GyMlhcLh41bgkdG+orTARxGX1nKmuaL3J9omes3cqrKILUCSQjlyeFqhdTC12pBgzE4LMflX6DvUGn6l5gKONrt74Df/AF6huT5l9tFuCIxzzxmtpyVVXjuZc2lyzFcTQBj0xyWHB/So9at7fV421GJsXUWGuowvDL03j1PrVe8MiyiJSkfG4gNgVlSXLWl2HidQ55KjkY9DXnVk1oLntub2lRwXW5L23WS3b5WiZsB1I5Bxzg185/GLwrD4V8UldMUJpd8vnQRgk+Uc4ZMnsOo9jXteoazFYSxXUaTf2PIQkkuwsbR/SQjjYex/A1b8caZL4v8AA97o9nbLc3Cj7TabAq/vF5GGPqMj8a68BinhqkZv4Xo/PX9N/T1NYP7DPEfhxdhrDxfokrSuklit7BEp4M0RHzf98sa3/DjiayiY9cZxjiuV+FrD/hY0lpdTtam7tbi0Y7ctuMZ+QD1JGK7zSNMNrCsIJ+QbfmOMYr0MzcYTa6tJ/p+iMaqd9TZsM+au4qqqM5rvNOYP4SiZTxBcEHBGcMOlcNAI25Y4IGM9q7Tw1tm0LU7YSRuwCSKp7YPWvEugo/FYuQQoyltjLnqDj+dExbmPClfzyPrUkksMcYSSQrJnAVBn86iTZKMByG7rjjNXVWrsaIZD5VpINQlx5uno7xPgk75FMYHXtkmuVhPmODn+Ik9smuj8Ru1npC25YGS9cPwMBVTt9etY+lQNI0a4U7Tnp0z3zWVJNtRfQmq9onZ+E4JIvLdAEJ5LNxkelbeu3+cwHrwzH3qpo6JHbmVgWROx68Vn312LiUyMeSele/VrKhQVNPccFZDRc2djHPqWqyNHp9knnzsoySAeFA9ScD8a1pvDtnqNpaTa7p1tNfMpmkDpu2O53ED2GcfhXP3um32qXWh2cShNFW6S81NyMmYo2Yol9QCN7fQVveOfFln4X0aXVL9i0srFLeBR998d/YcZqcvowlTdWWppOXKrHP8AjDV9E+H2iNPaWVqupXORbwJGFz6u2Odor5o1/VrzWtUuL/UpXluZjuZjz+A9B2qx4j1/UNevnvdUuXuZTwM9FBPQDsPaqekaZfa1qUGnaTaTXl9LkrFEMkj1PYD3PFdsYpa7I5pNy0KaDOCeAPfpX07+zzLOvw9D7Fjt/t0gSZjgNkDJz3wfSuR8HeA9L8MRw6h4jhh1TXiFeOxY7ra0P/TTs7foPfrXardXV7Ij3EgwmdixKBGueuAOBXn181hTfJS1f4GsKXLrLc7W5msp3dDds9svVIxgux65b0qr5NiX/dWmd3AVnPHv9aybUOuQqRMw5YfezWnGWkRSEbHQ4HSuWKjV+KOv9dzbmZNMWP3baEFfugIMAf1rOv4k1GIpq1ja30XB2zpgHHQHGMgZPB4rRWAS/NGSM9GycirNvA5lEcyKWxkSdN3sa3hhryutAVSS1TOSufB3hXV3jTUfCWnIkZJX7Ipti592Ugke1Zmr/Bbwfq7RGzs7zRRHnItLgymXI4yJMgY9uteoeUkKfOMdcDOeaj89dmVKoB3bj+dejCl7PSUhcze54Pc/s93jWTrF4jtbiTOIlktmTaP9pwT29q5e7+BnjHT723S0fSb4NkmSK52qns24D9M19MyXcaptaX8E/wAaRHV03xRkIOWd2wg98niplWUdFL8v8hcqfQ+YtU+B3jOC3FxDBpt67MF+zWl1l1Hr8wAx9DXBeJfDuq+GdRWw17T3srtohKscjKxKHIBypI7H8q+m/GHxh03QGubTQYY9W1SGMsXhcCBPX5v4iO4H518yeJdd1DxDrFxqerzGa9uDlj2UdlUdgK1oznJ+X9f1sZ1IxjpbUzbVngmWSIlZAeCDjFdfotsuvs8AdItRCExs3yrMR/Cff3rkE7kj6k10XhaOZr9JrcfNbFZjuHHB6fjSxa9xyTs0RB6m+/i7T/AWnyW1syXmtyj94qHIiPYE+1eXeKPFmreJplfVLguq/dRRhRWr8W9Ih0vxncS2ShbHUY1voADkBZPvD8HDj8K5G3jDyAv9wHk10ZdhKCpxxSV5SV7vf08ux1+zUDsfh7p2p6pqMFlZzSIJ2AJJO1V9a99+Kfhfw3oPw9jP2dGvogoScffZu5PrXz34d1i50u8S8tnKLHyo6ZrS8X+OtR8QWy292zFc5JB6VlXoVatdNbDVW/uWO6+G9v4e1+3lstTjMeqR/PHOZNomX+79RXd2+naLbuJG1S5V4xtBF84K+w56V802mpwWko3FzjoUPSuit9Tiv1DQM289Qf4q4cXltRz54yaRlNNK6PoFPGuj6FbP9m1G/uZtxfy/Pdxu9ck1gR/HnX4L6My2FlcWat8yMCsjKexYcZH0ryZJmA469xVWQ75wGOAzDmqoYf2fVv5mXM+579rfxx8F6zoN9pPiXQ9TCXMZDQoFkH+zhsjB98cV8uN++iyuQy9M88VPqkpmv5nOPvEcdOOKrxNiUZPHSvVo0uRc19WU5NlaVFmG08P61Va1kUkYBx71ZuFKSMB2PWopJj5fT5s9a7It9DSLa2K/lOP4TTTxUv2mTjnp0ppmZvvYNa6mmokUjxNuidkb1U4Nb+m+LdRtNiXLC7gUY2S9f++utY1oIZrmOOc+WjNguO1bMXhmW8mmXTLiKdYvvEnFYV3RelZf16kya2Zu2njGymOLiKW1Y8Db86/X1rTi1/TZGYJfRbQOd2Vrze4s5oJGSRPmU4OKhKkD7p/Kud4CjLWLJ5E9T0afxFpuBvvQ+f7qk4qpFf216/8Aos6szHGzkE/hXA45rT8OzrbarDJIQFzzmlPAwhFuLdyZU0lc+lVkeRgjk4POOw/Ct2wvhIVUlBcBdqs5++MdD71kSRCPB+U8YJzVO5aTzBg7VXoQK+NhJ30OZaO5rpFLI8szqNxyWL/w+31qjqG1ZAsrEuR8vc496uaRerczqLrabn7qPJgK49D/ALXvWXNFLLf3hliKFJCNrHkYq52kl3BpWuiuZ5oFeOMgwS/JLDIMpKvcMOhrNh1NvBurQGC6ubnw5dOFRZ/v2snpkHp6HuPetCeMmAu7qqjjuTWdOxS1uYZk8y1nTZNEw+8Pb0P0pU0leMlo91/XUUZdGea/Faw/sPx41/pV35sN4Vv7aeMbdrE5IGCejDr9K9e+1Ra5pVvrllCIra6UeYqciKXHzIT69/oa8r8W6Ylnpx0+URXEtswubW7RmOYiPmiPbI4z6EehrovhhrLTXcvhyXzHhv0WWyRR924C9P8AgQH5gV62LpOthISjq4de6/4b8UzacudJs6+3yqKNwP8AdrsfA0jNqNxHx+8tnX8QMiuNiaRW8uQLvUkFfQj3rqvBNyBr1oWAUMSp3D1GOK8Jq7M6b5ZIvQbQVeSTLEE8jqau25DR5V0BXtiqrqtuZBKrmUMyhQfQ479BUonVLWaW4OwKhOUAHGKptWuarR2MnxpdBdQsrZAGMdsCWGfmLcnjtU+iQuyqCv3m6g/54rC1+Uya+qqxxHHGhZuSxCjmur8MWKzvyGIXk5Xj862wkbyv8zOTvUsdLMY7W0EZk+Zhnr1rGgRrm5SCJSzOf4ep9asapIskhX5SE4HGPyqfw7AVJuUUMykhM9BjqTV4urzSszeMeaVkdPOI1u0iBUC2iCNg7QpblmP0AFfLfxf8XHxJ4mlS3f8A4ltmzQ2yDGCP4nz3yR+VeofHnxRdaJo9jptjL5V5qCN9pcH59n8X0yTj8K+eNPtLnU7+3sdPhee7uHEcUaKSc+vHYdSfQV7mHhyUlF9N/wCvLb5GdeXNLQ0PDGhX/ibVV03SRF5zKXkklbbHCg6u57D+ZNe1afZWXhfSH0nQF/eSKBeagf8AWXLdwD2TPQCksrCy0DTU0TSFhbaoW7vAmJLmTqxLddueg6VYgtV3Avg4/SvnMdj5Yl8sNIfn6+XkNLl0W4W9s7mNZPmIxgdsVv6dbvFlTwT2JqG0hAUbcMD3xg/StS0QI6hwWB6Zz8tc9GlfVlpWNSwhHQsVYdsdq0rJSrsQxZeoIqrBCRIoUMARkY4OPepxMlnGVllyx5Kryf8AAV79Nwo25ug7XLylN53AncMkAYyaheaO2l86QkbT/q/Xis+fUXIxF8mR1ByT+NUlMlzMsUCmSVzwAc/iaivj0tIIajc0bjVmZmKJtb+83J/D0qiGuL+Y7P3zICzFzhUHckngAVx/iD4geFfD7Ol3qTalfozIbHThuYMDjDyH5V569TXjPjX4jax4uhbT5imnaQshYWlkMB/TzGPLn68e1Z06GIxWtXSI5OMNz1HxN8XfD+iSXNvpUMuvX8fyCRTstN3s/wB5wPYYPrXjvibxrrniq5L6vfyvb7spZxHy4I/YIOPxOTXOy27lP9H/AHgX+HHIqsspz0A/pXqUMJSpL3Fr+JjKo2aXmSeek0b+VIowNgxTpraKYM8YZZ25Kdie+KriQ5UgjJOCKniOWGSc/wAJ9K0d1qhSm5u8ilHGVbDAgj1HSu58FWc5trqZQCuNuD1NVvD3hq48QSmOIFGXnzmHGPevT7bR00mGC1QErHF1IwWPqa8nMsdGMfZrcujSfxdDida0S18SaEul3hjt7qJi9leOv+rbvG3+y3H0PNeN3Ol3dhqElhfW0ltcxnDxupBHv7j3r6HvbIFWVgGDHv2qey0jTPGVjJoPiuSVJ7FSunajHjfbhjna399M44PTtill+Z/V04yfuP8ADz9O/wB/c2d2rM+crhgu2JB8o7etULyVjLt6BeK6PxH4b1Lw54huNJ1OCQXUTkKyqdsyZ4dDjlT61DBostznZZ3B9/LNfTxrU4pSvoRBWZzQGa3bB2gigeLhlGQatzeGZVg3Rhw+M7WU1TEE0FvEJ0KkZAz3pyrQqq0WKo7o34pvNiEkZBPVl9DQT++3Z/hJx+FZNnceRJk42tww/rXda94J1rQrCK+vrcfYp1+SaNwykEZFcFRKDszG2lzzhuSTxSRDMqjHftSuNrEAcjipLXmc4xuCmu5uyGUbp90sjdiaqsT0Per88e4Ejr3qg4wfet6drG0CI0VIE3rkEZ9KaylTyMVrc0GVJHLJFny5HTPXaxGaZWx4cOmrLM2pfeC/u89M1NSXLFu1xTdle1zNS6mVt28sffmphcpKAJAFb17VXuWVriRkGELHGPSo6OVPUVk9S5IAoGQMdiKjBjLDjB9aZFLsyrZKHt6VKURF8zO4HoKVrbha259Tab4p0bW/k1COLRtQ2/LMGzbSvkcHumeevFP1mxu7NC8q4Vlysq4eNvcEcV5b4sSOyuzPp+46XdSMLcORuUqcMjDtj36irOleINb02xxol64CqSbWUCSFx3BU/wAxg18ZLB3SnB2v0e3/AADkcukjpSDId5bc2eVY1rW+oLfQGzupdlyMKlweAw/usf61zWmeJ9J8VTuhhi0PXsgR228/Zrg452sfuPn+E8H1qUNsDxzxvHMrENG4O4Gs5UZRfLNWa/q/mgtbVGxqyPbmG2lBWQDcwP6VQmVXV0CHkdznNXLHUYryOK01J9gj4huurJ/st6j+VK8NzbX8sMqLvByrdnU9CvqKyaaepDXVGFrVtcXejfYowzpGTIqAdyMN+JH9K8sS5uNPvrW7spWiubYq0bjgqyn/AOtXtUIWEklsyA4wK85+I+kW+n6p59hE0VjcMXVGbcVc/e5+vP416eWVkpOlLqVF3Vj0mG+h1fSLHW7XYqXanzY+vlyjhlP48j2Na3h2YLqlpKSQFlVuPrXlvwm1VEvb3Q7pj5OoRlrZScBbleQfxUEe5xXoOlPtlRXBUowJJ7YrzsXh/q9VwW269P8AgbEPe53mrxpHq9/lsN5hIHJ688+lYXjW4MHhW/EDATyqsMIxkMzsFxnt1rrby0F7r6RCRVe7EewsTzlR/hXCfGq1l0K+0HS7lmFvPqETi4Vf4VYH6Z5HBrOhSlJwstL/AJa/kjqmneUkT6lCp8TXQQqSkgX5WyMgDPNdpoYKWE8xxtbCKQcD3NctKIv7Wu3/AIWlYjIySM966a8CW9jbWykhlUM3bDHnP8qvDtxprzMYfE5ditOGnuUjQZctheck11Ohbbq0tpbeaOOwjQyPLt++EP8ALPevMfHfiSPwl4Yn1aYJJclxDawtx5jnr+AGSav+JPEWrJ8DDqWsxRWV/rCokNvBkCOFugOe5XJ/GujBUXVm681otvX+tPmdMGoRb7njPxQ8TSeJvFl/fl/9HRvKhXOQI14H58n8a73wB4Zm8N6N9ulYDWdTjAwoIezhPO3P95uCcdOlcZ8M/Cw8Sa+bi5YJpmn7ZZty5Er5ysf44yfYe9e4PGZ3Z2DMx5Jp5piJWVCPXf8Ay/VmEFf3jItLKOKJSfMMo+8znhj61r2sCcO6YbHXsada2wVmDseD2rVsLKWTEyuERGwzOOB+HevLpU7+9I0UeiK9nAWHl4O4njHOa2ILWOAh7lyXXgRg8n6+lM+0LbgpaxFFJJLH7zfj2FU5d3nKVwGPBrp5lCJaSRfe7OPLjARBwAp6/WqRbC/MR+AqOR9odum04z61HcXFrYQRXGrXEdvBJkxK7hWlx6eg9655VuZ6FW7ly1gkuFY5EUCgs0jDOfZR3NU9a1aHSrETOfsttHgsc/PKc9Ce/wBKzL74k6HZQk+Y15Ki7VhgX92g9Nx4ArxXxh43bXr0PduJo4SfJt4gVjTPv1NdCwE60Uk99zKdeK+E5nx7qX9r/EbXL5II7dJrl5DEhyF4Azn1PX8aqWdlNKAVAWPr5jnANaS3jSTSyiKCMyHLFYxz9T1NMeRn4YhsDp2FfQOpKyjboZSmnqZ9zpUsskguNRFrEhGxbZd7P7k5GP1q+1ppEqDdFeLIuP3iuuX9cjGAaawUEEKMH1pBtHB+YjtUucpJa/d/X5k+0ZJ/ZWlzBWhv7m1HcXEYcZ+q44/Cuu8J+HvDJmSTUtZWcjH7sIUTP16muRSPzAByD6Gp7K3kuLhIYUMkkjbVAHJNc9dTnBx52vu/yBT62Pd9E02WO3kfR7V5rAHIkt4yygfhVq3b7bdP5yrsAwFK4ZcCs7RbK/0fS7W2tLiWMxIP9U5X5u/Q1qrrt7kDUkh1BguwGdTvQHqQwwSfrXy7dNtpt/1/Xmd8KtlqYOrWQ8/bGD5ZOSR2rIsHjtPEURkOVkPksMdfSu5W50SVyggvLFyRumeTz1+u04NZereFftrrPoMqag6rvaOIFXBBznaf6ZrSnC/uRd0/62epcuWSvF6nSWSxXrw22rFWMWUtbmVQxtyexzztOB9Kyry2vIJpAqwqVJU7VBBx6V01zpTAx5Tl4wSmPmzj+dTWKvet9nukBlQfeI2naPbvVRoV9KU9H0f6f5f8MZys0eP+KtMu72zkBCbgCwKrivENWglkMkM3DxyY+bjFfYlzosLiTkEdq+d/ivoC6frkrEYimXPA7ivXyudShPkqddjlkmndHPWPgG4ubZZW1GzijK7vmNSa3qEuk6aujtrDanbqMIm8lYz/AIe1ZWlXOi+UFvpLzdnBCNwa6/Q7n4e2sqS3dvLKQQSrZPFehUnVjP8Ae3kuyj+pnzO55pJbSnzGETlV6kKeKigG2ZTnGOOK981r4jeF7KzW10bR45YpFwSyADFeJX5i+1zSQoAjOWUDtnmuyhiJ1LqUbDbtojHLbywZSJFPI6VVlAckYAb+dWdXYJdRyJkF13H3PSqxZZBleD6V6UNkzoS6oqkYJHel3HoeR70+UZO786ZjNbGg5UDkBSAxOADWlqmgahpUEE99AVhmGUYcg1nKoLKG6Z5rqPE2uPLZW1hFN9otEUY3dR7VhUlUU4qG3UmUmmkjkTSVM8Y6qRz2qLGOtdCZaYU+N9vB5Q9RUdFPcZ7bo8kDLd2t7bxSw3kbKXl5aI9pF9CP5ViaXFe2l21ldLJHLAeQ4xkdjj0IOau6nObPR7u4IifbCVB9zx+dc94P8Q2+o6nFB4pvnhVYfLjuzyWI4RHPYY43dsCvmKdKcqc5xV1/Wx50IuUHYt+KdGUM93B8wbmRR2P94VteHPG1vJbi08UpNLPlVj1VTukRAMBXX+If7XX61sSQLGNgCtG38Wch19vauY1rwq+GuNNXOeWhBzj/AHf8Kyp1qVaHsq/yf9f13Gm0dvc2kUtkL7Sby21OxDFWltX3NEf9tDyv41Po2r20ka2WpF2hJ/dzAZaE/wDxPtXjdlcXul3iz2U01pcp1K8H6MO49jXb6drQ8ROgt7SC11ONAr21vkLcn++i/wB491H1FKtgnTjvePfqvX/NDXkdjeWv2TUJI2w8J+aNlOQ4PcGsXxRaJquh3cGwPKq+ZFxyGXsPr0q9oWrxOv8AZ+qo7W+75WH34G9R7eoqW9tn02d4pCCJPmjdeVkB6EGuC0qc1JboT0fMjw6CWSGRJYmZJo2Do6nBVgcg/nXu2m6pHrdha6tEqA3CYmRf4Jhwwx+v0NeReOLBLDxFOYIxFbTgSxov3Rn7wH410nwj1P8A0q90WbHl3a+fFk4xKg5A+q5/KvYzKmsRhlXj01+XX+vIbV1ofREjSPPoc8DESSQxrlfY1f8AjXpya94Hv2aMfabBUvrY9SCjjP0ypIrDFyYvD+iXsa5kiVlXPsa3fFN/OukQ6bBAZZtVgSCJN3GWIOCe3BNfOwqum/d7r790d1KzTv2R554E1KLxFeCSNgrecRNGRnbjk/pXXXk7Xl3MCFjAyxPYKPX8K8p+H0Vz4Q+IXiTTbrlmHkqQeDu+ZWH/AAGo/jT4vOlaG2hWcub7UFDTuD80MAPQHsW6fTPrXdLD89ZUaPW1vmrt/I5IQavDzMqUy/GH4r6do9k2PD+m7j5hBI8lSDI5/wB8gAfh71337RmsC7vNH8N6avmSQfOYYx0ZhtRB+H861fgD4UTwR4CuNa1eExalqCfaZUYYeOBQdifU9fxHpWH4Us21PxdqHiC9G+fzWbLHISRvuoPdVxn8K9SvWp4WnyQ2SsvP/h2VJ8zOl8I6JF4Z8PW+lBc3f+tu2JyGlI5GR2HT8K3o4OUKjG48DPU+lJbWsk0uyGMyEnoP51q+ZDYII4GWS5GcyAcJnsv+NfPN80uae7LjH7hsNlFbLvvGxKTlYQcH/gXpUN3dyTt8xwF4ULwBVZ5GkJYsWc9Se9CRtJlg0ccUQLSzSuFRB/eYngAVjOso7Gm+iJWmzJ8w49RSo2WyMknPJ7V5b4j+Mug6VNJBoVk+uTrlTcSSGG3Df7Ixuce/FZ9z8bdVkslNloOlaXK2D5mWnYj2U4Az75rrhl+KqR55Rtfv/luS5Rjuz1HxLqkHhvRJNT1GLzVQ7YbXdtaeQ9B7AdSewr5p1zxBqGp6zfajrV7Hf3FzgeQgIihA6Bc9ABwAPxo8T+JtZ8S3bXOsXkk7dl6Ko9Ao4FYawknkgA162Ay9YeLc7OT/AKsYVK/NotiS4vJrl8yMQBwqjgD6URYIGOppwg5GVyD3qWGPJxjIHAr0W0lZHOy7CCuO/FTopOdo7c02NCBgEHHrViOM9BxnqM1xyYyDb8+3mpI4eCeBxyD61MYf3gyPQnHWp/Ly3K4BPIHaoch2IfKOwFc8enFeg/DDw8ZLk6tIPljykS+rHqai8EeA73X5455IWi01cMZm43+yev1r3G201Le3iggg2wINqIigYx71w4lzqxdOH3m9On1ZzqWDL/yz3lvzpJ7YBRvQ+mK6GWzZlYLF0OMjt9aYLJnkAZVLAZyDkV4ywMk7WOjQ5w2wU/MkXT+7zSSWrJJv3lF6jsTXXJo8jAlbdWOM+oxVOXRLiVzmNY1A4wP5Vs8uqR6AZNtrmo2tuY4x9pgQ7ir/AHh/wLrUp8WadI0S30d1BcfxMpyFP8yKTVLCK1jeOaYiMjkM4A+vFc/NNZRwmNnR3ZeGUFmI+poUq9H3JPTz1Kbio3vqdNc6rZTsstjdRqHzuRztwfavMfid4f8AEOs3MEmnaXcXkQznyNrkDHUgHNdFH5R8tUhlct2IABHrS6v4v03wrYm61m5S3jJPlwq26SYjj5VHXtk9BVYec/bKUVdvoZaS3Pl7U9PvdLvWtdRs7q0nBJ8u4iMZI9eRVbcc471698RPGs3xFs9N+0mKDT4FMltEMFwx4JY9e3SvObnSZIBu6rnj3r6+lilJWmrSInG2xWAZrZHPUfLioHJ6YzXT6L4cvdUtZEt4t7qckZ7VO/gPWFTJtwTn+9UPFUoNqUkiHFnE6lB5lhDIOqMR+FYzMQMd69B8YeGrvw/4e0+5udjNcztEoHRSB3Nca9piFyRl8Zz7124WvGpDmTurm9N2jqUFOeDSgZYKOSelNRSx+XqKlJIYeYMN1zXYzVodPC8DhZRtbGajA+YE5p0rO77nJYnvTQRnOaSvbUhXtqEmS2QKQEH7/HvTy2VApu3c3AoGMdCv09qbU2drc8rSMnBKnIp3HcuX+r3l3D5E0pMQP3azgMkCpbtPLuZF981c0HRtS17UUsNFsbi+vZPuwwRljjuTjoB6ngVMVGEbrRExSS0NTw34u1HRPMhRlubKUr5lvNyOOm09VP0/GvUvD/iPRdYt4xbXQttQYc2sx24PordG/n7Vgad8IW0+F5/G+sRaWVIC2VmFurh89c7W2pj3J+lXT4b8A6e0rR2Wu6o23aou7pIUBz975FB/DNfPY6eCxDfJdy7xWn42T+/5mVSMOrsaXiLQItRiYuBDdKMrJt+97H1rzy7sbzSL2N2EkMqMHimQ4wR0KsK9Jh17R9H097aw0aeUZAUXN68qRqByEz0rPv8AX9Lv42t5dDk8koAStySd/wDe5H6Vy4WtXpe7ytx+X+f4HP7u1yto2rWuo6fJJd+ZHqqvmSYY8t1x1I9c966DSNVQRppmqt/ojndbzjnyW9Qe6nvXLJo9lJqyN4ZvXRD1i1MrGCMZI3jj1AB9qrXLTaRKDNG0mlSn5oc5MJPXaf8AIq5UYTlaHXp/X4dB67o2fHOjyz2U0M0QF3a5kjbOd4749iOfwrzrRryXT9Vs7y2bE0EqyLz6Hp+PSvY9Dnj1mxjsnkWWWFM2c7dWHUxN746ZryrX9Kl0XxFNYzKyBWDpnjKtyDXRgJ6SoS9f8yrXjdH2BDZWt54Nt7qLc9qIjdRgD+EjO39cVPPbXGo+JYrlB5Npp8SgmUbVjJQj8xn9Kq/DiRr34OW5Ub5Ira4jA7koxIH5VY1fX7XWPBUGo6WDc22sCHDQ/eHIVlP+0OQR6ivGrYWNNX6afk7How1ijwjxhrS2HxAvtdkGbK3lY4PBdETykA9yR+tc18JNAuPib8VGv9XQyafbP9tvf7oUf6uIexIAx6A19PeDvD2jrNf+I9WtkaeKdvJEqhljx3A/vc9e1aXwt8GweFdI1S7uYo4r3Vr2XUbkABVjDMSkfsFU/mTXqYGcY0uZL3rW9Ff9f08jOVDVy6s5v4v6sNP0aKxhIfWb+RY4LdR91egLVmeFtCa0sbfT7Yq4hy08xPG88s5/HpT7dYfGXjO98Q2snnabETBaXjrhSq8O6D+7nKg98E9MVpajf29tZS7ZYrPTIPmkuZ2CK3uxP8q8bFV3Kpr3/rvt+bZk4alme7jige3sw2z+OQ8F/wDAVWhgmlQypGfLTG5icKPxNeUeKPjRoumFofDVq2r3XINzcZjt1Pbav3m/SvH/ABb458Q+LHxrWoyvbD7trD+7hX6IOPxOTXTQynE4h3l7q7vf7v8AOwNn0P4q+JXhfwuk8f2sazqar8tpZPlA/o8vQAdwMmvCfG/j/X/GssdrfOILNT+6060BWIH1YdWPuf0rk7S2lnlWO3XnqSOAvuTW7bRC3QrGWeQ/6yU9W9gfSvYw+X4fBPmS5pd3/Wn5+ZE6lkQ2dktsd1ykck3ZAcqn19TVkqXbc+fXNSRx8HkfjVlUA5zx2rWdRt3ZyOTkVoogzc5qRYPQDrVlIwATjnpUyQ5z3HbmsXUCxWEY9OOnNOERB44b3roNG8La3rlvJNpGlXN3Cn3pEACj6EkA/hXQ23wt8UMpaW2soDjIjmvUV2PoAM81hLE04uzkr+papTeyOJiUseVAx3qbABAPXHavRU+E2uFYz/aWiBzncPtDHZ7EhcH8KgvfhdrdpGsvmWt7GW2EWJMjqT0JUgHHvWLxdH+Y09hPscQiAuoI79x2r0v4c/DifWXg1LWk8nSnHyLuw0x9B6Lx1rqvA3w4sNNxda9DHcTMo2wudwj+uOM16bDNDHtRUARBsUJwBgcAdK0p+9q1p6lRppbkVpYRWsccdsghto1CpH0CgdhWjGAGPlmTk8DGKqrcklduA/fHO32q2tyuFZn2nPzFjya6qMUtLpGt0TeSZj80aD1J5psVtbxnGdrc8oOKb9r/AHnyq2B3HU1FLcSMQ2Nmepx19K0bprV6tBdkjomwj5nx0LHg1l6wzvYyxWU6WtyR8ku0OVP+6eKsT3ezhM56HJqoUnmcQpkyMfugc49/QVyYjEQs4x/IqN73OG160mu9QAlZnm2jPGFY46jt+HasHUdY8L6Iks+sa3p8TwD/AFUcoeViP4Qi5Oa8p/aM+Ib6r4jPh/QrrbpemEpLNbynFzNj5jkfwryoH1PPFeJEcZrPCZC6q9rXla/TqDjzO6PuH4feIPBnipfN07WYJroRiRrOUGGSP2OfvY9uK2Pi74JsfG3w/vLKS3BvrWJp9OkiXLLKq5CD1DdCP6gV8DIxVtykgjoQcV6r8Nvjh4l8GnyLpv7Y0w4/0e5kIZMf3H5I/EGvVWX/AFaL9gr/AJ/19wNSucJp8zx28tnKkkdzA5IVhgrz8wI7EHtWja6tOhAZy6jqGrP8Ta8dc8X6jrv2aO1N5cvcGCM5CbjkjPf600nGHU5RvmH0rqnSUtZrf8+plUjrc7nQPFJtmkXbtLLxtqO88X6kSyw3MiqeRXJWsmJFPFS3JxK238K4HgqXPdxM3JtWY7xXq99qGmWUV3cySRpI7qrHgE45rmop5ITmNiPbsa0tYJaG24O35vzrKwK9TDwjGnypaa/mdFP4UKCS2R161amO60jbqRxUCoRC0nOAdoqa1XzVMecd61l37Gu5XDsOKeFOM9KsqkUMuJATjv0qdrWGfJSb5vSpdRIltFDbinKcdOKWZWhbYxyPWo9ye4p7iHHJzmm854pflPfk0pUjB7eopgejeG/hNrniZ2v3lt9L0RVAbULxiEcjjbGo+Zzx2446ivUCmn+HrB9J8G2UVjavEIZr/k3V503F26gEjIUYA9K9F1HQbrUZ7aS4jEdoi+XFCpISNR0AB7VjTeG41nfzSqwt90rz26V8ji8Tia8VGStFfic83KyijzS6sXVgMkDqGJ6n3qq2miYushZn6mvR5tLtN3lM/CnIMQyR+dU47aw89w8LuM5OWwG/KuGNaUdDDl7nnNzp/mMqbTsxwo4NRy6YMIxwO5r0aZbL5HSyhD/dy2eR+dT2dlcXMcjW2ipMi9xASo/HpWqxTSBQu9DzOSzXy/lXhumD0pIYJmhkt5v31o5+eJicH3B7GvTn0y8EAL6FFtbIUmLgkdR1pkti0YAudBtgSA2AhGRjg8GnHFLuvvK5Lbnk6JqHh3WbbWdBV57ZMC6sScl1U9h346HqK9S+Jfha18c+EbHxN4Zdbi4ijDw7RzNDn5oyP76nPHsRUVzbaf8Aen0WKMdykrof51teCNZ0/Rbl9PjaaK1upNxgkYMFkP8AECMEfjXTHEqTUvtLr/mdFKS2lsz03wnpVh4L8JQWjXMktuoM0krf8tHcZYBe30rnrXU0s9Isv7PsIdMjF4Vso9gRfnJwwHfruNUfHeoym2VnvEKcLbqeEPqGPavOtev5/FOh2HnaxBcz212YI7LCptRWGVV1wwIUA7q4Zc86nLJ2Sf8AX/APTo01tLY+iNGitry4i0+LFxDYANPMefMkPOD7k5Y/hXKeNb29+IPiOXwVoE8lvotsf+J9qMRwdv8Az7Rn+838R7D8qv8AgWO8uNGNtol5BYWEQcAFPOkZ2zyXJzx+fFXF0DUfD3hhtO8OeXHcTlnnvdu8hjyWCfxE5J5PWvUozUYe6t9/yS/4f19c5pXPPvjH8Q9D+HdlZ+HtFs4rm5hiCR2UT7Y4VUYXzCOce3U18t+KvFer+Kboza1dtMoJMcCnbFF7KvT8+a+ix+z/AGWvai93dXOtmRiXuJ7t0V7hz6DkgVk6r4A8AaPe/wBkz6Hf3VxBIDJLBemVpR/cG3p78cV0YdYbD/vpK8n1/wAtdvzOWr5nzYcdjV3TdNnvAGXCQZw0rdM+3rX0T4q8DeGrHQvtcfw81KB5CDBAjzO7Ac/Pj7o/WvK7yG+lCzvY3EMGAsYFsyRqOyrxiut4+MrqBlO8VovwMy3gjtoDFAML1Y92PqalVPlDdOa1YNEvWQPIiwL6ysF/Grdnocc86RC6aeZjgR20RkJPpXFPEQV22czjKRiRxhnBJwMVOuxWXn9a9g0P4QNKsMmryi0iY5MIfdL7ZA4H516TonhPw1ocCxWGkWxlOMzTIJZCQeuW6fhXN9aU/hX6GioNfEzwPQvAviPWUjktNNkSBzgT3H7tPrzyR9BXovh74Y2OkqbjW5F1C8Qho4Y8rAp/2geX/HAr0+aYs5EjHPfA6VSlUyFAdoJGOvWvPxFWrJcqdvQ2jCC1sYMkkzOBgRRr9xIRtVM+gHFQgg4GVds8561qyxb3ZSSrDpkVDJApGXTEnZlHBrw5UWnoaEagGMKoBU9ie9RNJPEX8pirgDlCQam+RVKjBPYHvUU8ZkGHcEY/h4rKbGFv4nurcbL+3W7jByGHyP8AmOo+tX7XxVo8y7pmv7ZR/CUV+fqMcVjy2fdT0HU96pSWQaUKqAY5IPc100cbUpq17ohqR31rqdjOFeLVLXzMZ8p0KfqeCatXEckaLLIkkKvzvZeDXn9tayoRsOwg8jGcfStqxu9QinjlnuJJ/LUqkcuGRR/u9zXfTzBTi1UXpb/gu40r9Dp4ZWQfKR7Be9SGZwd8g+Y9FByfxqra3Md9hmMNnOeAoBVXP1/hqZYpsybljhihz5skrhVTHUknjFdsakpL3Hf0/wAh2sKzyvIBECXPRV5Jrwz9oz4kPokVx4P0KWRNTlCvqF9FNgxKRnyF28gnjd7HHfin8WPjsbSW60XwBKY2jkKTawrBvMGMERAjgZ/i9uPWvm+8uJJ5pJJZHkkdizu7ZZiepJ7mvbwGXyUva1t+iJ30WxWY5NAPFJQOte8aAKKD1oxQAqgsQAMk8CvUm+H1yvhaC5hf97s80q30zivONJeKPU7SSf8A1KyqX+mea+mfFPjnw1pmlwCK5ilDIAI4+T071x4mT5lFHPXbS0PnKMlJCHyGU81bnYOisD2o1jVbXVdVmmtrdbVXbKqP4qhRsxlSBnHXNJp6NqzIafVEsiiSzQEdMjkVQ+wopyWJ+tSX908MMcaYGQST7VSE0rIEZiS3NXTjJK6ZvG/LoX2ZUsXjRRjB685rLiJR1YHGKuzZCbV7LzWjo02mJpLfa4QbgEkNt6+lHN7OLdr3HFtK5lXjhpFIPJHPFRx8HPPtTXPmvgdc/L9KktIZpw4ijZyvXHatdIx1HJLdDXAx83TNRvGydRkHvVryHXCyIVx2IxU/yRqqyfdPQ+lLntsRzW2M0ID0PPpQVdOoIq7Jb9Dt47H1pVRkJx8y96PaIOc+9rqXUbsEJZSkAY+6VGPQZrnL/T7iAH7dPb2cZ+bE8oBOPYZNZ0mlRjBu9Yi3DgorM+PSkWz0azdWe5uJpDzhUA/nXwtfHe1+L8/+ATyPr+ZWuzo0UrH7fdXTYBxbwbR+bf4VR+16f84t9Lnds5Vpbrr9QB/WtZ30SN/3enzOR3aXH6U2XUbKHLQ6VaKAcbnya4209/1JaXdGHLrM+xorS3t9P3Nkvbwq8o/3WkDY/KuO8Q+FtU10kS+LdeZG58u4BkT8kKgflXoUvjC3gTOdLhK9fu8D8aoRfEA3MvlWd6skhbASCLOfpgV0UZVaXvUlb5J/mSpx/mv8jydPg74rnVjpdxBe4/gEzwtj6MAP1qtcfDHx7pgJk0LVsDvbP5n/AKCxr3/T9c1jaGmlZQPvK6gHFb8Hie/CqRBAXbom5gceucV61DM67X7xfh/wTVeykrP+vzPHPg7qGpaHq7aT4ltLxLHUPuyagjAwzAccsOAen1xWn8YfCLxahY+JNNgDOs0cN6kfGBnCyjHp0Nd7qvxc0TSNUTSfEEscF26q23d5igE8bj0B+taul+N/C+stMlrPa3Yi+WURYlVRnHOO3vVTldqstPk0mjohGCXJ0PNtCsxP4d1CXxDf/YLbmOKS4k2K5Kk7OoJ7celW/hH4D8LXmjrruvurq87G1ihmZYsLwWO3kknPU9BWL8SrKTUbOS2tWtIYoJ3eMwghGQjGSD/ER1rzXR/Eet+GbZ9P0NReWcr7mRuV3eoxyPzqKFNyUvZvXtsjtqONJctOVz03X/Gr+B/GMVpoGq3Y0q5j3bWRWEbFiSoG3pyMZ5r2TRPHFxceGrTUD5P2oMY5rSbMbyjs6Dtx6jHWvEfCviRvNtpL+zmsVZtzNgSJu9ye1enyanGZ2W/0+1kLAESRjaTnuCK454idBKCVpJb30+VjgnP3nJ9Tp9T8YWF3CEbTWlJADBzgfpziuci1VrKe5l0m1tNPa4Yu7QRgMeMYzjIAx0FKkNhdEG1naCQcBJuR+YqtcafLbKTKjEHnevK4+tcVbEVpu7dvTQhym9iGbUtRe4WR765ZkOQxkJNOl1a6T/j4kNxbFv3sUvzKy/T8aiCYVeRjG6oJ1DKwx1HANcUuZu8tyE2upftfB3hu2dJI7CO7LAMkk5aTcD0PPFb1uEt4PJtLeG3Tj5Y0Cg49wK53w/4gh0sx2Wr25lsd3ySoSHhz/MV2NrA19KfsEMrW+A4mbBQgnjDDqfwr2KLhVV29Rpt/CQQ7t7Z5+Xcc9xU8gBRQMkNxz1q5/ZNzbsp2h0xjcpzj2pFtJiCDE/ByTtrrSSVrhyyXQqzjG1sfwgHB/AVCIl4Z1Axzjua0PsU2QXicR9cY5pLm3keIeXBIrrwPlPAqHTjK8rhZ9jOkiCSJlVft7EVWdckiMjr909q1p7aTZzE4P+73qNo9yscGQHn7uCDWU8MpaIeqMloSqjI2ydccYIqIwBs4UZ56cZrYMJBTn5iOfakki6Nww9MVzywXkPmMJ7c7CuOe2eDilgtVYqA2B0G4dDW79nBUAZVs5HrjuKieLD7XGUz97GD+NZfUOXUOYx2hKSE4G7pzyKsiNwvKoF7/AC8j6Voi3hBYIWDAc55p7W3yZjG7t1qlgZRvYfNczHQvERsLbecnt9RWd4k0+x8UaE+h+I7QS2T8pJG5jkt27MCOuOuCCK23gcDd5eSPQjIqCSIuMAbh+oNKNOrSlzQdmNSsfI3xL+FWveA0S7n8rUdDkIWPUbXmPJ/hcdUb68HsTXnjc195y2cFzZXVlqVot5p9yvl3FpKTskHUHjuDyD2NfOXxY+Dc2ih9W8Fx3uo6L8xngMZaWyI7Ej7y9fmHTHPrX1eAzaNW0K2kvz/r+vOl72x4vRRRXtiHUlKvNB60AWNPsrjULyO1somlnkOFRepqbVdOvdMuWttRgkhlXs4/lXpH7PeiJf8AieXUJ1Pl2a/Kf9o17d498GWHibSXEkK/aEGUkA5BrFzfM7dDKU7M+O607GdXKhiA/Q57iuj8X/DnWvD8a3Jgae0Y43oM4PvXH/ZZt4VopFPupFJThWjoxvlmjQ1GFcxMXU7QeBzmq1su64BI4HNBwCFX7o4qe3XCOcc+tT8MbEXsrDWO92GDzVbeFtyO+cVcC5IIPTNZYJ2n0zVwVy4DhwwI5Ir13wLr/h0Q21nPbQW1y4AdnAAdvrXkiI24HBwafIQf3eOccVhi8LHFR5JNr0L+L3T6ql8G6VrFoC9ujbhw4HPNeb/ED4Xzabp889kpeONS4XvirnwG+IQiZfD2tSEkn/RZWP8A44f6V754ihjvtAn2BWJjOK+WqPFZfV5ea9vxRcvZpe6tT4esboJmK6+4OAe6mrvl91wVPQis/V4hDqd1EP4ZWB/OpdOkeAgsf3XdTX1koprnj1OaUbrmR9Narq89q7Y0vULjH8SKAD9DXN33ivVsHydHaAEcPKjMR+lVPFvxPhS7S08JQRhUb57m5Te7+wXO1R+Z+lcxqvxP8TRvHLBNYq248paqACPbpXyWGy2rJJuCu+7ZnKKva5q3eva9dHaZ5YsDJEcfl4Hua5vUtXjDbL/Up7hgeY1kLkH+Vc74i8Ua14jvGutc1Ga5lbovCIPYKuAPyrJ3bk5ODnrXuUMuUEnOyfl/nb9AdJHofgOXStT8RpbX9mDCVJHmSfeI+le2izhtIm+ywxWyJ80axKB+VfL2mTzW13DPADviYNnoK9jl+Keg2dklzOJbu9Vgv2SEYVhjklugFcmPwtTnXsk2ZOL5uVbHptu5ufkXa3koHklY4UAcsWPpXmnj74s6fplncWPhac3mpSo0T3ajEVuc9Yz/ABHHQ9K8r8W/ELXfEjyRy3BtLFhtFrbfIm30bHLfjUXg/wACax4lZJYojaad/FeTqQmO+0dXPsPxIrWll8KMfa4ySS7X/r7johT5dZGHa295rWpiKEPc3s5LEs3LHqSSfxOTXufwu8F3Hhqxk1RvPlvrtDEGh3CIR9So6bicDnp6etdb8OvBWmaWot7CAeWq7rq8lAMkgHXnsPRRx9etbni3VJpbK9uYHEMNnATFn7qY4BxXDjs4dZezoq0Xp6/5I0pyUrdjgfEml+JNVe7sorBrSEKjG5lfCRLyTvAB5PQDIrzOOyGnajJJPcNbMhzIPMwshGedv5V6/wCFPijfizm0aJlTU5U8ySdsN5irwBz3wa8i+Lj3L+I7e/nI33UXL7R1U/8A1xXRhFNyVF6XX9euh2VJwUOWMdU9/I0Z/iE8NkLCx827iU7lEg2xq3cjv/Kuy+G/xIi1FF0XxbNFasWxZXoXCLn/AJZyd8eh9+a8F8xzncxz65qRRtYhs4PrXoVcroTg4yXz6nDJyZ9dy/aLG8eCZSkyHBXt9a07HUZ4seW+FHUE8flXnvwl8WL4w0ePQdRmc+ItOh/0eVssbyAdif7yjA9x+NddGxiLI5O4HG08Y+tfI1oTw1R0ai1X4ruZ2tqjpCbW9ILj7PMRlio+Q/4VnX9pLEuZMDeOGHINNsnGSS4JPQVq2sgMbq4zF/dPr6/WsXTU1oaJ825yc1vyy9XPNS+H9YudDuH8ppJbNz+8h3lc47j0NbV5puYjNbsXQg5BHK1kNaZZBgnAyeK5/fpvQlxa1R09kus6xezXkviuVdDf5IYYLZPNjJPCykgj8R19q272x1DT/JBkS7WRtiPGu0sfcdjXBaRf3OkXYmtsc/LJG33XXuCK7lZNYlW11Lw5DbajaZIls57lo3jP+y2CCfYgfWvToV/brlfxL+v66m0LT06m1ZacpUR3t3iXG7Yj/d/GoIreR76WJJf3UTYMu8hSadosll4msGlu9Ma0u8lJrW5TbLGR6kdR7jipJNHs7azGnWxls44f322F+SCeSS2SQT1rps4Ruoprvua8iewtynlAIL3zGPZHPy/rVYNPufy55SoUYyM4P1Io0ubQZ9ptr+CaTOPKeUA++BxmtqfdboG8qRrXgYh6r747iuiE4SSfL81/wCfZtt2ZmILgxueSAO8YP9KigkYkq4t8kdfL/wDr1P8A27AbiVLOR1mGQY57dwrEf7Q6VnTSSCRZLh90hPzcYwT2HtQnTfvW/H/gimuXZ6lmRmRwrpCRgkYyMH86IRH5gyvlnk8NnP51Wkky27IX6nNQG4/0hSDkkclqmdWnB3TZnqapjx82BwRjKdKkW3jaXBOAc/MvqazvthP3JC+eOhwKkF2QVPG5eMnHPvXTGtFdb/15CLU1vuUkjDZwOcnFOFiuFKogGMsNn3hTI7sEBSMnuf8ACrAuQGHlswfsuRge9dC5JatIRXmsBuGF+XBJPf8ACoRbPasrQu6ADIPc1om98puo5P3sdDSTXBlTG4Bc+vWm6VJhc8I+K3wHtfE8kuq+EZI7XXJpPNubedwlvLkclML8rZwfQ89K+ZfF3hXWvCGqnTvEVhLZXeNyq+Crr/eVhkMPoa/Q5XKlQRh1zx2INZ/iLSdG8QW/2XxBpVpqFqeES4QMY89Sp6qfcEV1UqsqMUk7rszRVF9o/OdOtB619S/EP9nGyvG+1eALlbSUKS2n3kpdGPbY/JHfhs9uRXzZ4h0TUvDurT6brdnLZ30Jw8UgwcdiPUHsRwa7qeIhUdlv2/r9Cul0e2/AaSCDQikbL50spLnPP0r3u0UNCF4wRivivwR4kk0DUonJPkFwWAr668Da3BrNnHcwurKQDgHNSk4ya7nI04z1LuuaabrS5bbaGIG5c18zfFC4W1zZ+THHOTyVHavqXUdQjiZ3b7iD5vYV8dfEPUhrPi/UbqHiAybY8/3RxXK6K9rf5iaUpI5he3HWryDFsAMfMahWOrbqFRVOeBXROVy5SKyj5wOKzbhQkrIvQGtVQASc4A5zWScu7Hnk1dLdl09y4kbCCP0xVe4j+USDIxwa04E328Y9BgUksAV9jZwwwalVLMlTszK3FWWaIlXUg5BwQexFfTfw08cXF14GH9stm4CFVY/8tAOh+pr5ritZo5mDREoOuehFdtpniRFt4U4SKEdK48ype2glFXsdLV48yOc1+Exa1eyzDYzys4X6mqaxyOpbawQV0PiHUrTU5RdIoVEHPua5aXUJm3BDsQ9gK6aDnOCurNGEU2jQsuLpMUs/NvPnnEgxRRS+2Zx+IoSfdqa2ALHIB+WiitnsW9iDUJH3hd7bdo4zxXR/Cu2guvHGmRXUEU0TSDKSIGU/gaKKn/l0yl8DPX/i7penw+JNLjhsbSON5kVlSFQGGehGK7K8RY7pIkULFFGEjQDCooHAA7D2oor5LM/gp+rM6250WnAR+FtQZBtYsoyODiuS8T/8ilrv/Xs38xRRXlv+JD5fmaR+yeW+FFB1tWIBYDr3+7Wr4zt4ZtL/AH0Mcm0ErvUHHHaiivoV/Hj8jaR4pKAG4GOalXlTmiivo5GDLelXVxZ6lZ3FpPLBcRygpLE5VlOexHIr7C8VKBqMLADc8KMx7sSBkmiivluIPjp/Mlfa+Rn2xJ3gnp09q1U/1afjRRXh0gWxoLwI8ccVm6gAty23j6UUVpiN0X9kpEAyPkD71WLK7uLTRtXa1uJoWVo2UxuVIPPIxRRU4H/eY/P8hLc4y/1XUXk1id7+7aeNHCSGZiy8djnIrS/Z81S/v/G10L6+urkDTmx50zP/AMtB6miivWpfHP1Ip/Gj1z4gWlsPBd7ILeESRsGRggypLjJB7V4n/b2sW6TC31XUIgOyXLr6+hoornwX+8wOvF7EHwz1O/lN75t7dPmYE7pWOSQcnrXsUpOyE5OSgJNFFdc/h+44aOz9SFyfLTk8g5pHJ3J9KKK8ye50oaCQ3Bpf48e9FFShl1P9XUqf6tD33Giiu6Adye3/ANZ/wKo2JEjgHjceKKK9Cn8Jm9wiJ81eT9ynA7rm33c8HrRRXT9n5krchmkddRwrsB6A186/tkgHxN4Yc8u2mnLdz8570UVWE/3j5/ozWGx889q9p+BlzOspRZpAuzoGOOtFFexUM6+yPX/ETuPCesuGbeIGw2eelfKk5JkJPXJoorCW6OePxDB1q1df6xfrRRWb3RTIiB9kuTjkL/Wsm3ooralszaGzNe3/AOPeH8akue31oorB/EYvci1MkWQIJB29RWTET9klGeMUUVtR+H5ndQ6li+ONNtwOAcZ9+tZlFFbUtn6kRP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nancy Bresich, PhD and Albert Greene, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31047=[""].join("\n");
var outline_f30_20_31047=null;
var title_f30_20_31048="Inflammatory breast cancer: Clinical features and treatment";
var content_f30_20_31048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Inflammatory breast cancer: Clinical features and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Alphonse Taghian, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Moataz N El-Ghamry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Sofia D Merajver, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Lori J Pierce, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31048/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/20/31048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. It is characterized by the inflammatory appearance of the breast, ie, diffuse erythema and edema (",
"    <a class=\"graphic graphic_picture graphicRef70894 \" href=\"mobipreview.htm?13/8/13442\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef82220 \" href=\"mobipreview.htm?2/34/2592\">",
"     picture 2",
"    </a>",
"    ). It can be confused with noninflammatory locally advanced breast cancer.",
"   </p>",
"   <p>",
"    The epidemiology, clinical features, treatment, and prognosis of IBC will be reviewed here. Locally advanced breast cancer and the pathology and molecular pathogenesis of IBC are presented separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=see_link&amp;anchor=H528513711#H528513711\">",
"       \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\", section on 'Locally advanced breast cancer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10103?source=see_link\">",
"       \"Inflammatory breast cancer: Pathology and molecular pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2010 American Joint Committee on Cancer and the International Union for Cancer Control (AJCC-UICC) TNM breast cancer staging system defines inflammatory breast cancer (IBC) as a clinical-pathologic entity characterized by diffuse erythema and edema (peau d'orange) involving one-third or more of the skin of the breast (",
"    <a class=\"graphic graphic_table graphicRef65393 \" href=\"mobipreview.htm?29/14/29920\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/1\">",
"     1",
"    </a>",
"    ]. These \"inflammatory\" skin changes are caused by tumor emboli within the dermal lymphatics, not by infiltration of inflammatory cells. The diagnosis is based upon the clinical presentation. Although dermal lymphatic involvement supports the diagnosis of IBC, it is neither necessary nor sufficient in the absence of classical clinical findings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10103?source=see_link\">",
"     \"Inflammatory breast cancer: Pathology and molecular pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Not all skin changes qualify as IBC or even locally advanced breast cancer (LABC). IBC, as described above, is designated as primary tumor stage T4d. Tumor presentation with ulceration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ipsilateral satellite skin nodules",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    edema are T4b. Invasion of the dermis alone, such as dimpling of the skin or nipple retraction, does not qualify as T4 and may occur in T1, T2, or T3 without changing the classification.",
"   </p>",
"   <p>",
"    Of note, if a cancer is designated as inflammatory before neoadjuvant chemotherapy, the patient will be designated to have inflammatory breast cancer throughout, even if the patient has complete resolution of inflammatory findings.",
"   </p>",
"   <p>",
"    Primary IBC has several characteristic biologic features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      It is rapidly progressive.",
"     </li>",
"     <li>",
"      It is highly angiogenic and angioinvasive; these features account for the high metastatic potential.",
"     </li>",
"     <li>",
"      The aggressive behavior and angiogenicity are intrinsic features of the tumor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given these observations, an international expert panel proposed the following consensus-based criteria for the diagnosis of IBC in 2011 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rapid onset of breast erythema, edema",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      peau",
"      <span class=\"nowrap\">",
"       d/orange,",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      warm breast, with or without an underlying palpable mass",
"     </li>",
"     <li>",
"      Duration of history no more than six months",
"     </li>",
"     <li>",
"      Erythema occupying at least one-third of the breast",
"     </li>",
"     <li>",
"      Pathologic confirmation of invasive carcinoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory breast cancer (IBC) is rare. It accounts for 0.5 to 2 percent of invasive breast cancers diagnosed in the United States, but may be higher elsewhere [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In the United States, its incidence appears to be increasing, particularly among white women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. As compared to locally advanced breast cancer, IBC is diagnosed at an earlier age (a median of 59 versus 66 years of age) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of IBC is higher in black Americans compared to white women, and black women are diagnosed at a younger age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In contrast, IBC is diagnosed at an older age in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4\">",
"     4",
"    </a>",
"    ]. Data on risk factors is limited and inconclusive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION AND DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with inflammatory breast cancer (IBC) typically present with pain and a rapidly progressing, tender, firm, and enlarged breast. The skin over the breast is warm and thickened, with a peau d'orange (skin of an orange) appearance (",
"    <a class=\"graphic graphic_picture graphicRef70894 \" href=\"mobipreview.htm?13/8/13442\">",
"     picture 1",
"    </a>",
"    ). The skin color can range from a pink flushed discoloration initially to redness or a purplish hue that seems to represent ecchymosis (",
"    <a class=\"graphic graphic_picture graphicRef82220 \" href=\"mobipreview.htm?2/34/2592\">",
"     picture 2",
"    </a>",
"    ). At presentation, almost all women with IBC have lymph node involvement, and approximately one-third have distant metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Nipple involvement may present as flattening, erythema, crusting, blistering, or retraction of the nipple [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several conditions may be confused with IBC, leading to potentially preventable delays in diagnosis and treatment. Infectious mastitis and breast abscess, which typically occur in lactating women, are generally associated with fever and leukocytosis, whereas IBC is not a true inflammatory process. The inflammation that can accompany ductal ectasia is usually localized. Involvement of the breast by lymphoma or even more rarely leukemia may also mimic the clinical presentation of IBC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/857?source=see_link\">",
"     \"Erythematous disorders of the breast\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9495?source=see_link\">",
"     \"Breast abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/19/36150?source=see_link\">",
"     \"Breast lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It may be difficult to differentiate IBC from noninflammatory locally advanced breast cancer or a breast cancer recurrence involving the skin, causing late inflammation. An inflammatory recurrence of a prior noninflammatory breast cancer has been termed secondary IBC. It usually develops on the chest wall at the site of prior mastectomy, but can rarely occur as a distant cutaneous recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis and staging evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An appropriate initial work-up of IBC should consist of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History and physical examination",
"     </li>",
"     <li>",
"      Diagnostic bilateral mammography and, as indicated breast ultrasound (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link&amp;anchor=H10#H10\">",
"       \"Diagnostic evaluation of women with suspected breast cancer\", section on 'Ultrasonography'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Laboratory tests including a complete blood count with platelets, liver function tests, and serum alkaline phosphatase",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mammography may show an obvious tumor mass, a large area of calcification,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parenchymal distortion. Mammographic findings in patients with IBC may also include characteristic skin thickening over the breast, with or without a dominant mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/10\">",
"     10",
"    </a>",
"    ]. There are limited data on the value of additional imaging studies of the breast, including ultrasonography, magnetic resonance imaging, computed tomography (CT), or positron emission tomography (PET), in the diagnostic evaluation of IBC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis is typically made by core biopsy guided by palpation, sonography, or stereotactic radiography. As with other invasive breast cancers, all IBC tumors should undergo testing for hormone receptors and HER2. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30058?source=see_link&amp;anchor=H6#H6\">",
"     \"HER2 and predicting response to therapy in breast cancer\", section on 'Assays for HER2 expression'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19194?source=see_link&amp;anchor=H3#H3\">",
"     \"Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy\", section on 'Clinical significance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A full thickness skin biopsy is often obtained if IBC is suspected, since a hallmark of this disease is dermal lymphatic invasion by tumor cells. An international expert group on IBC strongly recommended that every patient with suspected IBC undergo at least two skin punch biopsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24504?source=see_link\">",
"     \"Breast biopsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=see_link\">",
"     \"Diagnostic evaluation of women with suspected breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10103?source=see_link\">",
"     \"Inflammatory breast cancer: Pathology and molecular pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women with palpable or suspicious lymph nodes, it may be appropriate to perform an ultrasound of the axilla with a guided fine needle aspiration (FNA)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a core needle biopsy in order to make a more accurate determination of the tumor stage. The assessment of clinically negative axillary lymph nodes is discussed separately; sentinel lymph node biopsy is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for IBC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/49/10009?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features, diagnosis, and staging of newly diagnosed breast cancer\", section on 'Lymph nodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36602?source=see_link&amp;anchor=H17#H17\">",
"     \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\", section on 'Locally advanced and inflammatory breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional imaging to evaluate for bone, liver, or pulmonary metastases is usually indicated for patients with locally advanced breast cancer and IBC given their increased risk of distant metastases. However, the specific imaging studies used for breast cancer staging are not standardized, and practices vary. An international expert group recommended that all women with IBC undergo systemic staging with CT and a bone scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]. The data on PET and",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    were considered to be insufficient to recommend their routine use for staging. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/49/10009?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of newly diagnosed breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A photograph or other imaging of the breast at presentation may be useful in monitoring resolution of inflammatory changes. The role of imaging studies in monitoring response to therapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1529?source=see_link&amp;anchor=H1192123#H1192123\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Treatment evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT OF INFLAMMATORY BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer (LABC). Multimodality therapy, with neoadjuvant chemotherapy followed by locoregional therapy, has become the standard approach. While anthracycline- and taxane-containing regimens are most commonly recommended, the optimal chemotherapy regimen and sequencing of agents have yet to be defined.",
"   </p>",
"   <p>",
"    Historically, single modality therapy for IBC was associated with a poor outcome, with five-year overall survival of less than 10 percent for mastectomy alone or definitive radiation therapy (RT). Combining surgery and RT improved locoregional control, but had no impact on survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/12\">",
"     12",
"    </a>",
"    ]. &nbsp;With the adoption of neoadjuvant chemotherapy, outcomes for IBC have improved:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Series of patients treated with neoadjuvant chemotherapy followed by surgery and RT have reported five year disease-free survival rates of 20 to 45 percent and overall survival of 30 to 70 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/10,13-18\">",
"       10,13-18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who obtain a complete pathologic response from chemotherapy have a significantly higher disease-free survival and overall survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/12,14,17-19\">",
"       12,14,17-19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The combined local approach of surgery and RT following neoadjuvant chemotherapy provides optimal locoregional control, but appears to have no impact on OS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, women with IBC are approached similarly to those with noninflammatory LABC. However, breast conservation therapy is generally considered inappropriate for these women, as is SLN biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neoadjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neoadjuvant chemotherapy followed by locoregional treatment is the standard approach for IBC. However, the optimal chemotherapy regimen, including the sequence of agents and duration of treatment, is undefined.",
"   </p>",
"   <p>",
"    Anthracycline- and taxane-based adjuvant chemotherapy regimens are widely used for neoadjuvant chemotherapy. Anthracyclines and especially taxanes are particularly effective in IBC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/12,21-23\">",
"     12,21-23",
"    </a>",
"    ], and a regimen containing an anthracycline and a taxane was recommended by an international expert group on IBC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with IBC and HER2 overexpression should receive HER2-directed therapy in conjunction with neoadjuvant chemotherapy. The details of neoadjuvant chemotherapy selection and administration are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35466?source=see_link\">",
"     \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High dose chemotherapy followed by autologous stem cell transplantation has been investigated in patients with IBC. Although high objective and pathologic response rates were achieved, there was no convincing improvement in disease-free or overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/24-31\">",
"     24-31",
"    </a>",
"    ]. Moreover, this approach was associated with markedly increased toxicity and worse quality of life compared with standard dose chemotherapy.",
"   </p>",
"   <p>",
"    Monitoring of the response to primary systemic therapy should include a combination of physical examination and radiologic assessment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1529?source=see_link&amp;anchor=H1192123#H1192123\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Treatment evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Locoregional treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following neoadjuvant chemotherapy, standard locoregional treatment includes mastectomy and radiation therapy (RT). Patients who do not achieve optimal tumor debulking or who remain inoperable should receive radiation therapy with subsequent surgery, if feasible.",
"   </p>",
"   <p>",
"    In general, locoregional management decisions are based upon tumor response. Patients who achieve a pathologic complete remission compared to those who have a lesser response have a significantly higher disease-free survival and overall survival, whereas patients who have extensive residual disease after NCT have a poor prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/12,14,17-19,32\">",
"     12,14,17-19,32",
"    </a>",
"    ]. The combined local approach of surgery and RT following neoadjuvant chemotherapy provides optimal locoregional control, but may only minimally impact overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/13\">",
"     13",
"    </a>",
"    ]. Surgery generally precedes RT since higher doses of RT can be more safely delivered in the postoperative compared to the preoperative setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/16,33\">",
"     16,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Posttreatment evaluation and assessment of the response to neoadjuvant chemotherapy are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1529?source=see_link&amp;anchor=H1192123#H1192123\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Treatment evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mastectomy is generally considered an integral part of the multimodality treatment of IBC. Some have questioned whether mastectomy can be replaced with breast conservation surgery or radiation therapy alone, especially for patients who achieve a complete clinical response to neoadjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. However, others have shown in case series that mastectomy improves local control, disease-free survival, and cancer-specific survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/13,37\">",
"     13,37",
"    </a>",
"    ]. An international expert panel on IBC recommended that the only method of definitive surgery offered to women with IBC following preoperative systemic treatment should be a modified radical mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]. Skin-sparing mastectomy is",
"    <strong>",
"     contraindicated",
"    </strong>",
"    for women with IBC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12586?source=see_link&amp;anchor=H7005314#H7005314\">",
"     \"Mastectomy\", section on 'Skin-sparing mastectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgery should only be attempted if a macroscopically complete resection can be accomplished [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients who remain inoperable should receive locoregional RT, followed by surgery, if feasible. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1529?source=see_link&amp;anchor=H544206548#H544206548\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Definitive surgical treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because patients with IBC will need postmastectomy radiation, breast reconstruction is preferred to be delayed until after radiation. Although several small studies report reasonable success with immediate as compared with delayed reconstruction in IBC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/39,40\">",
"     39,40",
"    </a>",
"    ], the presence of a reconstructed breast can, in some patients, limit radiation coverage, particularly of the internal mammary lymph nodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/41\">",
"     41",
"    </a>",
"    ]. The international expert group on IBC recommended against immediate reconstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=see_link&amp;anchor=H2464163#H2464163\">",
"     \"Breast reconstruction in women with breast cancer\", section on 'Radiation therapy and reconstruction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Postoperative radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postmastectomy chest wall radiation therapy (RT) is generally recommended for patients with locally advanced and inflammatory breast cancer who are treated with neoadjuvant chemotherapy followed by mastectomy. Although a survival benefit for postmastectomy RT has not been definitively proven in patients with IBC, the improvement in locoregional control makes RT an important part of their management. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=see_link\">",
"     \"Postmastectomy chest wall irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dose-escalation with accelerated fractionation schedules has been investigated in IBC to improve locoregional control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/16,33,42-44\">",
"     16,33,42-44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Twice-daily postmastectomy RT to a total dose of 66 gray (Gy) for a series of 39 patients with IBC as compared to 32 patients treated twice daily to 60 Gy resulted in significantly improved five-year locoregional control (84 versus 58 percent) and a nonsignificant increase in disease free survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/33\">",
"       33",
"      </a>",
"      ]. Complications may include acute skin changes, including moist desquamation, and uncommonly, late complications such as brachial plexopathies, lymphedema, pneumonitis, rib fractures, and chest wall fibrosis.",
"     </li>",
"     <li>",
"      In a later review of locoregional control among 192 patients with IBC treated at the same institution with combined modality therapy, escalation of the postmastectomy radiation dose from 60 to 66 Gy significantly improved locoregional control for patients who experienced less than a partial response to chemotherapy, patients with positive, close, or unknown surgical margins, and patients under the age of 45 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Standard fractionation RT with treatment fields giving broad coverage to the chest wall and axillary, infraclavicular, supraclavicular, and internal mammary lymph nodes remains the standard approach. Generally, patients receive 50 Gy in 1.8 or 2 Gy fractions to locoregional sites followed by a 10 Gy boost to the chest wall (total dose 60 Gy).",
"   </p>",
"   <p>",
"    However, largely based on the retrospective analysis described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/44\">",
"     44",
"    </a>",
"    ], an expert consensus panel on IBC recommended escalating the dose to 66Gy in women who are &lt;45 years of age, who have close or positive margins, four or more positive nodes following preoperative systemic treatment, or a poor response to preoperative systemic treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data on the role of adjuvant chemotherapy after neoadjuvant chemotherapy and appropriate locoregional treatment. Outside of a clinical trial, if a patient has completed standard adjuvant chemotherapy preoperatively, such as four to six cycles of anthracycline- and taxane-based neoadjuvant chemotherapy, there is no role for additional postoperative chemotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adjuvant endocrine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with hormone receptor-positive IBC should receive adjuvant endocrine therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20106?source=see_link\">",
"     \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Adjuvant trastuzumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human epidermal growth factor receptor 2 (HER2)-positive patients should receive HER2-directed therapy in conjunction with neoadjuvant chemotherapy.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"     Trastuzumab",
"    </a>",
"    should be resumed postoperatively to complete one year of treatment. We avoid concomitant use of trastuzumab and an anthracycline outside of a clinical trial. The use of neoadjuvant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/23/9592?source=see_link\">",
"     lapatinib",
"    </a>",
"    remains investigational. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=see_link&amp;anchor=H517953427#H517953427\">",
"     \"Adjuvant medical therapy for HER2-positive breast cancer\", section on 'Trastuzumab-based therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"     Trastuzumab",
"    </a>",
"    -associated cardiotoxicity and pretreatment assessment and monitoring of cardiac function are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42232?source=see_link\">",
"     \"Cardiotoxicity of trastuzumab\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=see_link\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory breast cancer (IBC) is associated with a particularly poor prognosis and high risk of early recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/45\">",
"     45",
"    </a>",
"    ]. Data from the United States Surveillance, Epidemiology and End Results (SEER) database had suggested an improvement in 20-year cancer specific survival for patients with IBC who were treated in 1995 compared to 1975 (20 versus 9 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/6\">",
"     6",
"    </a>",
"    ]. These improvements were attributed to advances in multidisciplinary treatment.",
"   </p>",
"   <p>",
"    However, in a subsequent report from the SEER database, for breast cancer cases diagnosed between 2004 and 2007, the two-year breast cancer-specific survival rate of patients with IBC remained significantly worse than for women with noninflammatory locally advanced breast cancer (84 versus 91 percent, HR for death 1.43, 95% CI 1.10 to 1.86), despite improvements in treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31048/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of posttreatment surveillance after primary treatment for breast cancer are early recognition and treatment of disease recurrences, second primary breast cancers, and therapy-related complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=see_link\">",
"     \"Approach to the long-term survivor of breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=see_link\">",
"     \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/39/8818?source=see_link\">",
"       \"Patient information: Inflammatory breast cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/47/5875?source=see_link\">",
"       \"Patient information: Locally advanced and inflammatory breast cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory breast cancer (IBC) is characterized by diffuse erythema and edema (peau d'orange) involving a third or more of the skin of the breast.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of IBC is based upon clinical \"inflammatory\" skin changes, which are caused by tumor emboli within the dermal lymphatics. Although dermal lymphatic involvement supports the diagnosis of inflammatory breast cancer, it is neither necessary nor sufficient, in the absence of classical clinical findings. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with IBC have an increased risk for regional lymph node involvement and distant metastases making appropriate examination and radiographic evaluation important for accurate diagnosis and staging. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical presentation and diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with IBC, we recommend neoadjuvant chemotherapy followed by locoregional treatment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The optimal neoadjuvant chemotherapy regimen, including the sequence of agents and duration of treatment, is undefined, though anthracycline- and taxane-based chemotherapy regimens are typically recommended.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"       Trastuzumab",
"      </a>",
"      is indicated for HER2-positive disease. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Neoadjuvant chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with IBC, we suggest mastectomy rather than breast conserving surgery, even for those with a complete clinical response (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We generally recommend postmastectomy radiation therapy patients with IBC (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Postoperative radiation therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although IBC is associated with a particularly poor prognosis and high risk of early recurrence, there is evidence that outcomes have improved with neoadjuvant chemotherapy followed by locoregional treatment. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/2\">",
"      Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999; 59:5079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/3\">",
"      Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 2011; 22:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/4\">",
"      Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005; 97:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/5\">",
"      Anderson, WF, Schairer, C, Chen, BE, et al. Epidemiology of inflammatory breast cancer (IBC). Breast Dis 2005-2006; 22:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/6\">",
"      Tai P, Yu E, Shiels R, et al. Short- and long-term cause-specific survival of patients with inflammatory breast cancer. BMC Cancer 2005; 5:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/7\">",
"      Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2000; 2:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/8\">",
"      Jaiyesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol 1992; 10:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/9\">",
"      Walshe, JM, Swain, SM. Clinical aspects of inflammatory breast cancer. Breast Dis 2005-2006; 22:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/10\">",
"      Smoot RL, Koch CA, Degnim AC, et al. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg 2006; 141:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/11\">",
"      Chow, CK. Imaging in inflammatory breast carcinoma. Breast Dis 2005-2006; 22:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/12\">",
"      Yang, CH, Cristofanilli, M. Systemic treatments for inflammatory breast cancer. Breast Dis 2005-2006; 22:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/13\">",
"      Perez CA, Fields JN, Fracasso PM, et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer 1994; 74:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/14\">",
"      Thoms WW Jr, McNeese MD, Fletcher GH, et al. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 1989; 17:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/15\">",
"      Baldini E, Gardin G, Evagelista G, et al. Long-term results of combined-modality therapy for inflammatory breast carcinoma. Clin Breast Cancer 2004; 5:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/16\">",
"      Liauw SL, Benda RK, Morris CG, Mendenhall NP. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer 2004; 100:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/17\">",
"      Harris EE, Schultz D, Bertsch H, et al. Ten-year outcome after combined modality therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2003; 55:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/18\">",
"      Palangie T, Mosseri V, Mihura J, et al. Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer 1994; 30A:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/19\">",
"      Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN, et al. Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer 2006; 106:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/20\">",
"      Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/21\">",
"      Cristofanilli M, Gonzalez-Angulo AM, Buzdar AU, et al. Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience. Clin Breast Cancer 2004; 4:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/22\">",
"      Bauer RL, Busch E, Levine E, Edge SB. Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy. Ann Surg Oncol 1995; 2:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/23\">",
"      Cristofanilli M, Buzdar AU, Sneige N, et al. Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer 2001; 92:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/24\">",
"      Adkins D, Brown R, Trinkaus K, et al. Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer. J Clin Oncol 1999; 17:2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/25\">",
"      Cagnoni PJ, Nieto Y, Shpall EJ, et al. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer. J Clin Oncol 1998; 16:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/26\">",
"      Macquart-Moulin G, Viens P, Palangi&eacute; T, et al. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol 2000; 18:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/27\">",
"      Viens P, Palangi&eacute; T, Janvier M, et al. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). Br J Cancer 1999; 81:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/28\">",
"      Dazzi C, Cariello A, Rosti G, et al. Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study. Haematologica 2001; 86:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/29\">",
"      Arun B, Slack R, Gehan E, et al. Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinoma. Cancer 1999; 85:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/30\">",
"      Somlo G, Frankel P, Chow W, et al. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. J Clin Oncol 2004; 22:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/31\">",
"      Hanrahan EO, Broglio K, Frye D, et al. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Cancer 2006; 106:2327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/32\">",
"      Cristofanilli M, Buzdar AU, Hortob&aacute;gyi GN. Update on the management of inflammatory breast cancer. Oncologist 2003; 8:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/33\">",
"      Liao Z, Strom EA, Buzdar AU, et al. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys 2000; 47:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/34\">",
"      De Boer RH, Allum WH, Ebbs SR, et al. Multimodality therapy in inflammatory breast cancer: is there a place for surgery? Ann Oncol 2000; 11:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/35\">",
"      Brun B, Otmezguine Y, Feuilhade F, et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer 1988; 61:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/36\">",
"      Bristol, IJ, Buchholz, TA. Inflammatory breast cancer: current concepts in local management. Breast Dis 2005-2006; 22:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/37\">",
"      Panades M, Olivotto IA, Speers CH, et al. Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis. J Clin Oncol 2005; 23:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/38\">",
"      Curcio LD, Rupp E, Williams WL, et al. Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status. Ann Surg Oncol 1999; 6:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/39\">",
"      Chin PL, Andersen JS, Somlo G, et al. Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile? J Am Coll Surg 2000; 190:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/40\">",
"      Slavin SA, Love SM, Goldwyn RM. Recurrent breast cancer following immediate reconstruction with myocutaneous flaps. Plast Reconstr Surg 1994; 93:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/41\">",
"      Motwani SB, Strom EA, Schechter NR, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/42\">",
"      Pisansky TM, Schaid DJ, Loprinzi CL, et al. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol 1992; 15:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/43\">",
"      Gurney H, Harnett P, Kefford R, Boyages J. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. Aust N Z J Med 1998; 28:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/44\">",
"      Bristol IJ, Woodward WA, Strom EA, et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2008; 72:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/45\">",
"      Cristofanilli M, Valero V, Buzdar AU, et al. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer 2007; 110:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31048/abstract/46\">",
"      Dawood S, Ueno NT, Valero V, et al. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 2011; 117:1819.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 768 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-AB4CE9AEE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31048=[""].join("\n");
var outline_f30_20_31048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION AND DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis and staging evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT OF INFLAMMATORY BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neoadjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Locoregional treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Postoperative radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adjuvant endocrine therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Adjuvant trastuzumab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/768\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/768|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/8/13442\" title=\"picture 1\">",
"      Inflammatory breast cancer with peau d orange appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/34/2592\" title=\"picture 2\">",
"      Inflammatory breast cancer appearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/768|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/14/29920\" title=\"table 1\">",
"      TNM stage breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20106?source=related_link\">",
"      Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9495?source=related_link\">",
"      Breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24504?source=related_link\">",
"      Breast biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/19/36150?source=related_link\">",
"      Breast lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=related_link\">",
"      Breast reconstruction in women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42232?source=related_link\">",
"      Cardiotoxicity of trastuzumab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/49/10009?source=related_link\">",
"      Clinical features, diagnosis, and staging of newly diagnosed breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/36/24138?source=related_link\">",
"      Diagnostic evaluation of women with suspected breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/857?source=related_link\">",
"      Erythematous disorders of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/22/30058?source=related_link\">",
"      HER2 and predicting response to therapy in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19194?source=related_link\">",
"      Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10103?source=related_link\">",
"      Inflammatory breast cancer: Pathology and molecular pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/18/12586?source=related_link\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1529?source=related_link\">",
"      Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35466?source=related_link\">",
"      Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=related_link\">",
"      Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/39/8818?source=related_link\">",
"      Patient information: Inflammatory breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/47/5875?source=related_link\">",
"      Patient information: Locally advanced and inflammatory breast cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=related_link\">",
"      Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36602?source=related_link\">",
"      Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_20_31049="Pulp space infection Felon";
var content_f30_20_31049=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F80567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F80567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulp space infection (Felon)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 733px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The digital pulp is the fleshy mass at the finger tips, and is divided into multiple compartments by fibrous septae that provide structural support.",
"    <br/>",
"    Figure A demonstrates a transverse section through the distal fingertip showing septae that divides the pulp space into compartments.",
"    <br/>",
"    Figure B demonstrates an abscess involving multiple compartments of the pulp space. An infection of the pulp space is also called a felon.",
"    <br/>",
"    Figure C is an example of a tense pulp abscess.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31049=[""].join("\n");
var outline_f30_20_31049=null;
var title_f30_20_31050="Clinical features and management of ankle pain in the young athlete";
var content_f30_20_31050=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and management of ankle pain in the young athlete",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Christopher R Powers, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Albert C Hergenroeder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/20/31050/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/20/31050/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 20 percent of all musculoskeletal complaints are related to the foot and ankle, which is not surprising if one considers the functions of the foot:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      It provides a stable base on which the body can stand.",
"     </li>",
"     <li>",
"      It acts as a rigid lever to propel the body forward during walking.",
"     </li>",
"     <li>",
"      It provides shock absorption for the force generated during walking and running (approximately two to six times an individual's body weight).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ankle joint is formed by the distal tibia and fibula (superiorly) and the dome of the talus (inferiorly). Plantarflexion and dorsiflexion are the primary actions; inversion (supination) and eversion (pronation) are secondary (",
"    <a class=\"graphic graphic_figure graphicRef60173 \" href=\"mobipreview.htm?0/8/140\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/23/14711?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of foot and ankle pain in the young athlete\", section on 'Anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Foot and ankle pain in the young athlete can originate in the bones (fractures), ligaments (sprains), muscles and tendons (tendinitis), or fascia (fasciitis). Careful localization of the pain can help to narrow the differential diagnosis (",
"    <a class=\"graphic graphic_figure graphicRef63409 \" href=\"mobipreview.htm?0/44/711\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/23/14711?source=see_link\">",
"     \"Evaluation of foot and ankle pain in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    History, physical examination, and, when indicated, plain radiographs are usually sufficient to make the correct diagnosis.",
"   </p>",
"   <p>",
"    The clinical features and management of ankle pain in the young athlete, including high ankle sprains are reviewed here. Ankle sprains (other than high ankle sprains), pediatric ankle fractures, and foot and heel pain in the young athlete are discussed separately in the following topics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34296?source=see_link\">",
"       \"Ankle sprain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24345?source=see_link\">",
"       \"Ankle fractures in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/41/23190?source=see_link\">",
"       \"Clinical features and management of foot pain in the young athlete\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28775?source=see_link\">",
"       \"Clinical features and management of heel pain in the young athlete\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TALAR PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic injuries to the talus include acute osteochondral fractures, chronic osteochondritis dissecans, and stress fractures.",
"   </p>",
"   <p>",
"    Osteochondral fractures occur in approximately 6 percent of ankle inversion sprains. In contrast, osteochondritis dissecans of the talus is a relatively rare event, occurring in less than 1 percent of all fractures and 1 percent of all talar fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Osteochondritis dissecans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteochondritis dissecans (OCD) is a condition in which a segment of articular cartilage, with its underlying subchondral bone, gradually separates from the surrounding osteocartilaginous tissue. The most common mechanism of injury in children with OCD of the talus is inversion of the ankle, usually associated with trauma. Symptoms include pain, stiffness, weakness, mechanical sensation (eg, popping, clicking, or locking), and occasionally a loose body sensation (ie, of something floating around) in the ankle. No pathognomic signs exist, but pain may be produced by palpation over the anterior lateral talus with the foot in plantarflexion or palpation over the posterior medial talus with the foot in dorsiflexion if the injury occurred in plantarflexion or dorsiflexion, respectively. The clinical manifestations and treatment of OCD of the talus are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/37/13913?source=see_link&amp;anchor=H2510199#H2510199\">",
"     \"Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19014?source=see_link\">",
"     \"Management of osteochondritis dissecans (OCD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Stress fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures of the talus are rare events. When reported, they usually occur in runners, dancers, or military personnel. Stress fractures result when overuse leads to bony fatigue. Repetitive stress leads to bone remodeling (bone resorption followed by new bone formation). Under normal circumstances, remodeling results in the formation of strong bone along the lines of stress. However, if persistent or increased stress occurs during the period in which bone resorption predominates, new bone formation is prevented and stress fractures can occur. Stress fractures of the lateral process of the talus are seen in runners who supinate (invert) their feet. Stress fractures at the neck of the talus also can be associated with calcaneonavicular coalition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with stress fractures of the talus complain of having chronic rearfoot pain with activity. They also may complain of an ankle sprain that has failed to improve despite appropriate treatment and rehabilitation. The examination may show decreased subtalar movement and a discrete area of tenderness over the site of the injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs (an ankle series: AP, lateral, and mortise views) may demonstrate stress fractures of the talus, although the lesion is better visualized by MRI or CT. Bone scintigraphy can identify metabolically active lesions of the talus that are not visualized by the other modalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orthopedic consultation should be obtained for children with stress fractures of the talus because the long-term prognosis is poor (eg, failure to heal, development of subsequent arthritis), even with appropriate therapy. The initial treatment typically involves relative rest (ie, avoidance of activities that cause pain). Patients who are unresponsive to relative rest are treated with a nonweightbearing short leg cast.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LATERAL ANKLE PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of lateral ankle pain in the young athlete includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inversion ankle sprain after injury to the anterior talofibular ligament (ATFL)",
"     </li>",
"     <li>",
"      Anterior lateral OCD (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Osteochondritis dissecans'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Sinus tarsi syndrome",
"     </li>",
"     <li>",
"      Peroneal tendon injuries",
"     </li>",
"     <li>",
"      Os peroneum",
"     </li>",
"     <li>",
"      Systemic diseases that affect the foot and ankle, such as gout, spondyloarthropathy, rheumatoid arthritis, and infection (see appropriate topic reviews)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sinus tarsi syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus tarsi syndrome (STS) is synovitis of the lateral aspect of the anterior subtalar joint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/2\">",
"     2",
"    </a>",
"    ]. Synovitis of the subtalar joint may occur in patients with gout or rheumatoid arthritis, but in the young athlete, STS usually is a chronic complication of severe or recurrent lateral ankle sprains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In one prospective series of 639 patients presenting with ankle sprain, the sinus tarsi was involved in 14 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sinus tarsi or talocalcaneal sulcus is the space between the medial neck of the talus and the superior aspect of the anterior calcaneus. It runs an oblique course between the talus and calcaneus from lateral to medial coursing anterior to posterior. It is a funnel-shaped area located anterior and inferior to the lateral malleolus (ie, the soft spot beneath the ATFL) and is the lateral extension of the tarsal canal.",
"   </p>",
"   <p>",
"    The sinus tarsi contain three intrinsic ligaments:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The talocalcaneal ligament is an interosseous ligament that almost completely fills the sinus. It maintains the alignment of the talus and calcaneus. It is taut in supination (inversion) of the foot and relaxed in pronation (eversion) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cervical ligament is lateral to the talocalcaneal ligament.",
"     </li>",
"     <li>",
"      The inferior extensor retinaculum is lateral to the other two ligaments and only indirectly contributes to the stability of the talocalcaneus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In inversion injuries of the ankle, the extrinsic ligaments (ATFL and CFL) are the first to be injured. If the inversion is severe, the intrinsic ligaments of the sinus tarsi also are affected. Recurrent inversion injuries cause weakening of the ATFL and CFL and instability of the hindfoot, predisposing the ligaments of the sinus tarsi to injury with subsequent inversion sprain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have STS usually present soon after the injury with diffuse swelling and pain over the lateral ankle and difficulty bearing weight. In the acute phase, STS is not distinguishable from an ankle sprain and is treated as such. However, as the swelling and pain resolve, patients complain of functional instability of the involved ankle and diffuse pain on the lateral side of the foot, particularly when walking on uneven surfaces [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/6\">",
"     6",
"    </a>",
"    ]. The pain subsides with rest or immobilization.",
"   </p>",
"   <p>",
"    On examination, the patient has pain and point tenderness posterior and inferior to the ATFL. Pain can be provoked by even minor pressure over the lateral opening of the sinus tarsi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/6\">",
"     6",
"    </a>",
"    ]. The pain is reproducible with",
"    <span class=\"nowrap\">",
"     supination/inversion",
"    </span>",
"    and adduction of the hindfoot of the affected side. Pain is improved when the ankle is supported to hold the heel in pronation or valgus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/6\">",
"     6",
"    </a>",
"    ]. The local injection of 2 to 3 mL of 1 percent",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/57/37776?source=see_link\">",
"     lidocaine",
"    </a>",
"    into the sinus tarsi temporarily relieves the sensation of instability in patients with STS and is a useful diagnostic tool. Ankle stability is normal in patients with STS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/7\">",
"     7",
"    </a>",
"    ]; if ankle instability is detected on examination, other diagnoses should be considered (eg, ligamentous injury). Patients with chronic STS may develop peroneal spasm with associated pes planus as they try to compensate for subtalar pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine ankle radiographs (AP, lateral, and mortise) are normal in patients with STS. The abnormality may be demonstrated on stress radiographs, which are abnormal if there are &ge;7 degrees of talar tilt or &ge;2 mm of anterior displacement with the anterior drawer maneuver. MRI may reveal inflammation and fibrotic tissue in the sinus tarsi region. Arthrography reveals obliteration of the lateral talocalcaneal recesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial treatment for STS is conservative and includes injection of corticosteroid (20 mg of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/45/40656?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide [40",
"    <span class=\"nowrap\">",
"     mg/mL,",
"    </span>",
"    Kenalog-40&reg;] with 2 mL of 1 percent",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/57/37776?source=see_link\">",
"     lidocaine",
"    </a>",
"    ) into the sinus tarsi region, orthotics if appropriate, rest, and immobilization. The corticosteroid injection will provide immediate improvement that is usually sustained for two to three days. Long-term pain control may require weekly injections (one injection per session for three to six weeks). If the pain persists despite multiple weekly injections, surgical therapy is indicated.",
"   </p>",
"   <p>",
"    If surgery is necessary, subtalar arthroscopy is the desired approach. Surgical excision of the hypertrophied synovial tissue often is successful in relieving the pain symptoms. Patients who undergo surgical treatment also may require reconstruction of the ATFL to alleviate constant and chronic pain over the ATFL secondary to the precipitation injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Peroneal tendon injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peroneal tendons are contained in the lateral compartment of the leg (",
"    <a class=\"graphic graphic_figure graphicRef54716 \" href=\"mobipreview.htm?31/28/32196\">",
"     figure 3",
"    </a>",
"    ). They act to evert and weakly plantarflex the foot. The peroneus longus inserts on the base of the first metatarsal bone and medial cuneiform bone. The peroneus brevis inserts on the base of the fifth metatarsal. Injuries to the peroneal tendon include synovitis of the tendon sheath, longitudinal tears, and retinacular attenuation with peroneal tendon subluxation or dislocation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peroneal tendon injuries should be considered in any patient who presents with acute or chronic lateral ankle inversion sprains with or without associated swelling or instability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peroneal tendinitis usually is associated with insufficient rehabilitation of lateral ankle sprains. It also can be precipitated by changes in footwear, training regimen, or playing surface, or as a result of repetitive or prolonged activity (eg, endurance sports, such as marathon running). Patients with peroneal tendinitis may complain of pain, swelling, and warmth in the region of the peroneal tendons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15\">",
"     15",
"    </a>",
"    ]. The pain is worsened by passive inversion with plantarflexion or active eversion with dorsiflexion of the foot. The complaints are present for less than six weeks in acute tendinitis and for greater than six weeks in chronic tendinitis.",
"   </p>",
"   <p>",
"    The clinical features of peroneal tendon tears are similar to those of peroneal tendinitis. The presentation of peroneal tears is usually acute, with associated swelling and ecchymosis; subacute presentation also can occur and is usually more benign-appearing.",
"   </p>",
"   <p>",
"    Similar to peroneal tendinitis, peroneal dislocation or subluxation is often associated with acute or chronic lateral ankle sprains. However, the typical mechanism for this injury is forced dorsiflexion with reflex contraction of the peroneal muscles, leading to disruption of the retinaculum and peroneal tendon dislocation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Most reported cases of acute peroneal dislocation occur in injuries related to snow skiing, ice skating, running, basketball, soccer, or football [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/17\">",
"     17",
"    </a>",
"    ]. Complete peroneal dislocation has been estimated to occur in 0.5 percent of all skiing injuries and sprain of the peroneal retinaculum in 2.5 percent of all skiing injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have peroneal tendon dislocation or subluxation may complain of an audible snap around the lateral malleolus. In the acute injury, diffuse lateral swelling and ecchymosis usually are present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/19\">",
"     19",
"    </a>",
"    ]. Pain (both acute and chronic) is usually posterior to the fibula (in contrast to lateral ankle sprains, in which the pain is anterior to the fibula) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/19\">",
"     19",
"    </a>",
"    ]. Pain is worsened by passive inversion with plantarflexion or active eversion with dorsiflexion of the foot. Subluxation can be provoked by passively dorsiflexing the foot and then everting it with resistance. Lateral ankle pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    painful pop indicate",
"    <span class=\"nowrap\">",
"     subluxation/dislocation.",
"    </span>",
"    However, the absence of these findings does not exclude the diagnosis. Chronic peroneal tendon dislocation is suggested by lateral ankle pain, lateral ankle instability, and snapping peroneal tendons.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptoms of lateral ankle pain should undergo plain radiographs to investigate possible bony abnormalities (AP, lateral, and mortise views of the ankle) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15,20\">",
"     15,20",
"    </a>",
"    ]. MRI is the best diagnostic study to demonstrate a tendon tear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of peroneal tendinitis includes rest, ice, and NSAIDs. Immobilization of the lower leg may be necessary for patients with severe symptoms. As symptoms resolve, a well-designed and controlled rehabilitation program of stretching and strengthening is prescribed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ], emphasizing the balance between the tibialis posterior and peroneals. Steroid injections are not recommended for peroneal tendinitis because of the risk of subsequent tendon rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15\">",
"     15",
"    </a>",
"    ]. Once symptoms resolve (usually in several weeks), athletes may begin a controlled program of stretching and strengthening to prepare them for return to play [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of peroneal tendon tears depends upon the severity of symptoms. Athletes who have mild symptoms may be managed nonoperatively (ie, with rest, ice, and NSAIDs) if the treatment reduces pain and the athlete has full rehabilitation and a normal ankle examination at follow-up. Resolution of symptoms may take two to three months. Athletic participation can resume once examination reveals that the ankle has returned to normal. Relative rest (ie, avoidance of activities that cause pain) of the affected foot is recommended during rehabilitation to allow the athlete to maintain some level of fitness while his or her injury is healing. Operative treatment is indicated in athletes who have severe symptoms and in any patient who fails nonoperative treatment (ie, recalcitrant pain or disability despite aggressive therapy for two to three months).",
"   </p>",
"   <p>",
"    Acute peroneal dislocation requires surgical repair to reinforce the retinaculum and deepen the peroneal groove. The success rate for this surgery (defined by lack of recurrence) is reported to be as high as 96 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/12\">",
"     12",
"    </a>",
"    ]. Chronic peroneal tendon dislocation or subluxation may be managed nonoperatively if the pain is minimal and competitive performance is not affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ]. However, nonsurgical treatment of chronic peroneal dislocation or subluxation is usually unsuccessful (ie, 30 to 40 percent rate of redislocation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15,21\">",
"     15,21",
"    </a>",
"    ]. For athletes who have had surgical repair, return to play can be expected at about eight weeks following a graduated rehabilitation program designed to increase both strength and flexibility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Os peroneum",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accessory ossicle, the os peroneum, is present within the substance of the peroneus longus in 20 percent of feet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. These ossicles typically are located plantar to the cuboid bone, lateral to the calcaneus, or at the calcaneocuboid articulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. The presence of an os peroneum predisposes to the development of peroneus longus stenosing tenosynovitis in the region of the cuboid tunnel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lateral ankle",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    foot pain is the most common complaint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. Examination demonstrates pain with palpation of the region of the lateral plantar cuboid or near the calcaneocuboid articulation (",
"    <a class=\"graphic graphic_figure graphicRef63409 \" href=\"mobipreview.htm?0/44/711\">",
"     figure 2",
"    </a>",
"    ) and thickening and tenderness of the peroneus longus and brevis tendon sheath. Pain at the os typically is exacerbated in the heel-rise phase of gait, by resisted plantarflexion of the first ray (ie, the first metatarsal and the two phalanges of the great toe), and by the varus inversion stress test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. The varus inversion stress test is performed by placing the symptomatic foot in an inverted, supinated, and adducted position similar to testing the integrity of the ATFL ligament [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, patients may complain of pain or the sensation of stepping on a pebble with forced foot eversion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Os peroneum are demonstrated on the radiographs that are recommended in the evaluation of patients with lateral ankle pain (eg, AP, lateral, and mortise view of the ankle), and AP and oblique views of the foot. Os peroneum usually are seen best on the oblique view of the foot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. Acute fracture or diastasis of a multipartite os peroneum, callus formation seen about the os peroneum, or proximal migration of the os peroneum suggests pathology to the peroneus longus tendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Peroneal tendon injuries'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for pain in the region of the os peroneum includes rest, ice, and NSAIDs. Immobilization of the lower leg may be necessary for patients with severe symptoms. As symptoms resolve, a well-designed and controlled rehabilitation program of stretching and strengthening is prescribed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MEDIAL ANKLE PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of medial ankle pain in the young athlete includes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Flexor hallucis longus tendinitis or tear",
"     </li>",
"     <li>",
"      Flexor digitorum longus tendinitis",
"     </li>",
"     <li>",
"      Os tibiale externum (accessory navicular bone)",
"     </li>",
"     <li>",
"      Tibialis posterior tendinitis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28775?source=see_link\">",
"       \"Clinical features and management of heel pain in the young athlete\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Tarsal tunnel syndrome",
"     </li>",
"     <li>",
"      Achilles tendinitis (see",
"      <a class=\"local\" href=\"#H44\">",
"       'Posterior ankle pain'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Posteromedial tarsal coalition (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23706?source=see_link\">",
"       \"Overview of the causes of limp in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Osteochondritis of the posteromedial talus (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Osteochondritis dissecans'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Posterior deltoid ligament sprain",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Flexor hallucis longus injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;The posterior medial ankle contains three tendons: the posterior tibial, flexor digitorum longus, and the flexor hallucis longus (FHL) (",
"    <a class=\"graphic graphic_figure graphicRef54716 \" href=\"mobipreview.htm?31/28/32196\">",
"     figure 3",
"    </a>",
"    ). Of these tendons, only the FHL passes through a discrete fibro-osseous tunnel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/25\">",
"     25",
"    </a>",
"    ]. Because of this anatomy, which is similar to that of the abductor pollicis longus and extensor pollicis brevis of the thumb, the FHL tendon is prone to developing a tenosynovitis similar to de Quervain's tenosynovitis of the wrist. Other FHL injuries include swelling, triggering, partial tears, and complete ruptures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27270?source=see_link\">",
"     \"de Quervain's tenosynovitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Flexor hallucis longus tendinitis, sometimes called dancer's tendinitis because it is common among classical ballet dancers, also occurs in runners, soccer players, and other athletes. Ballet dancers are particularly prone to development of musculotendinous foot injuries for several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dancing on the toes places a high axial load on the structures of the feet.",
"     </li>",
"     <li>",
"      Frequent, prolonged repetition of dance movements can lead to irritation and swelling of the FHL tendon [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Extreme plantarflexion of the ankle and foot while en pointe may repetitively stress the musculotendinous structures beyond their capacity to support the foot [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Martial arts athletes who perform spin kicks also can irritate the FHL tendon. Injuries to the FHL tendon are commonly associated with os trigonum syndrome. (See",
"    <a class=\"local\" href=\"#H53\">",
"     'Os trigonum'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of FHL stenosing tenosynovitis typically begin insidiously and may be present for several months before coming to medical attention. Patients complain of pain and tenderness at the posteromedial ankle (",
"    <a class=\"graphic graphic_figure graphicRef63409 \" href=\"mobipreview.htm?0/44/711\">",
"     figure 2",
"    </a>",
"    ). The pain may radiate distally along the medial arch and is exacerbated by weightbearing or athletic activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examination reveals tenderness and, occasionally, crepitation over the sheath of the FHL tendon behind the medial malleolus (",
"    <a class=\"graphic graphic_figure graphicRef63409 \" href=\"mobipreview.htm?0/44/711\">",
"     figure 2",
"    </a>",
"    ). Passive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    active ankle range of motion is painful, and crepitus or triggering of the hallux (ie, locking of the toe in a certain position, caused by \"catching\" of the tendon, that is relieved spontaneously) may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The plantar flexion test should be performed to evaluate for posterior impingement, which if present suggests associated os trigonum syndrome. In this test, symptoms are accentuated by resisted plantarflexion because the FHL tendon pushes against the accessory ossicle as it passes over the bone. (See",
"    <a class=\"local\" href=\"#H53\">",
"     'Os trigonum'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with medial ankle pain should be evaluated with plain radiographs of the ankle (AP, lateral, and mortise views) and a lateral ankle view with the foot in full equinus (eg, fully flexed and inverted) to exclude bony abnormalities. If the patient is a ballet dancer, it is helpful to obtain a lateral ankle radiograph with the patient wearing a pointe shoe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/25\">",
"     25",
"    </a>",
"    ]. Pathology of the tendon is sometimes, but not always, visualized with MRI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/25\">",
"     25",
"    </a>",
"    ]. The diagnosis is usually made based upon history and physical examination, with or without MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsurgical treatment of FHL tendinitis consists of resting the tendon in its sheath by limiting the motion of the first metatarsal phalangeal (MTP) joint. This procedure can be accomplished with a removable boot, rigid forefoot insert, or restrictive taping. The avoidance of activities that cause pain (ie, relative rest) is necessary, but activities such as swimming and physical therapy are permitted. Physical therapy, including iontophoresis (ie, the use of electrical current to drive medications through the skin to areas of disease), is recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/29\">",
"     29",
"    </a>",
"    ]. NSAIDs and icing may be useful adjuncts to therapy. Ice packs should be applied for 20 minutes three to four times per day. To avoid injury to the peroneal nerve during icing, patients should avoid placing the ice packs directly on the skin and should not use the ice packs during sleep. Steroid injections into the FHL sheath are",
"    <strong>",
"     not",
"    </strong>",
"    recommended because of the risk of intratendinous damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/23\">",
"     23",
"    </a>",
"    ]. Patients who fail to respond to conservative therapy or have recurrence of symptoms may require MRI and possible surgery (for debridement of tenosynovitis or removal of the symptomatic os).",
"   </p>",
"   <p>",
"    Surgery may be performed to release the flexor hallucis longus tendon",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    excise a symptomatic os trigonum. Surgical results are variable. Full recovery may take three to eight months, depending upon the complexity of surgery. Postoperative physical therapy and rehabilitation are essential for full return to premorbid function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H53\">",
"     'Os trigonum'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Flexor digitorum longus tendinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries of the flexor digitorum longus (FDL) tendon are uncommon events and can be difficult to differentiate from plantar fasciitis. The FDL may become inflamed at the medial plantar aspect of the tendon secondary to excessive pronation or the increased effort of plantarflexing the toes during propulsion. Dancers and other athletes involved in jumping sports are the susceptible population. FDL tendinitis is diagnosed by history and examination showing pain with resisted toe flexion (which differentiates it from plantar fasciitis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28775?source=see_link\">",
"     \"Clinical features and management of heel pain in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute FDL tendinitis is treated with rest, ice, and NSAIDs. Unless biomechanical problems are corrected, the condition may recur. Rehabilitation involves strengthening the flexor tendons of the foot. Taping to decrease toe flexion of the second through the fifth toes is helpful and may be necessary for as long as six weeks after acute tendinitis develops. Toe crest pads can be used to decrease overuse of the long flexors of the foot during toe-off. Toe crest pads are single longitudinal pads that are placed in the sulcus of the second through fifth toes distal to the metatarsal heads; they create an upward force on the toes to decrease the degree of toe flexion and alleviate the symptoms of FDL tendinitis. Surgery is rarely indicated for flexor tendon pathology of the foot.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Os tibiale externum (Os navicularis syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The os tibiale externum is an accessory bone that is present in 2 to 21 percent of the population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/31\">",
"     31",
"    </a>",
"    ]. It is adjacent to the tuberosity of the navicular and may be attached to, enclosed partially within, or enclosed completely within the tibialis posterior tendon. Compared with a sesamoid in the tibialis posterior tendon, the os tibiale externum is larger and less mobile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Os tibiale externum may become symptomatic in hockey players, figure skaters, soccer players, and skiers who complain of insidious onset of medial arch pain. The pain is usually caused by direct pressure from a rigid, fixed boot (eg, ice skate, ski boot), direct trauma to the area (eg, hit with a soccer ball), or eversion injury of the ankle.",
"   </p>",
"   <p>",
"    On examination, palpation over the navicular tuberosity (",
"    <a class=\"graphic graphic_picture graphicRef52540 \" href=\"mobipreview.htm?35/33/36375\">",
"     picture 1",
"    </a>",
"    ) causes pain. The pain is exacerbated by resisted inversion. The diagnosis is confirmed radiographically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs (ie, foot series: anteroposterior, lateral, and oblique views) may demonstrate a cortical irregularity between the os and the navicular tuberosity, overlying swelling of the bursa, or callus formation. In contrast, a sesamoid of the tibialis posterior demonstrates a homogeneous cortex abutting the navicular tuberosity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonoperative treatment includes ice, NSAIDs, medial longitudinal arch support with a soft orthotic, expansion of the medial arch of the shoe by an orthotist, and a surrounding relief pad that decreases pressure on the medial arch. Operative treatment, indicated for patients who have recalcitrant pain despite conservative management for more than four to six months, involves removal of the prominence or accessory ossicle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     ANTERIOR ANKLE PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior ankle pain in the young athlete usually is caused by injury to the tibialis anterior tendon, typically manifested as tendinitis. Partial and complete rupture of the tendon can also occur. In highly trained athletes, tarsal navicular stress fractures must always be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Tibialis anterior tendinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibialis anterior tendinitis is an uncommon injury that occurs in athletes who wear a fixed boot (eg, skiers, skaters), runners, and \"weekend athletes,\" who do not maintain a consistent level of training. The most common etiology is mechanical pressure over the tendon from tight shoelaces, eyelets on the shoes, or a tight fixed boot. Tendinitis is also associated with running on hard surfaces, over striding, and excessive pronation of the foot. Excessive pronation elongates the anterior tibial tendon, which can predispose to tenosynovitis.",
"   </p>",
"   <p>",
"    The tibialis anterior muscle dorsiflexes and inverts the foot (",
"    <a class=\"graphic graphic_figure graphicRef60173 \" href=\"mobipreview.htm?0/8/140\">",
"     figure 1",
"    </a>",
"    ). During normal gait, contraction of the tibialis anterior muscle (TAM) slows the rapid plantarflexion of the foot at heel-strike to prevent the foot from slapping the ground. Slapping of the ground can lead to excess loading and degeneration of the tibialis anterior muscle, and excessive plantarflexion can lead to rupture of the tendon. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/23/14711?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation of foot and ankle pain in the young athlete\", section on 'Gait cycle'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have acute tibialis anterior tendinitis present with pain along the course of the tendon, usually along and over the anteromedial ankle. The pain is precipitated by activity and improves with rest. Patients should be questioned about change in the amount and type of activity, activity level, activity surface, and footwear, because change in any of these variables can cause tibialis anterior tendinitis.",
"   </p>",
"   <p>",
"    Physical examination reveals pain with either passive plantarflexion or active dorsiflexion. The area of tenderness and swelling along the tibialis anterior muscle is best appreciated with the foot actively dorsiflexed. Evaluation of the foot for biomechanical imbalance (ie, asymmetry in flexibility or strength between agonist and antagonist muscle groups) also should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs in patients with tibialis anterior tendinitis are normal, and need not be obtained if the diagnosis can be made clinically. Magnetic resonance imaging (MRI) is not usually indicated, but may reveal increased fluid within the synovial sheath, without a tendon tear. MRI is also useful for diagnosing an early stress reaction or fracture of the navicular bone when physical examination cannot distinguish between ATM and navicular pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative treatment of tendinitis consists of ice, NSAIDs, and rest (either relative or complete). As inflammation subsides, rehabilitation can be initiated with muscle strengthening and conditioning. Orthotics may be considered depending upon the individual patient's anatomy and needs, because altering the footwear to change the area of maximum pressure can help to alleviate symptoms. Tenosynovectomy is rarely indicated, but should be considered in patients who do not respond to other interventions after three to six months.",
"   </p>",
"   <p>",
"    Partial rupture of the tibialis anterior tendon requires four to six weeks of complete rest. Complete or open rupture of the anterior tibial tendon requires emergent orthopedic consultation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Navicular stress fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures of the navicular bone are considered high-risk because of their propensity for nonunion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/32\">",
"     32",
"    </a>",
"    ]. They have been reported in runners, pole vaulters, tennis players, and gymnasts. Repetitive loading of the medial column of the foot drives the head of the talus into the navicular, resulting in fracture in the middle one-third of the bone, an area of relative hypovascularity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients will often complain of diffuse midfoot pain, with or without discrete tenderness over the dorsal aspect of the navicular on physical examination. Athletes of all ages, especially runners who are overtraining, are at risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=see_link\">",
"     \"Overview of stress fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI appears to be the most sensitive imaging modality for demonstrating acute stress fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/33\">",
"     33",
"    </a>",
"    ]. Marrow edema is an early finding. Plain radiographs demonstrate fracture late and only in 33 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/34\">",
"     34",
"    </a>",
"    ]. Nuclear medicine bone scans are sensitive to early increased metabolic activity. Computed tomography (CT) with thin- cuts can be used as a follow-up study to better define the anatomy of the fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/35\">",
"     35",
"    </a>",
"    ]. However, CT may not identify 10 percent of navicular stress fractures.",
"   </p>",
"   <p>",
"    There is no consensus on the imaging modality of choice to evaluate for navicular bone healing. Bone healing on CT scan may lag behind clinical improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonweightbearing cast immobilization for a minimum of six weeks is recommended, although there are no well-controlled studies to confirm the efficacy of this approach. In one small retrospective series, about two-thirds of athletes were able to return to their previous level of sports participation. Persistent findings on CT were noted in 85 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical referral is indicated for those athletes with prolonged symptoms despite nonweightbearing immobilization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7907923\">",
"    <span class=\"h2\">",
"     Syndesmotic sprain (high ankle sprain)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to the distal tibiofibular syndesmosis complex (high ankle sprain) accounts for 10 to 20 percent of all ankle sprains, but occur more frequently in contact sports (eg, football) and those activities that use a rigid boot as part of their equipment (skiing, hockey) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. The distal tibiofibular syndesmosis complex (DTSFC) functions to maintain the relationship between the tibia and fibula at the ankle mortise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/42\">",
"     42",
"    </a>",
"    ]. The complex is maximally stressed when the ankle is dorsiflexed",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    externally rotated, which correlates with the most common mechanism of injury. Injuries classically occur when a player falls prone on the ground and another player falls or steps on the heel which forcefully externally rotates the ankle or in a skier whose ski externally rotates and body internally rotates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7907958\">",
"    <span class=\"h3\">",
"     Anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distal tibiofibular syndesmosis complex is made up of three components:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anterior tibiofibular ligament (ATiFL) attaches to the anterolateral tibial tubercle to the anterior aspect of the fibula (",
"      <a class=\"graphic graphic_picture graphicRef66111 \" href=\"mobipreview.htm?1/59/1970\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The posterior tibiofibular ligament (PTiFL) and the inferior transverse ligament attach the posterolateral tibial tubercle to the posterior aspect of the fibula (",
"      <a class=\"graphic graphic_figure graphicRef66189 \" href=\"mobipreview.htm?2/26/2464\">",
"       figure 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The interosseous ligament is a thick osteofascial membrane that runs the length of the tibia and fibula and terminates distally in the thicker syndesmosis (",
"      <a class=\"graphic graphic_figure graphicRef77999 \" href=\"mobipreview.htm?28/2/28705\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The deltoid ligament is also important in the evaluation and treatment of the high ankle sprain because it is the medial stabilizer of the talus that prevents it from translating laterally and putting stress on the fibula and the DTFSC (",
"    <a class=\"graphic graphic_figure graphicRef51952 \" href=\"mobipreview.htm?34/57/35728\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Widening of the DTFSC as little as 1 mm will decrease the contact area between the tibia and talus by 42 percent and increase the risk for ankle instability and arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/45\">",
"     45",
"    </a>",
"    ]. The most predictive factor of ankle instability at six months post-acute injury was the involvement of the DTFSC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7907930\">",
"    <span class=\"h3\">",
"     Physical exam",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical findings are relatively similar to other types of ankle sprains with marked swelling, ecchymosis, and pain. The area of maximal tenderness may be slightly more proximal where the DTFSC is located. The more proximal the tenderness to palpation extends over the syndesmosis the longer the injury takes to return to play [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/46\">",
"     46",
"    </a>",
"    ]. Provocative testing is based on reproducing the talar external rotation or lateral displacement or the splaying of the tibiofibular joint. Tests include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Squeeze test",
"      </strong>",
"      &ndash; The examiner squeezes the more proximal tibia and fibula together. Pain more distally at the tibiofibular syndesmosis complex (DTFSC) indicates a syndesmosis sprain (",
"      <a class=\"graphic graphic_picture graphicRef55899 \" href=\"mobipreview.htm?23/15/23793\">",
"       picture 3",
"      </a>",
"      ). The squeeze test is not sensitive to milder injuries, but if positive may indicate a more prolonged recovery.",
"     </li>",
"     <li>",
"      <strong>",
"       External rotation stress test",
"      </strong>",
"      &ndash; The patient is seated. The examiner stabilizes the lower leg with the outside hand and provides a gentle external rotation force to the foot with the inside hand which will reproduce pain over the DTFSC (",
"      <a class=\"graphic graphic_picture graphicRef57674 \" href=\"mobipreview.htm?20/42/21153\">",
"       picture 4",
"      </a>",
"      ). If there is pain over the medial joint line, this may implicate the deltoid ligament injury and a more severe injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Fibular drawer",
"      </strong>",
"      &ndash; With the patient in the seated position, the examiner stabilizes the tibia with the inside hand and the outside hand grips the distal fibula between the thumb and index finger. The fibular head in an injured ankle will have asymmetric translation in the anterior posterior plane when compared to the uninjured side. It may also reproduce pain in the tibiofibular ligaments.",
"     </li>",
"     <li>",
"      <strong>",
"       Eversion stress test &ndash;",
"      </strong>",
"      The patient is seated with the injured ankle crossed over the opposite leg and the uninjured foot flat on the floor. The examiner applies pressure to the medial side of the knee which causes pain in the DTFSC (",
"      <a class=\"graphic graphic_figure graphicRef80550 \" href=\"mobipreview.htm?42/59/43953\">",
"       figure 7",
"      </a>",
"      ). &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Cotton talar translation test &ndash;",
"      </strong>",
"      While holding the lower leg with one hand, the examiner grasps the heel from underneath and moves the talus medially and laterally. Pain or laxity when compared to the uninjured side indicates DTFSC disruption. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7907937\">",
"    <span class=\"h3\">",
"     Diagnostic imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic evaluation of the ankle should always include three views of the ankle (AP, Lateral, and mortise). The following radiographic findings are consistent with a distal tibiofibular syndesmosis complex (DTFSC) injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased space between the distal tibia and fibula at 1 cm above the ankle joint on the AP view consisting of increased clear space (&gt;10 mm) and decreased tibiofibular overlap (&lt;6 mm) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased clear space (&gt;3 mm) between the medial malleolus and talus indicate lateral translation of the talus and both DTFSC injury as well as deltoid involvement (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74769 \" href=\"mobipreview.htm?24/32/25102\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In the chronic injury or remote ankle fracture, there may be calcification of the syndesmosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/49,50\">",
"       49,50",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings are not sensitive to identifying injuries that are noted at arthroscopy. The use of stress radiographs have been advocated by some, but are not predictive of ankle instability or need for surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/51\">",
"     51",
"    </a>",
"    ]. MRI of the ankle is more highly sensitive and specific to identifying injury than plain radiographs, but has not demonstrated a relationship between findings and outcomes, including the need for surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the pediatric age group (usually 12 to 15 years old), injury to the DTFSC complex needs to be differentiated from a Tillaux fracture, a Salter Harris 3 fracture of the anterolateral distal tibial epiphysis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24345?source=see_link&amp;anchor=H17#H17\">",
"     \"Ankle fractures in children\", section on 'Juvenile Tillaux fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7907944\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no standard classification of DFTSC injuries. The West Point Ankle Sprain Scale assesses severity based physical exam and ability to weight bear. Injuries to the DTFSC generally take about two times as long to rehabilitate as other ankle sprains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. The treatment and rehabilitation of high ankle sprains does not have an established protocol but in general follows the three phase approach; acute, sub acute, and advanced training. Certain accepted principles must be considered when designing a treatment plan.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tibiofibular compression will approximate the injured structures to optimize the integrity of healing after injury.",
"     </li>",
"     <li>",
"      Air stirrup, taping, and cast immobilization have all been advocated, but there is no consensus on the duration or advantage of one type of immobilization.",
"     </li>",
"     <li>",
"      Avoid early resisted eversion rehabilitation and dorsiflexion passive range of motion which may further injure the distal tibiofibular syndesmosis complex.",
"     </li>",
"     <li>",
"      Protected weightbearing will minimize the talar dome engagement into the mortise but the duration of nonweightbearing and timing of progression to partial and full weightbearing is not agreed upon. Nonweightbearing recommendations vary from one to three weeks. Partial weightbearing will then last until the patient is able to walk with a normal gait and will vary from patient to patient according to the severity of injury. Full weightbearing progresses from walking to jogging, and then running with the patient pain free at each stage before progressing.",
"     </li>",
"     <li>",
"      Surgical management is indicated for frank diastasis of the DFTSC indicated by deltoid ligament involvement and an increased clear space &gt;3 mm medially on plain radiograph as well as chronic injuries that have not progressed with proper conservative management for four to six months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h1\">",
"     POSTERIOR ANKLE PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of posterior ankle pain in the young athlete includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Achilles tendon pathology (eg, tendinitis, rupture)",
"     </li>",
"     <li>",
"      Os trigonum syndrome (posterior impingement syndrome)",
"     </li>",
"     <li>",
"      Retrocalcaneal bursitis",
"     </li>",
"     <li>",
"      Pericalcaneal bursitis (which can involve the pre-Achilles bursa, the retrocalcaneal bursa, or both)",
"     </li>",
"     <li>",
"      Haglund deformity (a prominent enlarged bony posterior superior calcaneal tubercle)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Injuries to the Achilles tendon are the most common lower extremity tendon injuries, and are estimated to occur in 6 to 19 percent of athletes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. Runners, both athletes and nonathletes, are most commonly affected.",
"   </p>",
"   <p>",
"    The Achilles tendon is formed by the fibrous coalescence of the gastrocnemius and soleus tendons and is the thickest and strongest tendon in the body. The Achilles tendon is approximately 15 cm in length. The proximal Achilles tendon receives its blood supply from the posterior tibial artery, whereas the distal Achilles tendon is supplied by the osseous and periosteal vessels. This arrangement leaves a hypovascular area 2 to 6 cm proximal to the insertion of the Achilles on the calcaneal tuberosity. The point at which the tendon inserts onto the bone is called the enthesis. A retrocalcaneal bursa is located between the Achilles tendon and the posterior aspect of the calcaneal tuberosity. A pre-Achilles bursa is located superficial to the tendon at the same level as the retrocalcaneal bursa.",
"   </p>",
"   <p>",
"    The Achilles tendon is not encased in a tendon sheath but in a paratenon that is highly vascular and susceptible to inflammatory processes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/54\">",
"     54",
"    </a>",
"    ]. The paratenon has two layers: the endotenon, which consists primarily of lymphatics, nerves, and a limited blood supply; and the epitenon, which covers the endotenon. The epitenon and paratenon together are referred to as the peritendon. The peritendon, rather than the Achilles tendon, is affected by inflammation because the intratendinous blood supply is sparse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Achilles tendinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrinsic and extrinsic factors contribute to the development of injuries to the Achilles tendon. Intrinsic factors include the hypovascular zone 2 to 6 cm proximal to the insertion. Excessive rearfoot motion (as occurs in patients with subtalar instability), tibia varum, or functional overpronation increases torque stress in the hypovascular zone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. Additional intrinsic factors include tight hamstrings, tight Achilles tendons, and systemic disease such as rheumatoid arthritis, spondyloarthropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/55,56\">",
"     55,56",
"    </a>",
"    ], gout, sarcoidosis, and the hyperlipidemias. Extrinsic factors include repetitive microtrauma, improper footwear, errors in training technique, the use of systemic or local steroids, and the use of fluoroquinolone antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/60/28618?source=see_link\">",
"     \"Fluoroquinolones\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions of the Achilles tendon can be classified as peritendinitis, tendinosis, pantendinitis (peritendinitis and tendinosis), and insertional lesions (",
"    <a class=\"graphic graphic_table graphicRef69838 \" href=\"mobipreview.htm?30/13/30939\">",
"     table 1",
"    </a>",
"    ). Peritendinitis is an inflammatory process of the peritendon (epitenon and paratenon) without associated tendon degeneration. Tendinosis is a degenerative lesion of the tendon without coexisting inflammation of the peritendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Morning stiffness, pain at the start of exercise, and resolution of pain with rest are characteristic of acute peritendinitis, whereas pain is typically constant in chronic peritendinitis and chronic pantendinitis. Patients with insertional tendinopathies complain of heel pain, particularly when wearing poorly fitting shoes.",
"   </p>",
"   <p>",
"    On physical examination, the areas around the Achilles tendon should be inspected and palpated for edema, crepitus, or tendon thickening, which are present in tendinosis. Bony prominence and skin irritation of the heel should be noted because they can indicate insertional lesions. The insertion of the Achilles tendon should be palpated to evaluate insertional tendinopathies.",
"   </p>",
"   <p>",
"    The \"painful arc\" sign is helpful in differentiating peritendinitis from pantendinitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. In this test, the ankle is passively moved through a full range of dorsiflexion and plantarflexion. The pain associated with peritendinitis does not change with this maneuver because of the relative immobility of the paratenon, whereas pain from inflammation within the tendon is exacerbated by the movement of the ankle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. Examination of ankle dorsiflexion should be performed with the knee both flexed and extended. Examination with the knee extended facilitates detection of a tight Achilles tendon (indicated by inability to dorsiflex past the neutral position), which suggests flexibility problems in the gastroc-soleus complex. The arches of the feet should be evaluated with the patient standing and the examiner behind the patient. Subtalar motion and transversal tarsal motion should be examined with the patient sitting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/23/14711?source=see_link\">",
"     \"Evaluation of foot and ankle pain in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tuberosity impingement, as occurs in Haglund deformity, is most painful at the superior-posterior border of the calcaneal tuberosity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44681?source=see_link&amp;anchor=H20#H20\">",
"     \"Plantar fasciitis and other causes of heel pain\", section on 'Haglund's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Enthesopathy is most painful to palpation at the insertion of the Achilles, which is at the superior aspect of the calcaneal tuberosity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lateral, weightbearing heel radiograph is the standard view for all patients with suspected Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. Such radiographs may be helpful in the diagnosis of insertional disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ], but they are of limited value in determining treatment for any of the soft tissue injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/57\">",
"     57",
"    </a>",
"    ] in the Achilles tendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/58\">",
"     58",
"    </a>",
"    ]. Ultrasonography and MRI are the imaging techniques that best demonstrate abnormalities within the Achilles tendon. Sonography plays a larger role in European countries, particularly in Scandinavia, whereas MRI appears to be the test of choice for most clinicians in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of Achilles tendinopathy depends upon the type of lesion and whether it is acute or chronic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"     53",
"    </a>",
"    ]. As a general rule, acute inflammatory conditions are treated conservatively, whereas chronic inflammatory conditions commonly require surgical intervention. Steroid injections of the tendon sheath or at the insertion of the Achilles tendon are",
"    <strong>",
"     not",
"    </strong>",
"    recommended because they have been associated with Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53,59\">",
"     53,59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A systematic review concluded that there is insufficient evidence from randomized controlled trials to identify a best method for treatment of acute or chronic Achilles tendinitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Peritendinitis",
"      </strong>",
"      &ndash; Pain relief and reducing inflammation are the goals in the treatment of acute peritendinitis. NSAIDs, ice, and ice massage are the initial modalities. A",
"      <span class=\"nowrap\">",
"       3/8-inch",
"      </span>",
"      heel lift prevents the tendon from stretching during the acute inflammatory phase. Corticosteroid injections should be avoided because of the danger of tendon rupture from intratendinous injection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/59\">",
"       59",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Once inflammation is reduced (which may take one to two weeks), rehabilitation is begun. Rehabilitation involves stretching the Achilles tendon, the hamstrings, and the calf muscles. Strengthening the lower extremity musculature also is important. Training regimens should be modified as necessary, with changes made in frequency, duration,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intensity. Biomechanical factors should be corrected if possible. Footwear should be modified as needed; heel wedges and functional orthoses may help [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/61\">",
"       61",
"      </a>",
"      ]. Such conservative treatment of peritendinitis and pantendinitis has a success rate of 90 to 95 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/62\">",
"       62",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      More aggressive intervention is indicated if symptoms fail to resolve with a minimum of 12 weeks of treatment. Some authors advocate the use of brisement, which is the mechanical lysis of adhesions using a local anesthetic injected into the peritendinous space followed by aggressive range-of-motion rehabilitation exercises [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/63\">",
"       63",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Operative treatment is often necessary for chronic peritendinitis and the results are usually good. In one retrospective review of 201 patients who underwent operative treatment after failure of two to three months of conservative management, good to excellent results, including early return to full activity, were reported in 97 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Pantendinitis",
"      </strong>",
"      &ndash; Acute pantendinitis is treated in the same manner as is acute peritendinitis (see above). As in peritendinitis, surgery is indicated for patients who fail to respond to 12 weeks of nonoperative management. Successful results (return to full activities at three or more weeks after surgery) have been reported in 78 to 100 percent of adult patients treated surgically for pantendinitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/63,65\">",
"       63,65",
"      </a>",
"      ]. Studies in healthy children are lacking.",
"     </li>",
"     <li>",
"      <strong>",
"       Insertional lesions",
"      </strong>",
"      &ndash; Pericalcaneal bursitis can be treated with a",
"      <span class=\"nowrap\">",
"       3/8-inch",
"      </span>",
"      heel lift, NSAIDs, and a heel wedge with a space cut out to relieve pressure on the posterior heel. Local steroid injections of the retrocalcaneal bursa can be used, with care given to avoid injection into the Achilles tendon. Surgical resection of the pericalcaneal bursa is occasionally needed.",
"     </li>",
"     <li>",
"      <strong>",
"       Tuberosity impingement",
"      </strong>",
"      &ndash; Tuberosity impingement is treated nonoperatively. Treatment consists of pressure relief over the prominent calcaneal tuberosity and avoidance of wearing shoes that have heel counters (the firm part of the shoe that surrounds the heel) that cause pain. NSAIDs may help with pain relief. Recalcitrant cases should be referred for surgical evaluation.",
"     </li>",
"     <li>",
"      <strong>",
"       Enthesopathy",
"      </strong>",
"      &ndash; Enthesopathy is treated by lifting the heel, which unloads the Achilles at its insertion. Immobilizing devices, such as boot braces or casting, may be necessary for a few weeks until the acute phase of the inflammation has subsided. NSAIDs are useful in the acute phase. Correcting structural abnormalities and adding orthotics may be of benefit when indicated (eg, pes planus, calcaneovalgus, or uncompensated forefoot varus). After the acute phase has resolved, aggressive stretching of the gastoc-soleus complex is beneficial. Adjusting training schedules as needed to reduce the chance of a relapse is helpful. Local steroid injections are",
"      <strong>",
"       not",
"      </strong>",
"      recommended because of the risk of tendon rupture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h2\">",
"     Achilles tendon rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of Achilles tendon rupture has increased significantly in the last 20 years, primarily because of the increase in physical activity in the older population. However, 25 percent of Achilles tendon ruptures are not related to sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/65\">",
"     65",
"    </a>",
"    ]. This injury rarely occurs in children.",
"   </p>",
"   <p>",
"    Achilles tendon rupture can occur during sports activity or in accidental trauma. Factors that predispose to Achilles tendon rupture include the use of local or systemic steroids, degeneration of the tendon caused by repetitive microtrauma, aging of the tendon, infectious diseases, and postinfectious changes. Spontaneous ruptures have been reported after organ transplantation. In addition, the tendon's mechanical properties are affected by temperature and acidity. Low temperature muscle fatigue in athletes (causing increased lactic acid and decreased pH) leads to decreased maximal load resistance of the Achilles tendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have Achilles tendon rupture may hear a loud popping sound at the time of the rupture. The sudden onset of severe pain in the region of the Achilles often causes patients to think they were hit at the site of the rupture. Patients may complain of ankle instability and weakness in the injured foot.",
"   </p>",
"   <p>",
"    Physical examination findings include a gap along the calf in the region of the rupture. The gap may be visibly concealed by a hematoma, but it is usually palpable. The patient has weakness with plantarflexion and inability to raise the heel of the affected foot. Plantarflexion may be preserved in patients with Achilles tendon if the plantaris muscle (another muscle that plantar flexes the ankle) is unaffected. Thus, the ability to plantarflex the affected foot does not exclude a diagnosis of Achilles tendon rupture. Patients with complete rupture of the Achilles tendon have a positive Thompson test: with the patient lying prone and the foot hanging off the table, the gastrocnemius is squeezed (",
"    <a class=\"graphic graphic_picture graphicRef74412 \" href=\"mobipreview.htm?36/62/37860\">",
"     picture 5",
"    </a>",
"    ). The test is positive if the maneuver does not cause plantarflexion of the foot.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Achilles tendon rupture can be made clinically if a gap is palpable along the calf in the region of the rupture. Ultrasonography can provide a definitive diagnosis in cases in which the gap is obscured by hematoma. Performance of ultrasonography in both dorsiflexion and plantarflexion increases the sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. MRI is helpful in planning surgery and in the identification of intratendon abnormalities, such as tears and tendinosis, and retrocalcaneal bursitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/69\">",
"     69",
"    </a>",
"    ], although the findings are not specific. MRI does not demonstrate abnormalities in the paratenon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for Achilles tendon rupture may be nonoperative (functional) or surgical.",
"   </p>",
"   <p>",
"    In nonoperative treatment, the patient wears an immobilization cast for one to three days until a modified boxer boot is available. This boot prevents dorsiflexion, reduces torsion of the Achilles tendon, and has a reducible heel pad to allow for a gradual adjustment from 20 degrees of plantarflexion to neutral position. Early weightbearing has been shown to have advantages in long-term strength and functional abilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/66\">",
"     66",
"    </a>",
"    ]. Ultrasonography is performed before the short-term cast or modified boxer boot is applied. Complete adaptation of the torn tendon ends when the foot is plantarflexed to 20 degrees must be demonstrated before weightbearing is permitted. Patients who are treated with the modified boxer boot require a very specific rehabilitation program.",
"   </p>",
"   <p>",
"    Nonoperative (functional) treatment of Achilles tendon rupture may be considered in select patients who understand the treatment protocol. Functional treatment is indicated for patients who have risk factors for developing surgical complications (eg, diabetics, transplant patients, and patients who are receiving systemic corticosteroids) and in nonathletes. In contrast, high-level athletes with complete rupture should be treated surgically.",
"   </p>",
"   <p>",
"    Surgical repair may be performed using either an open or a percutaneous technique. In open surgery, the anatomic defects are reconstructed; this procedure is usually performed in elite athletes. Two systematic reviews concluded that the incidence of rerupture was significantly reduced with surgical repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. However, the risk of infection was increased with surgical intervention, as compared with conservative, nonsurgical treatment. Wound infection risk may be reduced by performing surgery percutaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/70\">",
"     70",
"    </a>",
"    ]. Other risks of surgery include nerve damage and deep vein thrombosis.",
"   </p>",
"   <p>",
"    Surgical outcomes are best if performed within three weeks of a primary rupture to prevent atrophy of the medial gastrocnemius [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/66\">",
"     66",
"    </a>",
"    ]. Post operative use of a functional brace appears to reduce hospital stay, time off work and sports, and may lower the overall complication rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/70\">",
"     70",
"    </a>",
"    ]. Several studies suggest that early weightbearing and mobilization of the ankle may be beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53\">",
"    <span class=\"h2\">",
"     Os trigonum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The os trigonum is the persistence of the lateral ossification center on the posterior aspect of the talus after skeletal maturation. The groove for the flexor hallucis longus on the posterior aspect of the talus has an elongated lateral wall called Steida's process. Between the ages of 8 and 11 years, separate ossification centers appear and usually rapidly fuse with the medial and lateral tubercles of the groove. Persistence of the lateral ossification center occurs in approximately 13 percent of the population; it occurs bilaterally in 50 percent of patients. Acquired os trigonum can result from a fracture that fails to reunite (usually sustained in a hyperplantarflexion injury) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Os trigonum is seldom symptomatic; it is a normal structure and should not deter a career in dance or other athletic endeavor. The os trigonum syndrome results when the os trigonum causes posterolateral ankle pain. Os trigonum syndrome may be caused by a free accessory bone or a bone fused to the talus at Steida's process. Although the pathogenesis of pain is not known, the most accepted theory proposes that the os becomes impinged between the calcaneus and the posterior lip of the tibia during extreme plantarflexion. Os trigonum syndrome is considered part of the posterior impingement syndrome, which can involve the os trigonum, Steida's process, or the FHL tendon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with os trigonum syndrome describe pain in the posterior lateral aspect of the ankle; symptoms may be exacerbated when walking downhill. Tenderness is present at the posterolateral aspect of the ankle. Pain is accentuated by squatting, resisted plantarflexion, or dorsiflexion of the great toe because these maneuvers cause the flexor hallucis longus to push against the ossicle as the FHL passes over the talus. Plantarflexion of the foot with axial loading to the heel reproduces the symptoms. The plantarflexion sign is the key to diagnosis because it distinguishes posterior impingement from the other causes of posterior ankle pain (eg, Achilles tendinitis, bursitis, Haglund's deformity).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs (lateral ankle and lateral ankle in plantar flexion) can demonstrate the presence of the os or Steida's process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/20/31050/abstract/74\">",
"     74",
"    </a>",
"    ]. Bone scan is not necessary for diagnosis but can be helpful to evaluate the presence of fracture or cortical edema. Similarly, MRI is not necessary for diagnosis but can help to determine the presence of inflammation in the posterior capsule, FHL, bursa, or the os trigonum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H56\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modified activity and NSAIDs can provide symptomatic relief. Improvement of rearfoot strength and proprioception may prevent recurrence. If excision is indicated (eg, recalcitrant pain despite conservative management), the procedure usually includes excision of both the os trigonum and Steida's process, and adjacent release of the FHL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/14/17634?source=see_link\">",
"       \"Patient information: Achilles tendinopathy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17112575\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Foot and ankle pain in the young athlete can originate in the bones (fractures), ligaments (sprains), muscles and tendons (tendinitis), or fascia (fasciitis). Careful localization of the pain can help to narrow the differential diagnosis (",
"      <a class=\"graphic graphic_figure graphicRef63409 \" href=\"mobipreview.htm?0/44/711\">",
"       figure 2",
"      </a>",
"      ). History, physical examination, and, when indicated, plain radiographs are usually sufficient to make the correct diagnosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traumatic injuries to the talus include acute osteochondral fractures, chronic osteochondritis dissecans, and stress fractures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Talar pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lateral ankle pain in the young athlete typically indicates one of the following (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Lateral ankle pain'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inversion ankle sprain after injury to the anterior talofibular ligament (ATFL)",
"     </li>",
"     <li>",
"      Anterior lateral OCD (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Osteochondritis dissecans'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Sinus tarsi syndrome",
"     </li>",
"     <li>",
"      Peroneal tendon injuries",
"     </li>",
"     <li>",
"      Os peroneum",
"     </li>",
"     <li>",
"      Systemic diseases that affect the foot and ankle, such as gout, spondyloarthropathy, rheumatoid arthritis, and infection (see appropriate topic reviews)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medial ankle pain in the young athlete typically results from (see",
"      <a class=\"local\" href=\"#H24\">",
"       'Medial ankle pain'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Flexor hallucis longus tendinitis or tear",
"     </li>",
"     <li>",
"      Flexor digitorum longus tendinitis",
"     </li>",
"     <li>",
"      Os tibiale externum (accessory navicular bone)",
"     </li>",
"     <li>",
"      Tibialis posterior tendinitis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28775?source=see_link\">",
"       \"Clinical features and management of heel pain in the young athlete\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Tarsal tunnel syndrome",
"     </li>",
"     <li>",
"      Achilles tendinitis (see",
"      <a class=\"local\" href=\"#H44\">",
"       'Posterior ankle pain'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Posteromedial tarsal coalition (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23706?source=see_link\">",
"       \"Overview of the causes of limp in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Osteochondritis of the posteromedial talus (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Osteochondritis dissecans'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Posterior deltoid ligament sprain",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anterior ankle pain in the young athlete usually is caused by injury to the tibialis anterior tendon, typically manifested as tendinitis or injury to the tibiofibular ligaments and syndesmosis (&ldquo;high ankle sprain&rdquo;). Partial and complete rupture of the tendon and ligaments can also occur. In highly trained athletes, tarsal navicular stress fractures must also be considered. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Anterior ankle pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of posterior ankle pain in the young athlete includes (see",
"      <a class=\"local\" href=\"#H44\">",
"       'Posterior ankle pain'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Achilles tendon pathology (eg, tendinitis, rupture)",
"     </li>",
"     <li>",
"      Os trigonum syndrome (posterior impingement syndrome)",
"     </li>",
"     <li>",
"      Retrocalcaneal bursitis",
"     </li>",
"     <li>",
"      Pericalcaneal bursitis (which can involve the pre-Achilles bursa, the retrocalcaneal bursa, or both)",
"     </li>",
"     <li>",
"      Haglund deformity (a prominent enlarged bony posterior superior calcaneal tubercle)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/1\">",
"      Flick AB, Gould N. Osteochondritis dissecans of the talus (transchondral fractures of the talus): review of the literature and new surgical approach for medial dome lesions. Foot Ankle 1985; 5:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/2\">",
"      O'Conner, D. Sinus tarsi syndrome. A clinical entity. J Bone Joint Surg 1958; 40:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/3\">",
"      Oloff LM, Schulhofer SD, Bocko AP. Subtalar joint arthroscopy for sinus tarsi syndrome: a review of 29 cases. J Foot Ankle Surg 2001; 40:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/4\">",
"      Dozier TJ, Figueroa RT, Kalmar J. Sinus tarsi syndrome. J La State Med Soc 2001; 153:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/5\">",
"      Fallat L, Grimm DJ, Saracco JA. Sprained ankle syndrome: prevalence and analysis of 639 acute injuries. J Foot Ankle Surg 1998; 37:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/6\">",
"      Taillard W, Meyer JM, Garcia J, Blanc Y. The sinus tarsi syndrome. Int Orthop 1981; 5:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/7\">",
"      Kjaersgaard-Andersen P, Wethelund JO, Helmig P, S&oslash;balle K. The stabilizing effect of the ligamentous structures in the sinus and canalis tarsi on movements in the hindfoot. An experimental study. Am J Sports Med 1988; 16:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/8\">",
"      Shear MS, Baitch SP, Shear DB. Sinus tarsi syndrome: the importance of biomechanically-based evaluation and treatment. Arch Phys Med Rehabil 1993; 74:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/9\">",
"      Kuwada GT. Long-term retrospective analysis of the treatment of sinus tarsi syndrome. J Foot Ankle Surg 1994; 33:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/10\">",
"      DIGiovanni BF, Fraga CJ, Cohen BE, Shereff MJ. Associated injuries found in chronic lateral ankle instability. Foot Ankle Int 2000; 21:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/11\">",
"      Berlet, GC, Anderson, RB, Davis, WH. Chronic lateral lnkle lnstability. Foot Ankle Clin 1999; 4:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/12\">",
"      Eckert WR, Davis EA Jr. Acute rupture of the peroneal retinaculum. J Bone Joint Surg Am 1976; 58:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/13\">",
"      Geppert MJ, Sobel M, Bohne WH. Lateral ankle instability as a cause of superior peroneal retinacular laxity: an anatomic and biomechanical study of cadaveric feet. Foot Ankle 1993; 14:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/14\">",
"      Sobel M, Geppert MJ, Warren RF. Chronic ankle instability as a cause of peroneal tendon injury. Clin Orthop Relat Res 1993; :187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/15\">",
"      Clarke HD, Kitaoka HB, Ehman RL. Peroneal tendon injuries. Foot Ankle Int 1998; 19:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/16\">",
"      Sammarco, GJ, Mangone, PG. Peroneal and anterior tibial tendon injuries. Athletic injuries of the foot and ankle. Foot Ankle Clin 1999; 4:755.",
"     </a>",
"    </li>",
"    <li>",
"     Clanton TO, Schon LC. Athletic injuries to the soft tissues of the foot and ankle. In: Surgery of the Foot and Ankle, 6th, Mann RA, Coughlin MJ.  (Eds), Mosby-Year Book, St. Louis 1993. p.1167.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/18\">",
"      Arrowsmith SR, Fleming LL, Allman FL. Traumatic dislocations of the peroneal tendons. Am J Sports Med 1983; 11:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/19\">",
"      Safran MR, O'Malley D Jr, Fu FH. Peroneal tendon subluxation in athletes: new exam technique, case reports, and review. Med Sci Sports Exerc 1999; 31:S487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/20\">",
"      Church CC. Radiographic diagnosis of acute peroneal tendon dislocation. AJR Am J Roentgenol 1977; 129:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/21\">",
"      STOVER CN, BRYAN DR. Traumatic dislocation of the peroneal tendons. Am J Surg 1962; 103:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/22\">",
"      Sobel M, Pavlov H, Geppert MJ, et al. Painful os peroneum syndrome: a spectrum of conditions responsible for plantar lateral foot pain. Foot Ankle Int 1994; 15:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/23\">",
"      Hamilton WG, Geppert MJ, Thompson FM. Pain in the posterior aspect of the ankle in dancers. Differential diagnosis and operative treatment. J Bone Joint Surg Am 1996; 78:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/24\">",
"      Sammarco GJ, Cooper PS. Flexor hallucis longus tendon injury in dancers and nondancers. Foot Ankle Int 1998; 19:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/25\">",
"      Hamilton, WG, Chao, W. Posterior ankle pain in athletes and dancers: Athletic injuries of the foot and ankle. Foot Ankle Clin 1999; 3:74.",
"     </a>",
"    </li>",
"    <li>",
"     Lipscomb PR. Nonsuppurative tenosymovitis and paratendinitis. In: Instructional Course Lectures, 7, The American Academy of Orthopedic Surgens.  (Ed), JW Edwards, Ann Arbor 1950. p.254.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/27\">",
"      Cowell HR, Elener V, Lawhon SM. Bilateral tendonitis of the flexor hallucis longus in a ballet dancer. J Pediatr Orthop 1982; 2:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/28\">",
"      Oloff LM, Schulhofer SD. Flexor hallucis longus dysfunction. J Foot Ankle Surg 1998; 37:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/29\">",
"      Hedrick MR, McBryde AM. Posterior ankle impingement. Foot Ankle Int 1994; 15:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/30\">",
"      Hamilton WG. Stenosing tenosynovitis of the flexor hallucis longus tendon and posterior impingement upon the os trigonum in ballet dancers. Foot Ankle 1982; 3:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/31\">",
"      Bareither DJ, Muehleman CM, Feldman NJ. Os tibiale externum or sesamoid in the tendon of tibialis posterior. J Foot Ankle Surg 1995; 34:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/32\">",
"      Boden BP, Osbahr DC, Jimenez C. Low-risk stress fractures. Am J Sports Med 2001; 29:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/33\">",
"      Ariyoshi M, Nagata K, Kubo M, et al. MRI monitoring of tarsal navicular stress fracture healing--a case report. Kurume Med J 1998; 45:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/34\">",
"      Khan KM, Brukner PD, Kearney C, et al. Tarsal navicular stress fracture in athletes. Sports Med 1994; 17:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/35\">",
"      Kiss ZS, Khan KM, Fuller PJ. Stress fractures of the tarsal navicular bone: CT findings in 55 cases. AJR Am J Roentgenol 1993; 160:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/36\">",
"      Khan KM, Fuller PJ, Brukner PD, et al. Outcome of conservative and surgical management of navicular stress fracture in athletes. Eighty-six cases proven with computerized tomography. Am J Sports Med 1992; 20:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/37\">",
"      Burne SG, Mahoney CM, Forster BB, et al. Tarsal navicular stress injury: long-term outcome and clinicoradiological correlation using both computed tomography and magnetic resonance imaging. Am J Sports Med 2005; 33:1875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/38\">",
"      Cedell CA. Ankle lesions. Acta Orthop Scand 1975; 46:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/39\">",
"      Gerber JP, Williams GN, Scoville CR, et al. Persistent disability associated with ankle sprains: a prospective examination of an athletic population. Foot Ankle Int 1998; 19:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/40\">",
"      Boytim MJ, Fischer DA, Neumann L. Syndesmotic ankle sprains. Am J Sports Med 1991; 19:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/41\">",
"      Fritschy D. An unusual ankle injury in top skiers. Am J Sports Med 1989; 17:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/42\">",
"      Fites B, Kunes J, Madaleno J, et al. Latent syndesmosis injuries in athletes. Orthopedics 2006; 29:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/43\">",
"      Michelson JD, Waldman B. An axially loaded model of the ankle after pronation external rotation injury. Clin Orthop Relat Res 1996; :285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/44\">",
"      Boden SD, Labropoulos PA, McCowin P, et al. Mechanical considerations for the syndesmosis screw. A cadaver study. J Bone Joint Surg Am 1989; 71:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/45\">",
"      Ramsey PL, Hamilton W. Changes in tibiotalar area of contact caused by lateral talar shift. J Bone Joint Surg Am 1976; 58:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/46\">",
"      Nussbaum ED, Hosea TM, Sieler SD, et al. Prospective evaluation of syndesmotic ankle sprains without diastasis. Am J Sports Med 2001; 29:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/47\">",
"      Alonso A, Khoury L, Adams R. Clinical tests for ankle syndesmosis injury: reliability and prediction of return to function. J Orthop Sports Phys Ther 1998; 27:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/48\">",
"      Harper MC, Keller TS. A radiographic evaluation of the tibiofibular syndesmosis. Foot Ankle 1989; 10:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/49\">",
"      Hopkinson WJ, St Pierre P, Ryan JB, Wheeler JH. Syndesmosis sprains of the ankle. Foot Ankle 1990; 10:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/50\">",
"      Taylor DC, Englehardt DL, Bassett FH 3rd. Syndesmosis sprains of the ankle. The influence of heterotopic ossification. Am J Sports Med 1992; 20:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/51\">",
"      Beumer A, Valstar ER, Garling EH, et al. External rotation stress imaging in syndesmotic injuries of the ankle: comparison of lateral radiography and radiostereometry in a cadaveric model. Acta Orthop Scand 2003; 74:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/52\">",
"      Takao M, Ochi M, Oae K, et al. Diagnosis of a tear of the tibiofibular syndesmosis. The role of arthroscopy of the ankle. J Bone Joint Surg Br 2003; 85:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/53\">",
"      Marks, RM. Achilles' tendinopathy: Peritendinitis, pantendinitis, and insertional Disorders. Athletic Injuries of the Foot and Ankle. Foot Ankle Clin 1999; 4:789.",
"     </a>",
"    </li>",
"    <li>",
"     Comprehensive Textbook of Foot Surgery, 2nd, McGlamry ED.  (Ed), Williams &amp; Wilkins, Philadelphia 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/55\">",
"      Jacobs JC, Berdon WE, Johnston AD. HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr 1982; 100:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/56\">",
"      Gerster JC. Plantar fasciitis and Achilles tendinitis among 150 cases of seronegative spondarthritis. Rheumatol Rehabil 1980; 19:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/57\">",
"      Movin T, Kristoffersen-Wiberg M, Shalabi A, et al. Intratendinous alterations as imaged by ultrasound and contrast medium-enhanced magnetic resonance in chronic achillodynia. Foot Ankle Int 1998; 19:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/58\">",
"      Schepsis AA, Jones H, Haas AL. Achilles tendon disorders in athletes. Am J Sports Med 2002; 30:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/59\">",
"      Skovgaard D, Feldt-Rasmussen BF, Nimb L, et al. [Bilateral Achilles tendon rupture in individuals with renal transplantation]. Ugeskr Laeger 1996; 159:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/60\">",
"      McLauchlan GJ, Handoll HH. Interventions for treating acute and chronic Achilles tendinitis. Cochrane Database Syst Rev 2001; :CD000232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/61\">",
"      Mohr, RN. Achilles tendonitis &ndash; rationale for use and application of orthotics. Foot Ankle Clin 1997; 2:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/62\">",
"      Clancy WG. Runners' injuries. Part two. Evaluation and treatment of specific injuries. Am J Sports Med 1980; 8:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/63\">",
"      Johnston E, Scranton P Jr, Pfeffer GB. Chronic disorders of the Achilles tendon: results of conservative and surgical treatments. Foot Ankle Int 1997; 18:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/64\">",
"      Kvist H, Kvist M. The operative treatment of chronic calcaneal paratenonitis. J Bone Joint Surg Br 1980; 62:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/65\">",
"      Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in achillodynia. Foot Ankle Int 1997; 18:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/66\">",
"      Thermann, H. Treatment of Achilles' tendon ruptures. Athletic injuries of the foot and ankle. Foot Ankle Clin 1999; 4:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/67\">",
"      K&auml;lebo P, Allenmark C, Peterson L, Sw&auml;rd L. Diagnostic value of ultrasonography in partial ruptures of the Achilles tendon. Am J Sports Med 1992; 20:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/68\">",
"      Paavola M, Paakkala T, Kannus P, J&auml;rvinen M. Ultrasonography in the differential diagnosis of Achilles tendon injuries and related disorders. A comparison between pre-operative ultrasonography and surgical findings. Acta Radiol 1998; 39:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/69\">",
"      Beltran J, Noto AM, Herman LJ, Lubbers LM. Tendons: high-field-strength, surface coil MR imaging. Radiology 1987; 162:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/70\">",
"      Khan RJ, Fick D, Brammar TJ, et al. Interventions for treating acute Achilles tendon ruptures. Cochrane Database Syst Rev 2004; :CD003674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/71\">",
"      Bhandari M, Guyatt GH, Siddiqui F, et al. Treatment of acute Achilles tendon ruptures: a systematic overview and metaanalysis. Clin Orthop Relat Res 2002; :190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/72\">",
"      Maffulli N, Tallon C, Wong J, et al. Early weightbearing and ankle mobilization after open repair of acute midsubstance tears of the achilles tendon. Am J Sports Med 2003; 31:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/73\">",
"      Mortensen HM, Skov O, Jensen PE. Early motion of the ankle after operative treatment of a rupture of the Achilles tendon. A prospective, randomized clinical and radiographic study. J Bone Joint Surg Am 1999; 81:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/20/31050/abstract/74\">",
"      Omey ML, Micheli LJ. Foot and ankle problems in the young athlete. Med Sci Sports Exerc 1999; 31:S470.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6530 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-60.18.131.125-8F74BD76B3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31050=[""].join("\n");
var outline_f30_20_31050=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17112575\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TALAR PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Osteochondritis dissecans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Stress fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LATERAL ANKLE PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sinus tarsi syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Peroneal tendon injuries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Os peroneum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MEDIAL ANKLE PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Flexor hallucis longus injuries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Flexor digitorum longus tendinitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Os tibiale externum (Os navicularis syndrome)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      ANTERIOR ANKLE PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Tibialis anterior tendinitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Navicular stress fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7907923\">",
"      Syndesmotic sprain (high ankle sprain)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7907958\">",
"      - Anatomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7907930\">",
"      - Physical exam",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7907937\">",
"      - Diagnostic imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7907944\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      POSTERIOR ANKLE PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Achilles tendinitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      Achilles tendon rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H50\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H51\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H52\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H53\">",
"      Os trigonum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H54\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H55\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H56\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17112575\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6530\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6530|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?24/32/25102\" title=\"diagnostic image 1\">",
"      Ankle mortise widening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6530|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/8/140\" title=\"figure 1\">",
"      Actions of the ankle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/44/711\" title=\"figure 2\">",
"      Location foot ankle pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/28/32196\" title=\"figure 3\">",
"      Foreleg and foot muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/26/2464\" title=\"figure 4\">",
"      Posterior tibiofibular ligament and inferior transverse ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/2/28705\" title=\"figure 5\">",
"      Syndesmosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/57/35728\" title=\"figure 6\">",
"      Medial ankle ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/59/43953\" title=\"figure 7\">",
"      Ankle eversion stress test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6530|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/33/36375\" title=\"picture 1\">",
"      Bones of the foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/59/1970\" title=\"picture 2\">",
"      Anterior tibiofibular ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/15/23793\" title=\"picture 3\">",
"      Squeeze test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/42/21153\" title=\"picture 4\">",
"      External rotation ankle stress test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/62/37860\" title=\"picture 5\">",
"      Thompson squeeze test for Achilles tendon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6530|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/13/30939\" title=\"table 1\">",
"      Achilles tendon injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32537?source=related_link\">",
"      Achilles tendinopathy and tendon rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24345?source=related_link\">",
"      Ankle fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34296?source=related_link\">",
"      Ankle sprain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/41/23190?source=related_link\">",
"      Clinical features and management of foot pain in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/6/28775?source=related_link\">",
"      Clinical features and management of heel pain in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/37/13913?source=related_link\">",
"      Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/23/14711?source=related_link\">",
"      Evaluation of foot and ankle pain in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/60/28618?source=related_link\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19014?source=related_link\">",
"      Management of osteochondritis dissecans (OCD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23706?source=related_link\">",
"      Overview of the causes of limp in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/14/17634?source=related_link\">",
"      Patient information: Achilles tendinopathy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44681?source=related_link\">",
"      Plantar fasciitis and other causes of heel pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27270?source=related_link\">",
"      de Quervain's tenosynovitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_20_31051="Thyroid hormone preparations";
var content_f30_20_31051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of the thyroid hormone preparations available in the United States",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Generic name",
"      </td>",
"      <td class=\"subtitle1\">",
"       Composition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Brand names",
"      </td>",
"      <td class=\"subtitle1\">",
"       Average adult dose, mcg/day",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Levothyroxine*",
"      </td>",
"      <td>",
"       T4",
"      </td>",
"      <td>",
"       <p>",
"        Euthyrox&bull;",
"       </p>",
"       <p>",
"        Levothroid&bull;",
"       </p>",
"       <p>",
"        Levoxyl&bull;",
"       </p>",
"       <p>",
"        Synthroid&bull;",
"       </p>",
"       <p>",
"        Unithroid&bull;",
"       </p>",
"      </td>",
"      <td>",
"       150 (men), 112 (women)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liothyronine",
"      </td>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       Cytomel",
"      </td>",
"      <td>",
"       50",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liotrix",
"      </td>",
"      <td>",
"       4:1 mixture of T4 and T3",
"      </td>",
"      <td>",
"       Thyrolar",
"      </td>",
"      <td>",
"       T4 (75)/T3 (18.75)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thyroid USP",
"      </td>",
"      <td>",
"       <p>",
"        Dessicated thyroid extract",
"       </p>",
"       <p>",
"        Pork or beef",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Armour thyroid",
"       </p>",
"       <p>",
"        S-P-T",
"       </p>",
"       <p>",
"        Thyrar",
"       </p>",
"       <p>",
"        Thyroid strong",
"       </p>",
"      </td>",
"      <td>",
"       90 mg",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Best preparation",
"     <br>",
"      &bull; Available in tablet strengths from 25 to 300 mcg.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31051=[""].join("\n");
var outline_f30_20_31051=null;
var title_f30_20_31052="Morse Fall Scale";
var content_f30_20_31052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F77876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F77876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Morse Fall Scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Item",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         1. History of falling",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         2. Secondary diagnosis",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        3. Ambulatory aid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        None/bed rest /nurse assist",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Crutches/cane/walker",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Furniture",
"       </td>",
"       <td>",
"        30",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         4. Intravenous therapy/saline lock",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        5. Gait",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Normal/bed rest/wheelchair",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Weak",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Impaired",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        6. Mental status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Oriented to own ability",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Overestimates/forgets limitations",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        <strong>",
"         Total",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Janice Morse. Copyright &copy; 2011. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31052=[""].join("\n");
var outline_f30_20_31052=null;
var title_f30_20_31053="BAL fluid in former smokers";
var content_f30_20_31053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy former smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn;&nbsp;SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        62.3 &plusmn; 1.4",
"       </td>",
"       <td>",
"        42.6",
"       </td>",
"       <td>",
"        80.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        20.01 &plusmn; 1.5",
"       </td>",
"       <td>",
"        8.7",
"       </td>",
"       <td>",
"        44.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        13.9 &plusmn; 1.1",
"       </td>",
"       <td>",
"        5.2",
"       </td>",
"       <td>",
"        31.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        86.5 &plusmn; 1.4",
"       </td>",
"       <td>",
"        66.6",
"       </td>",
"       <td>",
"        97.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.9 &plusmn; 0.9",
"       </td>",
"       <td>",
"        4.0",
"       </td>",
"       <td>",
"        29.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.5 &plusmn; 1.2",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        29.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.69 &plusmn; 0.31",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        2.1 &plusmn; 0.5",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        8.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.27 &plusmn; 0.049",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.2 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.08 &plusmn; 0.035",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        74.23 &plusmn; 4.31",
"       </td>",
"       <td>",
"        15.8",
"       </td>",
"       <td>",
"        96.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        46.88 &plusmn; 3.69",
"       </td>",
"       <td>",
"        11.2",
"       </td>",
"       <td>",
"        77.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        20.65 &plusmn; 2.14",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        44.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        2.78 &plusmn; 0.32",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        6.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        3.46 &plusmn; 1.00",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        17.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        9.14 &plusmn; 0.82",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"       <td>",
"        17.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        7.63 &plusmn; 0.80",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"       <td>",
"        22.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.33 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        46.39 &plusmn; 3.82",
"       </td>",
"       <td>",
"        13.6",
"       </td>",
"       <td>",
"        84.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        97.69 &plusmn; 5.78",
"       </td>",
"       <td>",
"        43.4",
"       </td>",
"       <td>",
"        171.1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 50.",
"        <br>",
"         &loz; n = 26.",
"         <br>",
"          &sect; = 46.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31053=[""].join("\n");
var outline_f30_20_31053=null;
var title_f30_20_31054="Metabolism of cyclophosphamide";
var content_f30_20_31054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F70026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F70026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Pathways of cytochrome P450-catalyzed cyclophosphamide metabolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 492px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Takada, K, Arefayene, M, Desta, Z, et al. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum 2004; 50:2202. Copyright&copy; 2004 American College of Rheumatology. Permission from John Wiley &amp; Sons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31054=[""].join("\n");
var outline_f30_20_31054=null;
var title_f30_20_31055="Endoscopic component separation technique incision placement";
var content_f30_20_31055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F69854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F69854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Endoscopic component separation technique incision placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the placement sites for the two short incisions medial to the anterior iliac spine. This figure also includes the locations of the incisions for insertion of the trochars for the endoscopic approach to the component separation technique.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Lowe JB, Garza JR, Bowman JL, et al. Endoscopically assisted \"components separation\" for closure of abdominal wall defects. Plast Reconstr Surg 2000; 105:720.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_20_31055=[""].join("\n");
var outline_f30_20_31055=null;
